virus-host adaptation and co-evolution of … · de mixoma vírus (virulento) nas últimas cinco...
TRANSCRIPT
VIRUS-HOST ADAPTATION AND CO-EVOLUTION OF
MYXOMA VIRUS (MV) AND RABBIT HAEMORRHAGIC
DISEASE VIRUS (RHDV) IN THEIR NATURAL HOST, THE
WILD RABBIT (ORYCTOLAGUS CUNICULUS)
ALEXANDRA MÜLLER
Tese de doutoramento em Ciências Veterinárias
2010
2
3
ALEXANDRA MÜLLER
VIRUS-HOST ADAPTATION AND CO-EVOLUTION OF MYXOMA
VIRUS (MV) AND RABBIT HAEMORRHAGIC DISEASE VIRUS
(RHDV) IN THEIR NATURAL HOST, THE WILD RABBIT
(ORYCTOLAGUS CUNICULUS)
Tese de Candidatura ao grau de Doutor em Ciências Veterinárias submetida ao Instituto de Ciências Biomédicas de Abel Salazar da Universidade do Porto.
Orientador – Doutora Gertrude Averil Baker Thompson
Categoria – Professor Associado
Afiliação – Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto.
Co-orientador – Doutora Paula Cristina Gomes Ferreira Proença
Categoria – Professor Associado
Afiliação – Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto.
Co-orientador – Doutor Júlio Gil Vale Carvalheira
Categoria – Professor Associado
Afiliação – Instituto de Ciências Biomédicas Abel Salazar da Universidade do Porto.
4
5
Os resultados dos trabalhos experimentais incluídos na presente Tese fazem parte
dos seguintes artigos científicos e publicações:
Müller, A., J. Freitas, E. Silva, G. Le Gall-Reculé, F. Zwingelstein, J. Abrantes, P. J.
Esteves, P. C. Alves, W. van der Loo, Y. Kolodziejek, N. Nowotny & G. Thompson (2009).
Evolution of Rabbit haemorrhagic disease virus (RHDV) in wild rabbits (Oryctolagus
cuniculus) in the Iberian Peninsula. Veterinary Microbiology 135, 368-373
Müller, A. , E. Silva, J. Abrantes, P.J. Esteves, P.G. Ferreira, J.C. Carvalheira, N.
Nowotny & G. Thompson (2010). Partial sequencing of recent Portuguese myxoma virus
field isolates exhibits a high degree of genetic stability. Veterinary Microbiology, 140, 161-
166
Müller, A. & G. Thompson (2010). Evolution of RHDV in the Iberian Peninsula: A brief
review of recent findings. II Seminario Internacional sobre el Conejo Silvestre. Córdoba
28-30 Abril 2010 (in press)
6
7
ACKOWLEDGEMENTS
My sincere thanks go to all colleagues that accompanied me in these years for their contribution to
the present thesis, in particular to:
Professor Gertrude Thompson, for the encouragement to enrol in this postgraduate study and for
her excellent supervision and guidance through the overall progress of work, for stimulating
discussions, for the disposal of the Infectious Diseases Laboratory knowhow and facilities, for all
the numerous opportunities given within and without this project, which contributed to the
attainment of scientific maturity, and, importantly, also for all her continuous support, kind
understanding and friendship at all times.
Professor Paula Ferreira and Professor Júlio Carvalheira for their co-supervision and collaboration
during the development of this work, helpful discussions and for their continuous encouragement
and support. Professor Artur Águas for his co-supervision and constructive suggestions, especially
in the initial phases of the study.
All members of the Laboratory of Infectious Diseases, in particular: Eliane Silva and Sara Marques
for sharing their expertise, technical support, aid in troubleshooting, and for their overall friendship;
Jaime Freitas for his contribution to the work on RHD; Sónia Paupério, Isabel Santos, Teresa
Pena, Joana Correia, Maria João Vieira, Luís Pinho, Dr. Raquel Souto for their contribution to the
enriching laboratory environment. To all for the constructive lab meetings, discussions and the
good moments spent together.
The Institute for Biomedical Studies (ICBAS) and the Multidisciplinary Unit for Biomedical Research
(UMIB) of Porto University for infrastructural and financial support.
CIBIO for infrastructural support as well as for the permission to use valuable wild rabbit samples.
Professor Pedro Esteves for the opportunity to participate in the Project on RHD and Myxomatosis
(POCTI/BIA-BDE/61553/2004), him and Dr. Joana Abrantes for the interesting discussions and
collaboration throughout. A special thanks to Joana for providing “hot off the press” and “hard to
get” bibliography! Professor Paulo Célio Alves for interesting discussions and his persistent positive
reinforcement to take up a “wild rabbit subject”.
The Zoonoses and Emerging Infections Group and all members of the Clinical Virology of the
University of Veterinary Medicine, Vienna, in particular Professor Norbert Nowotny for the
acceptance and supervision of the work as well as for the kind hospitality and friendship. Dr.
Jolanta Kolodziejek, Helga Lussy and Hans Homola for sharing their experience and making my
stay at the Clinical Virology in Vienna productive, and above all, for their friendly welcome in the
group, making my stay highly enjoyable and enriching.
8
Professor Támas Bakonyi, guest researcher at the Clinical Virology, Vienna, for sharing his
experience on real time PCR.
Dr. Ghislaine le Gall-Recoulé, AFSSA Ploufragan, for the collaboration and constructive
discussions of the joint work on RHD.
Bioportugal, Lda., in particular Dr. Joaquim Teixeira, Dr. Sónia Martins and Dr. Carla Simões for
technical support in the use of the StepOne Real-time PCR.
The Laboratório de Investigação Veterinária (LNIV), Vairão, for infrastructural support, and in
particular Dr. Fátima Mota for her friendship.
The Foundation for Science and Technology (FCT) for the doctoral grant (SFRH/BD/31048/2006).
And finally, my parents, for their unconditional love and support, in particular for taking care of
Natália during my participation in scientific meetings and for their presence during the three month
research period in Vienna.
9
SUMÁRIO
A mixomatose e a doença hemorrágica viral (RHD) são doenças infecciosas que
emergiram em populações de coelho-bravo (Oryctolagus cuniculus) na década de 1950 e
1980, respectivamente. Nos primeiros anos após o seu aparecimento, foram observadas
elevadas taxas de mortalidade, mas em anos subsequentes, o impacto destas infecções
parecia ter diminuído. A hipótese postulada foi de que estes vírus foram co-evoluindo
com o seu hospedeiro, resultando na selecção de estirpes virais menos virulentas e de
hospedeiros mais resistentes. É neste contexto, que os presentes estudos foram
desenhados, visando contribuir para o conhecimento actual sobre a adaptação vírus-
hospedeiro e a co-evolução do vírus da mixomatose (MV) e do vírus da doença
hemorrágica viral (RHDV) ao seu hospedeiro natural, através da análise da variabilidade
genética (parcial) dos vírus. Para tal, um total de 4863bp (approximadamente 3% do
genoma) englobando 12 genes de nove estirpes de campo recentes de MV virulentos e
de uma estirpe vacinal viva atenuada (“MAV”, Alemanha) foram sequenciadas e
comparadas à estirpe virulenta originalmente introduzida “Lausanne” e ao seu derivado
de campo atenuado “6918”. As nossas estirpes de campo apresentaram um máximo de
três (estirpes C43, C95) e um mínimo de uma (estirpes CD01, CD05) substituições
nucleotídicas em comparação com “Lausanne”. Estas estavam distribuídas ao longo de
todas as regiões codificantes analisadas, excepto no gene M022L (maior proteína do
envelope), onde todas as estirpes eram idênticas a “Lausanne” e “6918”. Duas novas
inserções nucleotídicas simples foram observadas em algumas das estirpes de campo:
na região intergénica M014L/M015L e no gene M009L, onde levou a um frameshift. Estas
inserções foram localizadas após regiões homopoliméricas. A estirpe vacinal exibiu 37
substituições nucleotídicas localizadas predominantemente (95%) nos genes M022L e
M036L. As regiões M009L e M014L/M015L da vacina não foram amplificadas com
sucesso, sugerindo alterações genómicas maiores, que poderiam explicar o seu fenótipo
atenuado. Os nossos resultados demonstraram um elevado grau de estabilidade genética
de mixoma vírus (virulento) nas últimas cinco décadas. No âmbito do objectivo
supracitado, também analisámos o genoma de RHDVs obtidos entre 1994 e 2007 em
Portugal (40 amostras), Espanha (3 amostras) e França (4 amostras) de coelhos
selvagens que sucumbiram à doença. As análises filogenéticas baseadas em sequências
parciais do gene que codifica a VP60 (maior proteína estrutural do virus) permitiram um
agrupamento destes RHDVs em três grupos, denominados "Grupos Ibéricos".
Curiosamente, estas agruparam separadamente, embora não muito longe de RHDVs
mais antigas do genogrupo 1 (contendo, por exemplo, "AST89"), mas claramente
separadas de outras estirpes globais de RHDV. Este resultado deu origem à hipótese de
10
que o vírus evoluiu independentemente desde a sua introdução nas populações de
coelho-bravo na Península Ibérica, com os Pirenéus agindo como uma barreira natural ao
movimento de coelhos e, portanto, à dispersão do vírus. Não foram observadas
diferenças entre RHDV obtidas a partir de regiões geográficas onde a subespécie coelho
Oryctolagus cuniculus algirus prevalece comparadas com as obtidas a partir de
Oryctolagus cuniculus cuniculus. Os resultados deste trabalho foram recentemente
citados por publicação internacional, na qual foi revista a origem e a filodinâmica de
RHDV. A hipótese frequentemente citada sobre a coevolução vírus-hospedeiro de ambas
as doenças, mixomatose e RHD, foi revista à luz dos conhecimentos actuais. Para
ambas, parece ser necessário adquirir evidência adicional, que continue a apoiar esta
hipótese. Finalmente, no âmbito dos trabalhos desta tese, foram desenvolvidos testes de
PCR em tempo real para a detecção do RHDV e do vírus da syndrome da lebre parda
(EBHSV) e apresentados os resultados preliminares do seu desempenho. Ambos os
testes parecem identificar correctamente as amostras negativas, sugerindo uma alta
especificidade. No entanto, algumas amostras positivas não foram correctamente
identificadas, requerendo investigações adicionais e a optimização dos testes. Os
trabalhos apresentados nesta tese foram desenvolvidos no âmbito do projecto
“Investigação dos mecanismos que estão na base da resistência genética do coelho à
mixomatose e à doença hemorrágica viral”, financiado pela Fundação para a Ciência e
Tecnologia (FCT; POCTI/BIA-BDE/61553/2004) e do trabalho realizado no contexto de
uma bolsa de doutoramento (SFRH/BD/31048/2006) e assim como da Unidade
Multidisciplinar de Investigação Biomédica (UMIB).
11
SUMMARY
Myxomatosis and rabbit haemorrhagic disease (RHD) are highly infectious diseases that
emerged in wild European rabbit populations (Oryctolagus cuniculus) in the 1950s and
1980s, respectively. In the first years after their appearance, high mortality rates were
observed, but in subsequent years, the impact of these infections seemed to have
decreased. The hypothesis had been postulated that these viruses were co-evolving with
their hosts, leading to the selection of less virulent strains and more resistant hosts. It is
within this context, that the present studies were designed, aiming to contribute to the
current knowledge on virus-host adaptation and co-evolution of myxoma virus (MV) and
rabbit haemorrhagic disease virus (RHDV) in their natural host, by analysing the (partial)
genetic variability of field viruses. A total of 4863bp (approximately 3% of the genome)
spanning 12 genes of nine recent virulent myxoma field strains and a live attenuated
vaccine strain (“MAV”, Germany) were sequenced and compared to the originally
introduced virulent strain “Lausanne” and its attenuated field derivative strain “6918”. Our
field strains displayed a maximum of three (strains C43, C95) and a minimum of one
(strains CD01, CD05) nucleotide substitutions when compared to “Lausanne”. These were
distributed through all analysed coding regions, except gene M022L (major envelope
protein), where all strains were identical to “Lausanne” and “6918”. Two new single
nucleotide insertions were observed in some of the field strains: within the intergenic
region M014L/M015L and within gene M009L, where it lead to a frameshift. These
insertions were located after homopolymeric regions. The vaccine strain displayed 37
nucleotide substitutions, predominantly (95%) located in genes M022L and M036L.
Regions M009L and M014L/M015L of the vaccine were not amplified successfully,
suggesting major genomic changes that could account for its attenuated phenotype. Our
results support a high degree of genetic stability of (virulent) myxoma virus over the past
five decades. Within the above mentioned objective, we also analysed the genome of
RHDVs obtained between 1994 and 2007 in Portugal (40 samples), Spain (3 samples)
and France (4 samples) from wild rabbits that succumbed to the disease. Phylogenetic
analyses based on the partial gene sequences codifying the major structural protein VP60
allowed a grouping of these RHDVs into three groups, termed “Iberian Groups”.
Interestingly, these clustered separately, though not far from earlier RHDVs of Genogroup
1 (containing e.g. strain “AST89”), but clearly distinct from globally described RHDV
strains. This result gave rise to the hypothesis that the virus evolved independently since
its introduction to wild rabbit populations on the Iberian Peninsula, with the Pyrenees
acting as a natural barrier to rabbit and hence to virus dispersal. No differences were
observed in RHDV sequences obtained from geographic regions where the rabbit
12
subspecies Oryctolagus cuniculus algirus prevails compared with those obtained from
Oryctolagus cuniculus cuniculus. The results of this work was recently cited by
international publication, in which the origin and phylodynamics of RHDV analised. The
frequently cited hypothesis on virus-host coevolution for both diseases, myxomatosis and
RHD, was re-assessed in the light of current knowledge. For both, further evidence seems
necessary further support this hypothesis. Finally, within work carried out for this thesis,
Real-time PCR assays were developed for the detection of RHDV and European brown
hare syndrome virus (EBHSV), and the preliminary findings on the assays performance
are presented. Both assays seem to correctly identify negative samples, suggesting high
specificity. However, some positive samples were not correctly identified, warranting
further investigations and optimization of these assays. The studies presented in this
thesis were developed within the project "Investigation of the mechanisms that underlie
the genetic resistance to myxomatosis and rabbit hemorrhagic disease virus", funded by
the Foundation for Science and Technology (FCT; POCTI/BIA-BDE/61553/2004),
supported by a doctoral grant (SFRH/BD/31048/2006) and the Multidisciplinary Unit for
Biomedical Research (UMIB).
13
RESUMÉ
La myxomatose et la maladie hémorragique virale du lapin (RHD) sont des maladies
hautement infectieuses qui ont émergé dans les populations sauvages de lapin Européen
(Oryctolagus cuniculus) dans les années 1950 et 1980, respectivement. Dans les
premières années après son apparition, des taux de mortalité élevés ont été observés,
mais dans les années suivantes, l'incidence de ces infections semble avoir diminué.
L'hypothèse a été postulée que ces virus ont co-évolué avec son hôte, résultant en la
sélection de souches virales moins virulentes et d’hôtes plus résistants. C'est dans ce
contexte que les études actuelles ont été conçues en vue de contribuer aux
connaissances actuelles sur l'adaptation du virus-hôte et sur la co-évolution du virus de la
myxomatose (MV) et du virus de la maladie hémorragique (RHDV) chez son hôte naturel,
par l´analyse de la variabilité génétique (partielle) du virus. Pour ça, un total de 4863bp
(environ 3% du génome) englobant 12 gènes de neuf dernières souches virulentes de MV
et une souche de vaccin vivant atténué ("MAV", Allemagne) ont été séquencés et
comparés à la souche virulente "Lausanne" introduite à l'origine et son dérivé atténué du
champ "6918". Nos souches de terrain ont montré un maximum de trois (souches C43 et
C95) et un minimum de une (souche CD01et CD05) substitutions nucléotidiques par
rapport à "Lausanne". Elles ont été distribuées dans toutes les régions de codage
analysées, sauf dans le gène M022L (protéine majeure d'enveloppe), où toutes les
souches étaient identiques à "Lausanne" et "6918." Deux nouvelles insertions de
nucléotides simples ont été observées dans certaines des souches de terrain: au sein de
la région intergénique M014L/M015L et à l'intérieur du gène M009L, où elle conduit à un
décalage. Ces insertions sont situées après les régions homopolymériques. La souche
vaccinale affiche 37 substitutions nucléotidiques, situées principalement (95%) dans les
gènes M022L et M036L. Fait intéressant, les régions M009L et M014L/M015L du vaccin
n'ont pas été amplifiées avec succès, ce qui suggère des modifications majeures de la
génomique qui pourraient expliquer son phénotype atténué. Nos résultats démontrent un
degré élevé de stabilité génétique du virus de la myxomatose (virulent) au cours des cinq
dernières décennies. Dans le objective supra-citeé, nous avons aussi analysé le génome
de RHDVs obtenus, entre 1994 et 2007, au Portugal (40 échantillons), en Espagne (3
échantillons) et en France (4 échantillons), de lapins sauvages qui y avaient succombé de
la maladie. Les analyses phylogénétiques basées sur des séquences partielles du gène
que codifique la proteine estructurale VP60 a permis un regroupement de ces RHDVs en
trois groupes, appelés " Groupes Ibériques". Fait intéressant, ces derniers ont été
groupés séparément, bien que pas très loin de RHDVs du génogroupe 1 (contenant, par
exemple, "AST89), mais nettement séparés des autres souches de RHDV globale. Ce
14
résultat conduit à l'hypothèse que les virus ont évolué indépendamment depuis leur
introduction dans les populations de lapins sauvages sur la péninsule ibérique, avec les
Pyrénées agissant comme une barrière naturelle à la circulation des lapins et donc á la
propagation du virus. Aucune différence n'a été observée entre le RHDV obtenu à partir
de régions géographiques où la sous-espèce de lapin Oryctolagus cuniculus algirus
prévaut par rapport à ceux obtenus à partir de Oryctolagus cuniculus cuniculus. Les
résultats de notre travail ont été recement cités par publication internacionale sur l'origine
et la phylodymamique de RHDV. L'hypothèse fréquemment citée sur la coévolution virus-
hôte à la fois pour la myxomatose et RHD a été réévaluée à la lumière des connaissances
actuelles. Nous avons constaté qu´il est necessaire de continuer à acquérir des éléments
de preuve pour maintenir et continuer à soutenir cette hypothèse dans le cas des deux
maladies infectieuses. Finalement, dans les travails de cette thèse, ont été développés
tests de PCR en temps réel pour la détection de RHDV et du virus du syndrome du lièvre
brun européen (EBHSV) et les résultats préliminaires de la performance des tests sont
présentés. Les deux tests semblent identifier correctement les échantillons négatifs, ce
qui suggère une spécificité élevée. D'autre part, certains échantillons positifs n'ont pas été
correctement identifiés, justifiant de nouvelles investigations et l'optimisation de ces tests.
Le travail a été élaboré dans le cadre du projet "Étude des mécanismes qui sous-tendent
la résistance génétique à la myxomatose et la maladie hémorragique virale du lapin",
financé par la Fondation pour la Science et la Technologie (FCT; POCTI/BIA-
BDE/61553/2004) et financé par FCT grâce à une subvention de doctorat
(SFRH/BD/31048/2006) et grâce au travail de l'Unité Multidisciplinaire pour la Recherche
Biomédicale (UMIB).
15
CONTENTS
1. Introduction ...................................................................................................................... 21
1.1 The European wild rabbit (Oryctolagus cuniculus) ............................................................. 24
1.2 Virus-host interactions ............................................................................................................. 26
1.3 Aim and objectives ................................................................................................................... 28
2. Myxomatosis .................................................................................................................... 29
2.1 Literature review ....................................................................................................................... 31
2.1.1 History of the introduction ................................................................................................ 33
2.1.2 Clinical signs...................................................................................................................... 35
2.1.3 Aetiology and virus evolution .......................................................................................... 39
2.1.4 Pathogenesis and immunology ...................................................................................... 41
2.1.5 Immunomodulation ........................................................................................................... 43
2.1.6 Laboratory Diagnosis ....................................................................................................... 44
2.1.7 Epidemiology and control ................................................................................................ 45
2.1.8 Other areas of myxoma virus research ......................................................................... 48
2.2 Partial sequencing of recent Portuguese myxoma virus field isolates exhibits a high degree of genetic stability. ............................................................................................................ 49
3. Rabbit haemorrhagic disease (RHD)................................................................................ 63
3.1 Literature review ..................................................................................................................... 65
3.1.1 Introduction and brief history .......................................................................................... 67
3.1.2 Aetiology ............................................................................................................................ 68
3.1.3 Epidemiology ..................................................................................................................... 74
3.1.4 Clinico-pathological features ........................................................................................... 77
3.1.5 Laboratory diagnosis ........................................................................................................ 80
3.1.6 Control ................................................................................................................................ 82
3.2 Evolution of Rabbit haemorrhagic disease virus (RHDV) in wild rabbits (Oryctolagus cuniculus) in the Iberian Peninsula. ............................................................................................. 85
3.3 Evolution of RHDV in the Iberian Peninsula: A brief review of recent findings. ............. 97
3.4 Real-time PCR for the detection of rabbit haemorrhagic disease virus (RHDV) - Preliminary results ........................................................................................................................ 107
3.5 Real-time PCR for the detection of European brown hare syndrome virus (EBHSV) - Preliminary results ........................................................................................................................ 115
4. Discussion ..................................................................................................................... 125
4.1 Virus-host adaptation and co-evolution of myxoma virus in the European rabbit ........ 128
4.2 Virus-host adaptation and co-evolution of RHDV in the European rabbit ..................... 132
4.3 Development of real-time PCR assays for RHDV and EBHSV ...................................... 134
5. Conclusions and perspectives ....................................................................................... 137
6. References .................................................................................................................... 141
7. Appendices .................................................................................................................... 159
16
17
TABLES Table 1 Virulence grading of myxoma virus according to Fenner and Marshall (1957) .... 36
Table 2 Selected genes and primers used for the genetic characterisation of myxoma virus field strains. The nucleotide positions refer to myxoma virus strain “Lausanne” (GenBank accession no. AF170726) ......................................................................................... 54
Table 3 Observed nucleotide polymorphisms and deduced amino acid variations in recent myxoma virus field strains. The nucleotide and amino acid positions refer to myxoma virus strain “Lausanne” (GenBank accession no. AF170726) ......................................................... 56
Table 4 Genbank accession numbers of RHDV sequences included in the phylogenetic analysis ........................................................................................................................................... 90
Table 5 Cycle threshold (Ct) values obtained by the application of two different primer-probe pairs in a real-time PCR assay of positive samples as determined by conventional nested RT-PCR (Moss et al., 2002) ......................................................................................... 112
Table 6 Comparison of diagnostic tests for the detection of European brown hare syndrome virus (EBHSV) ........................................................................................................... 121
Table 7 Comparison of simple and nested PCR for the detection of European brown hare syndrome virus (EBHSV) in 10-fold dilutions of samples 684/04 and 685/04 ................... 122
18
19
FIGURES Figure 1 Monopartite, linear, single-stranded, positive-sense RNA genome of 7.3 to 8.3 kb. At 5’-terminus a virus protein (VPg)is covalently linked to genome, whereas 3’-terminus is polyadenylated (Source: ViralZone www.expasy.ch/viralzone, Swiss Institute of Bioinformatics). .......................................................................................................................... 69
Figure 2 Map of the Iberian Peninsula and South of France displaying the geographic origin of the RHDV samples analysed in this study and the time period they were collected. The distribution areas of the wild rabbit subspecies Oryctolagus cuniculus algirus and Oryctolagus cuniculus cuniculus as well as the contact zone across the Iberian Peninsula are indicated. ............................................................................................................... 88
Figure 3 RHDV strains from Portugal cluster separately from known genogroups based on phylogenetic analysis of partial VP60 gene sequences. The neighbour joining tree was rooted with RCV. Bootstrap probability values above 75% for 1000 replicate runs are indicated at the nodes. .................................................................................................................. 92
Figure 4 Alignment of EBHSV partial capsid gene sequences and primer-probe pairs selected for real-time PCR. The shown nucleotide positions correspond to positions 1332-1421 of the VP60 capsid gene and to positions 6563-6652 of the complete EBHSV genome (examples strain “GD”, Genbank accession numbers Z32526 and Z69629, respectively) ................................................................................................................................. 120
20
21
1. Introduction
22
23
“Novel infectious diseases can emerge either by a species-jump into a new host or by mutation of an existing
microorganism to a more virulent form. An example of each type of emerging disease has occurred in the
European rabbit (Oryctolagus cuniculus): myxomatosis, where the poxvirus myxoma virus jumped to O. cuniculus
from the tapeti (a lagomorph, Sylvilagus brasiliensis), in which it caused an innocuous cutaneous fibroma, and
rabbit haemorrhagic disease (RHD) where a pre-existing avirulent virus of European rabbits appears to have
mutated to the lethal rabbit haemorrhagic disease virus (RHDV) that has spread around the world since 1984.” In
(Kerr et al., 2009).
Myxomatosis and rabbit haemorrhagic disease (RHD) are highly infectious diseases
which have emerged in wild European rabbit populations (Oryctolagus cuniculus) within
the past six or seven decades. In the initial months and years after their appearance in
wild and also in domestic rabbits, high mortality rates were observed. In subsequent
years, the impact of these infections seemed to decrease, and the hypothesis was
postulated that these viruses were co-evolving with their hosts, leading to adaptation by
the selection of less virulent strains and more resistant hosts (Anderson and May, 1982;
Fenner and Ross, 1994; Kerr and Best, 1998; Villafuerte et al., 1995). Much research has
been carried out on this subject. In this thesis it will briefly be reviewed in the respective
chapters on each disease. Some evidence has been gathered that this may be true for
myxomatosis and to some extent for RHD, but knowledge on the genetic mechanisms
related to host and virus is still scarce, especially for “real-life” scenario, i.e. wild rabbit
populations (Best et al., 2000; Best and Kerr, 2000; Fouchet et al., 2009). This may be
related, in part, to the difficulty in obtaining samples and controlling population
parameters. Outbreaks in nature are typically suspected by the sudden disappearance of
wild rabbits. They commonly die in their warrens. Only in areas of high rabbit density,
rabbits may be found dead and eventually be sampled.
Similar to other European countries, myxomatosis and RHD have been introduced into the
Iberian Peninsula in the 1950s and early 1990s, respectively (Anonymous, 1989;
Monteiro, 1999; Muñoz, 1960; Villafuerte et al., 1995). Within a few years of their
introduction in wild rabbit populations, both diseases caused a severe decline in rabbit
abundance in the Iberian Peninsula to the extent that in Portugal the wild rabbit is
currently considered a “vulnerable” species, i.e. of high risk of being extinguished (ICNB,
2005) and even as “near threatened” by the World Conservation Union in 2008 (Smith and
Boyer, 2008). RHD is now considered endemic in Spain and Portugal, and despite many
efforts, rabbit numbers have not fully recovered (Delibes-Mateos et al., 2008b, 2009; Dias-
Pereira et al., 2004; Moreno et al., 2007; Muller et al., 2004; Santos et al., 2006;
Villafuerte et al., 1995; Ward, 2005). The impacts of decreasing wild rabbit populations in
Spain and Portugal are mainly twofold. On one hand, wild rabbit populations are
considered a keystone species in the Iberian Mediterranean ecosystems as they
represent the major food source of currently endangered specialist predators, such as the
24
Iberian lynx (Lynx paradina) and the Spanish imperial eagle (Aquila adalberti) (Delibes-
Mateos et al., 2008a; Moreno et al., 2004) and on the other hand, the decline of wild rabbit
numbers has a severe negative economic impact on the hunting industry (Angulo and
Villafuerte, 2004).
It is within this context, that a project denominated RIPAC, was developed in 2002-2004
by the Algarve´s Hunters Federation and the Regional Agricultural Directorate (RIPAC,
2004). The objectives were to determine the sanitary status and the main causes of death
of small game animals, especially the wild rabbit, in the Algarve Province, Portugal. A total
of 200 specimens were analysed by different elements of Porto University, including the
Laboratory of Infectious Diseases, ICBAS. The presence of myxoma virus and RHDV was
demonstrated in the wild rabbit subspecies Oryctolagus cuniculus algirus (Dias-Pereira et
al., 2004; Muller, 2004; Muller et al., 2004; RIPAC, 2004). However the genetic
characterisation of these and other virus strains from Portugal were subject of the present
thesis. The overall aim of the present study is to contribute to the current knowledge on
virus-host adaptation and co-evolution of MV and RHDV to their natural host, by studying
the heterogeneity of selected viral genes obtained from samples taken from wild rabbits at
different geographical locations in Portugal. Our studies formed part of a larger project
(POCTII/BIA-BDE/61553/2004), whose goal it was to study the role of natural selection on
the hypothetical increased genetic resistance of wild rabbit populations to myxomatosis
and RHD.
1.1 The European wild rabbit ( Oryctolagus cuniculus )
The European rabbit (Oryctolagus cuniculus) is a mammal that, together with the hare,
belongs to the family Leporidae of the Order Lagomorpha. The first fossil records of
lagomorphs have been attribited to the Early Paleogene, around 45 Ma (Lopez-Martinez,
2008). The first fossils of the Oryctolagus genus were dated to the Middle Pleiocene,
about 3.5 Ma, from Spain and probably southern France, and those attributed to modern
European rabbit species were dated to the Mid Pleistocene i.e. around 0.5 Ma (Lopez-
Martinez, 2008). Based on analyses of fossil records, the Iberian Peninsula is considered
the probable ancestral area of the European rabbit (Lopez-Martinez, 2008). The
evolutionary history has also extensively been studied using different molecular markers
such as mitochondrial DNA (Biju-Duval et al., 1991; Branco et al., 2000; Branco et al.,
2002), protein polymorphism and genetic diversity on the X and Y chromossomes
(Geraldes and Ferrand, 2006; Geraldes et al., 2006; Geraldes et al., 2005). Despite some
25
incongruences between these different techniques, results agree that two groups of the
European rabbit have been evolving in allopatry (i.e. in entirely separate ranges) during
the Pleistocene (Ferrand, 2008). These correspond to the subspecies Oryctolagus
cuniculus cuniculus and Oryctolagus cuniculus algirus (Ferrand, 2008). Geographically,
Oryctolagus cuniculus algirus are located in the southwest and Oryctolagus cuniculus
cuniculus in the northeast of the Iberian Peninsula. Both populations contact forming a
line of hybridization in the central region of the Iberian Peninsula (Branco et al., 2000;
Branco et al., 2002; Ferrand, 2008). From the Iberian Peninsula, and probably during the
Middle Ages, O .c. cuniculus spread or was taken by humans to many other parts of
continental Europe and domesticated, giving origin to different rabbit breeds (Ferrand and
Branco, 2007). The geographical distribution of Oryctolagus cuniculus algirus, however,
remains confined to the southwest of Spain and Portugal. Rabbits of either subspecies are
not readily distinguished phenotypically, whereby molecular testing techniques currently
also play an role as important conservation management tool (Esteves et al., 2006).
The European rabbit is small grey-brown mammal. It differs from the hare by smaller ears,
a shorter tail and the fact that newborns are blind and furless nestlings, fully dependent on
the doe. The body weight of adults ranges between 800 and 1300g (Paupério et al.,
2006). The habitat consists of a mixture of pasture and scrublands as important sources
of feed and shelter (Delibes-Mateos et al., 2008b). Also important is the consistence and
structure of the soil, as rabbits are burrowing animals, and burrows are an essential
element for social structure and reproduction (Delibes-Mateos et al., 2008b; Paupério et
al., 2006). Social structure is complex and groups are generally formed by a dominant
male and various female, juvenile and subordinate male animals. Social structure is
strongly influenced by the habitat. Abundant feed and shelter leads to less evident
hierarchy and higher reproductive indices as well as higher survival rates of juveniles. On
the contrary, fragmentated or less suitable habitats lead to higher competition between
individuals, more stringent social structures and in some cases to a discontinuous
distribution of rabbits. Rabbits living in smaller colonies that are isolated from other
colonies are also considered much more vulnerable to local extinction (Paupério et al.,
2006). Each group occupies a territory of generally less than 1 hectar and rabbits normally
graze within 500m of their burrows (Paupério et al., 2006). Only juveniles may disperse at
longer distances. The reproductive cycle of rabbits is strongly influenced by its habitat. In
mediterranean ecosystems, reproductive activities coincides with the availability of feed,
i.e. Autumn, Winter and Spring (Goncalves et al., 2002; Paupério et al., 2006). The mean
litter size is 4 kits per female, and each female may have 3 to 4 litters per year
(Goncalves et al., 2002; Paupério et al., 2006). Juveniles leave their warren at three
26
weeks of age and reach sexual maturity by 4 to 5 months. The population dynamics of
wild rabbits are influenced by various factors and display seasonal fluctuations. Mortality
rates are higher in juveniles that in adults. It has been estimated that up to 80% of rabbits
die before reaching adulthood. Rabbit densities also vary accordingly. Higher densities
are observed in Spring and early Summer, reflecting births. In Autumn, rabbit numbers
decline, related to scarcity in feed, but also other factors as hunting pressure and
infectious diseases such as myxomatosis and RHD (Paupério et al., 2006).
1.2 Virus-host interactions
Here, a more general approach is taken to elucidate virus-host interactions and to define
related terms. More specific findings related to myxomatosis and RHD will also be
reviewed in the respective disease chapters below. Viruses are small infectious agents
that require living cells for replications. An infection results if a virus is able to invade and
to replicate within a host. The outcome of infection frequently may vary, and thus not
always results in clinical disease. Disease may result when invasion and replication of the
agent and/or the host’s immune responses result in tissue damage and impair
physiological functioning. The mechanisms involved vary among different host-pathogen
scenarios (Mims et al., 1995). The term virulence is generally used to describe the ability
of any agent to cause damage and disease and may be measured, for example, by case
fatality rates or clinical scoring systems (Mims et al., 1995). Several virulence factors have
been described for infectious agents, such as, e.g. Mt-7 protein for myxomatosis
(Mossman et al., 1996). Host resistance is a term frequently used in the context of
infectious disease, particularly in the context of RHD and myxomatosis. As for other
infections, the following two situations need to be differentiated (Mims et al., 1995). On
one hand, host resistance can be defined as resistance to infection, meaning that, despite
exposure of a host to a particular virus, the virus is not able to infect the host. Typically,
these infection-resistant animals remain seronegative despite exposure. On the other
hand, it could be meaning resistance to disease, i.e. infection of the host does take place,
but does not result in clinical disease. The disease-resistant host remains healthy but
seroconversion occurs upon exposure. If specific antibodies are protective, this host may
then be considered resistant to re-infection. The term host resistance reflects the opposite
of host susceptibility. In analogy, susceptibility may mean susceptibility to either infection
or disease.
27
The factors determining host resistance to infection and/or clinical outcome are complex.
For example, the presence of specific viral receptors on host cells is considered essential
for viral attachment and entry, and thus a prerequisite for infection. In other words,
resistant individuals of a susceptible species may display altered receptor configuration
that do not allow virus attachment and thus infection does not occur. On the other hand,
the innate immune system may play a role in preventing infection. The innate immune
system includes anatomical barriers, secretory molecules as well as cellular components.
As it is non-specific for a particular agent, it is also frequently termed innate resistance. In
cases where successful infection occurs of a susceptible host, clinical outcome may vary
considerably. In many diseases, a proportion of susceptible hosts may remain healthy
(asymptomatic infection), whereas others may display mild or severe signs, and in a
proportion outcome may be fatal. Different factors may have been associated to outcome
of infection, such as body condition, concurrent disease, immunosupression, age, breed
etc. Most of these factors do affect the immune system and as such the ability to control
infection and modulate the development of disease. Both, innate and acquired immunity,
are genetically programmed, as is the expression of putative viral host cell receptors.
There is growing interest in genetically characterizing resistance to infection and disease.
Different approaches are being taken such as the genetic characterisation of individual
candidate genes up to the analysis of complete host genomes in an attempt to identify
genes related with susceptibility to infectious disease (Boon et al., 2009; Brotherstone et
al., 2010; Schnappinger and Ehrt, 2006; Tuite and Gros, 2006; Vidal et al., 2008).
Co-evolution of host and parasite (including viruses) does occur, when these complex
interactions take place over time, resulting in selective pressures over each. Generally
speaking, hosts may be under selection pressure to escape parasitism, whereas parasites
may be under selection pressure to evade host defences (Anderson and May, 1982).
Depending on each host-parasite scenario, the outcomes of host-parasite co-evolution
may be different. Some pathogens may evolve to be harmless to their hosts. Others, such
as myxoma virus, whose selection depends on transmissibility, may be expected to evolve
to intermediate or even higher values of virulence alongside increasing proportions of
resistant rabbits (Anderson and May, 1982; Ross and Sanders, 1977, 1984). In most
cases, infectious diseases may be important drivers in the survival and adaptation of
animal populations, and in the particular context of wildlife, they may also have a
considerable impact on population size and host genetic diversity (Altizer et al., 2003;
Daszak et al., 2000; O'Brien and Evermann, 1988; Smith et al., 2009).
28
The impact and the effects of myxomatosis and RHD in European wild rabbit populations
have been subject to many investigations (Boots et al., 2004; Delibes-Mateos et al.,
2008b; Forrester et al., 2003; Fouchet et al., 2009; Queney et al., 2000). There is field
evidence of viral attenuation as well as increasing genetic resistance in some rabbits, but
underlying genetic features are far from being fully understood. Some studies aiming to
identify host factors related to disease resistance have been published. These found
unique changes in the chemokine receptors CXCR4 and CCR5 of Oryctolagus compared
to other lagomorph members, suggesting that these may be major candidates related to
resistance to myxomatosis (Abrantes et al., 2010; Abrantes et al., 2008a; Carmo et al.,
2006). On the other hand, resistance to RHD has been linked to the presence of ABH
blood group antigens and the presence of non-functional alleles of fucosyltransferase
genes such as Fut2, determining a so-called “nonsecretor phenotype” possibly resistant to
RHD (Guillon et al., 2009; Ruvoen-Clouet et al., 2000). For both diseases, these
candidate host resistance factors require further studies using infectious virus under
controlled conditions.
1.3 Aim and objectives
The overall aim of the present study is to contribute to the current knowledge on virus-host
adaptation and co-evolution of MV and RHDV to their natural host, the wild rabbits.
Specific objectives were:
1- To genetically characterize viral strains of myxoma virus and rabbit haemorrhagic
disease virus obtained from wild rabbits from different geographical locations of Portugal.
2- To assess genetic variability of selected viral genes and to compare our findings with
those obtained for other European and international strains.
3- To correlate our findings with those obtained of the genetic variation of host cell
receptors in order to approach the question related to viral and/or host adaptation and co-
evolution.
4- To develop real-time PCR assays for the detection of RHDV and EBHSV.
This manuscript is outlined into the following sections. The next two chapters are
dedicated to each disease: myxomatosis and RHD. Within each, a general literature
review is presented, followed by the original research carried out. These are followed by a
general discussion, in which the role of recent findings for virus-host co-evolution of both
diseases will be addressed. Finally, conclusions and perspectives for future research are
presented.
29
2. Myxomatosis
30
31
2.1 Literature review
32
33
Before the introduction of MV into the European wild rabbit in Europe and in Australia,
interest in myxomatosis was mainly limited to some members of the scientific community
(E.g. Hobbs, 1928; Hurst, 1937). But ever since the outbreaks of myxomatosis among
European wild rabbits (Oryctolagus cuniculus) in Australia in 1950 and in Europe in 1952,
interest exploded, not only of the larger scientific community but also of the general public.
There are two major issues related with myxomatosis. First, it is the only example of the
use of an infectious agent as a biological control weapon to eradicate a vertebral animal
species considered a “pest”, especially in Australia where rabbits compete with
autochtonous flora and fauna and also cause major agricultural losses. And second, this
infection with a very lethal virus in a large population of highly susceptible mammals
provided opportunities to observe the course of virus-host interaction, i.e. provided a
model system to study the evolution of an infectious disease agent, and the effects of this
infectious disease on the evolution of a mammal (Anderson and May, 1982; Kerr and
Best, 1998).
Numerous studies were published in scientific journals (E.g. Fenner and Chapple, 1965;
Fenner and Marshall, 1957; Fenner et al., 1953; Ross and Sanders, 1977, 1984, 1987),
book chapters on Myxomatosis (E.g. Fenner, 1994) and even whole books on
Myxomatosis were written (E.g. Fenner and Ratcliffe, 1965). In view of these excellent
scientific publications and especially reviews, which are impossible to surpass, we here
aim to succinctly review key aspects of the disease and to complete these with recent
findings.
2.1.1 History of the introduction
Myxomatosis was recognized as a new disease in European rabbits in 1896 in Uruguay
(Sanarelli, 1898). Subsequently it caused sporadic lethal infections in domestic and
laboratory rabbits in Brasil and its etiological agent was shown to be a poxvirus in 1927 by
Dr. H. B. Aragão at the Oswaldo Cruz Institute in Brasil. In 1918, Dr. Aragão suggested
the use of myxomatosis as a means to control wild rabbit populations in Australia. The
strain that was eventually introduced in Australia was termed “Standard Laboratory Strain”
(SLS) or “Moses strain”, as it was recovered from a naturally infected laboratory rabbit in
Rio de Janeiro (Moses, 1911 cit. by Fenner and Ross, 1994). It had been maintained by
passage in laboratory rabbits for nearly 40 years before its use in field trials in the Murray
Valley, Australia, in 1950, which eventually lead to the spread of the infection over this
continent (Ratcliffe et al., 1952). The mortality in rabbit populations was enormous,
exceeding 99% case fatality-rate. Ever since and up to now, myxomatosis is endemic in
34
Australia, and epizootics occur periodically in association with local and seasonal vector
activity.
In 1952, Myxomatosis was introduced in France by Dr. P. F. Armand Delille, a
paediatrician who was concerned with the excessive numbers of wild rabbits at his private
estate at Maillebois. He obtained a strain of myxoma virus from a friend at the Laboratoire
de Bacteriologie, Lausanne, Switzerland. This introduced virus was termed “Lausanne
strain”, although it originated in Campinas, Brasil, in 1949 (Bouvier 1954, cit. by Fenner
and Ross, 1994). Dr Delille released two inoculated rabbits on June 14th on his land. By
the end of August 1952, virtually all rabbits on his estate were dead and further outbreaks
of myxomatosis were occurring in surrounding villages. By 1954 about 90% of wild rabbits
had been killed, and subsequently control measures, such as immunisations, were
implemented in an attempt to limit the spread of myxomatosis (Fenner and Ross, 1994).
In the following years, rabbit numbers recovered, with slight geographic variations,
probably also due to environmental factors, agricultural habits and hunting pressures
(Arthur et al., 1988 cit. by Fenner and Ross, 1994). The disease rapidly spread to other
European countries. Myxomatosis was deliberately introduced in 1953 in Kent by a
resident who had brought an infected rabbit from France (History reviewed by Bartrip,
2008). By 1955 the disease had spread over most of Britain, killing an estimated 99% of
rabbits (Hudson et al., 1955 and Brown et al., 1956 cit. by Fenner and Ross, 1994).
Despite large local fluctuations, rabbit numbers started to increase during the 1960s,
reaching 20% of the pre-myxomatosis population in 1979 (Lloyd, 1970 and Lloyd 1981 cit.
by Fenner and Ross, 1994) and about one third of the pre-myxomatosis population in the
1990s (Flowerdew et al., 1992). Case-mortality rates observed in the 1970s were between
47 and 69%, and as such much lower than during the 1950s and 1960s (Ross et al.,
1989). Still, myxomatosis is nowadays considered to be an important mortality factor,
contributing to the control of rabbit numbers, with autumn/winter peaks of disease
reducing the numbers of rabbits present at the start of the breeding season (Ross et al.,
1989). The first case of myxomatosis was reported in northern Spain in 1953 (Muñoz,
1960 cit. by Alda et al., 2009), probably appearing concomitantly in Portugal. Following
the initial outbreak, wild rabbit populations in the Iberian Peninsula were reduced by over
90% (Cabezas-Díaz et al., 2005). In Spain, rabbit population density appeared to increase
in the 1980s, but declined again due to the introduction of rabbit haemorrhagic disease
(Calvete et al., 1997; Villafuerte et al., 1995). As in other countries, myxomatosis is now
endemic in Spain and Portugal (Calvete et al., 2002a; Muller et al., 2004).
35
2.1.2 Clinical signs
The clinical signs of myxomatosis may vary considerably due to a variety of factors, such
as host species, virus-host adaptation and attenuation of viral virulence, vector-borne
transmission, ambient temperature, genetic resistant rabbits and immune status (Fenner
and Marshall, 1957).
In its natural hosts, the South American tapeti (Sylvilagus brasiliensis) and the North
American brush rabbit (Sylvilagus bachmani) MV only induces a benign cutaneous
fibroma at the site of inoculation, reflecting the long evolutionary association between the
virus and its host. On the contrary, in its evolutionary new host, the European rabbit
(Oryctolagus cuniculus), myxoma virus predominantly causes a highly lethal disease,
termed myxomatosis. To date, actually, two forms of disease are recognized in the
European rabbit: the more frequent systemic or nodular form (E.g. Silvers et al., 2006)
and the less frequent amyxomatous, atypical or respiratory form (Marlier et al., 1999;
Marlier et al., 2000b). Clinical signs of the nodular (classic) form include protuberant skin
lesions, blepharoconjuntivitis and oedematous swellings of the head and the genital
organs. The clinical signs and high mortality rates are believed to result from multiorgan
dysfunction coupled with uncontrolled secondary gram-negative bacterial infections due to
a progressive failure of the host’s cellular immune response. The clinical signs of the
amyxomatous or atypical myxomatosis are predominantly respiratory and mortality is not
a feature. Skin nodules may appear but usually are small and in reduced numbers. As this
milder clinical manifestation has mostly been reported in France and Belgium (Marlier et
al., 1999; Marlier et al., 2000b), a possible link between the use of the SG33 vaccine
strain and the occurrence of amyxomatous myxomatosis has been postulated (Brun et al.,
1981 cit. by Marlier et al., 1999). Atypical myxomatosis has been reported in the context of
vaccination the Czech Republik, but genetic analyses have shown differences between
the vaccine and the field strain (Psikal et al., 2003).
In between these two extreme clinical forms (classical and atypical), a whole plethora of
possible clinical outcomes has been described based on field observations and on
experimental inoculations (Fenner, 1994; Fenner and Marshall, 1957; Fenner and Ross,
1994; Kerr and Best, 1998). These have been linked to the process of virus-host
adaptation that occurred after the introduction of MV into European wild rabbits
populations. So within a few years of the release of MV in Australia and Europe, a
reduction in case-fatality rates and the occurrence of attenuated MV strains has been
recorded (Fenner and Chapple, 1965; Fenner and Marshall, 1957; Kerr and Best, 1998).
36
For example, in Australia, a highly attenuated field strain of myxoma virus, denominated
Uriarra-2-53/1 (Ur), was isolated in 1953, only 2 years after the release of SLS. It also
became apparent, that there could be a selection of genetically resistant rabbits in the
field, and as a result, studies were set up for monitoring the development of genetic
resistance and the virulence of MV field strains (Edmonds et al., 1975; Fenner and
Chapple, 1965; Fenner et al., 1953; Ross and Sanders, 1977, 1984, 1987; Sobey, 1969).
The numerous experimental inoculations carried out in this context were complex,
involving virus strains obtained at different geographical and temporal points and the
inoculation of so-called genetically unselected laboratory rabbits, and of so-called selected
rabbits, which were directly obtained from the field or bred from survivors in the field
(Reviewed in Fenner, 1994; Fenner and Ross, 1994; Kerr and Best, 1998). Based on the
observation of average survival time (AST) and mortality (%) of groups of inoculated
laboratory rabbits, field strains were grouped into five (I to V) virulence grades (Fenner
and Marshall, 1957), as shown in Table 1.
Virus (virulence) grade Average survival time (AST) Mortality (%) I < 13 days 100 II 13-16 days 95-99 III 17-28 days 70-95 IV 29-50 days 50-70 V Not relevant < 50
Table 1 Virulence grading of myxoma virus accordin g to Fenner and Marshall (1957)
This classification is considered the basis for detecting and monitoring the emergence of
attenuated viruses in the field. Some discrepancies were found in more recent studies.
For example, work in Australia has shown that viral virulence (lethality) did not always
correlate with mean survival times in rabbits taken from the different localities, suggesting
that the virulence of field strains may actually be higher than previously estimated (Parer,
1995; Parer et al., 1994). These results undermine previous studies that advocated an
increase in the proportion of attenuated virus strains in Australia, and as such questions
the concept of virus-host co-adaptation. Further interesting observations related to the
virulence grading of myxoma virus strains were made recently in a pathogenicity
assessment of 20 myxoma virus field strains obtained in the 1990s in Spain (Bárcena et
al., 2000). The horizontal transmission of these viruses to in-contact rabbits was as also
evaluated. This study found, that the average length of disease was significantly longer in
the group of rabbits infected by contact in comparison to those inoculated and suggested
that the stringent experimental condition could be responsible for the observed enhanced
37
severity of the disease in the subcutaneously inoculated animals. In this study, a high
inoculation dose of 104 plaque forming units was used instead of 5 rabbit-infectious doses
of the virus (rabbit ID50), and further, very young rabbits were used: 30 days-old instead of
at least 4 month-old. The authors concluded that the results of the contact-infected rabbits
would reflect more closely the real situation in the field than those of the inoculated
rabbits. Although mortality rates between both groups of animals were identical (except for
one strain), the AST of the contact-infected animals were higher than in the inoculated
animals. As such, most of the virus strains that were classed as virulence grade I and II
according to mean survival time in the inoculated animals, would actually be classified as
grade III viruses in the contact-infected animals. In another recent study involving the
virulence grading of two Californian MV, the observation was made for grade I and III
viruses, that survival of rabbits was not altered over a dose range of 5 to 105 rabbit ID50
although the AST was reduced by around 2 days at the highest dose (Silvers et al., 2006).
These recent experiments highlight the difficulty in standardizing experimental settings for
evaluating myxoma virus virulence.
The selection and emergence of attenuated virus strains has also been strongly linked to
the vector-borne mode of transmission of myxomatosis. Although the virus can also
spread via direct contact by the respiratory route, the most important mode of
transmission is by arthropod vectors. In Australia, mosquitoes such as Culex annulirostris
and Anopheles annulipes are considered important, whereas in Europe, fleas such as
Spilopsyllus cuniculi seem to be the principal vectors (Bull and Mules, 1944 and Lockley,
1954 cit. by Fenner and Ross, 1994). Both, mosquitoes and rabbit fleas act as mechanical
vectors. The virus adheres to their mouthparts, as they probe through infected skin.
Moderately attenuated viruses such as grade III or IV are more likely to be transmitted in
the field as they are present in the skin for longer periods of time. On the contrary, highly
virulent viruses are only present shortly before the rabbits death, and very attenuated
viruses, such as grade V strains, are only infectious during a very short period as virus
replication is rapidly controlled by the hosts immune response (Edmonds et al., 1975;
Fenner and Marshall, 1957; Fenner et al., 1956 cit by Kerr and Best, 1998).
Interestingly, ambient temperature also has a considerable effect on the severity of
disease. High temperatures favour milder clinical signs and cold climates favour severe
clinical manifestation, higher case-fatality rate and higher levels of viraemia (Marshall,
1959). This may be important in that, initially, rabbits in Australia may have survived
infection with moderately attenuated viruses during early stages of evolution of resistance,
and may have favoured the selection of resistant rabbits in hotter climates (Kerr and Best,
38
1998). The exact mechanisms underlying this phenomenon are not fully understood.
Further complicating is the fact that the assessment of virulence grades by survival rates
in colder indoor laboratory conditions may have led to an underestimation of host
resistance in the field. As such, viruses may favour higher recovery rates, i.e. have lower
mortality, in field sites with higher ambient temperatures than in colder laboratory
environment (Marshall and Douglas, 1961).
Last but not least, the severity of clinical signs induced by a given myxoma virus strain is
influenced by factors linked to the individual host, which in the literature has frequently
been termed “resistance” or “genetic resistance”. The emergence of resistant rabbits has
been studied in parallel with the monitoring of viral virulence in numerous field
observations and experimental inoculations (Fenner and Chapple, 1965; Marshall and
Douglas, 1961; Ross and Sanders, 1984; Williams et al., 1990). It may be exemplified by
a longitudinal study performed at Lake Urana in New South Wales, Australia (Kerr and
Best, 1998; Marshall and Douglas, 1961; Marshall and Fenner, 1958). Briefly, rabbit
kittens taken at different field sites were taken to a central laboratory and seronegative
animals were challenged at the age of 4 months or older with myxoma viruses of known
virulence. Interestingly, a decrease in mortality rates and in severity of clinical signs was
observed in rabbits trapped after 2 to 3 epidemics in comparison to those taken after
seven epidemics. It has been postulated that the interplay between virus and host would
eventually lead to the replacement of moderately virulent strains by more virulent strains
as the proportion of resistant rabbits increased, and this was postulated to have occurred
in the field (Anderson and May, 1982; Bárcena et al., 2000; Ross and Sanders, 1977).
Attention, though, must be paid to the limitation of the diagnostic test commonly used in
the 1950s and 1960s. Seronegativity was commonly assessed by the immunodiffusion
test. The use of this test in longitudinal studies revealed that specific antibodies against
the soluble antigen were inconsistently detected after infection, contrasting a persistent
humoral response as measured by neutralisation test or ELISA (Kerr, 1997; Williams et
al., 1973). In other words, the milder disease observed in challenge-inoculated “resistant”
rabbits was probably, at least partly, due to the presence of antibodies not detected by the
assay. The selection of resistant rabbits by mortality due to myxomatosis is expected to
cause a genetic population bottleneck, leading to a reduction in genetic variation, i.e. an
increase in genetic homogeneity of rabbits. A study on the genetic structure of European
wild rabbits has found high degree of genetic differentiation several sites in Great Britain
(Surridge et al., 1999). The authors conclude that the existence of such a myxomatosis
bottleneck is possible, and that the heterozygosity observed in present populations was
caused by the rapid population growth rate of rabbits. Importantly, the interpretation of this
39
study is difficult due to the inexistence of data from before the introduction of
myxomatosis.
2.1.3 Aetiology and virus evolution
Myxoma virus is a member of the genus Leporipoxvirus, subfamily Chordopoxvirinae,
family Poxviridae (ICTVdB, 2006). Other members of the Leporipoxvirus genus include
Shope fibroma virus (SFV), hare fibroma virus and squirrel fibroma virus. There are two
geographic types of myxoma virus, the South American or Brazilian myxoma virus that
circulates in the jungle rabbit or tapeti (Sylvilagus brasiliensis), and that is now endemic in
Europe and Australasia, and the so-called Californian myxoma virus (E.g. MSW and
MSD) that circulate in the brush rabbit (Sylvilagus bachmani) in the west coast of the
United States of America and the Baja peninsula of Mexico. The leporipoxvirus Shope
fibroma virus is genetically and antigenically closely related to myxoma virus (Cameron et
al., 1999; Willer et al., 1999). Its natural host is the eastern cottontail rabbit (Sylvilagus
floridanus) in North America. As this virus does not induce disseminated disease in the
European rabbit, it is widely used as immunizing agent (OIE, 2009a).
Like all poxviruses, MV has a classic brick shape replicates exclusively in the cytoplasma
of infected cells. Poxvirus particles consist of an envelope acquired by budding through
the host cell membrane, a surface membrane, a biconcave core that contains the genome
and two lateral bodies. During their life cycle, extracellular enveloped virions (EEV) and
intracellular mature virions (IMV) are produced, which contain different envelopes and are
infectious, but the infection is initiated by extracellular virions (ICTVdB, 2006). The
genome is not segmented and contains a single molecule of linear double-stranded DNA.
The central portion of approximately 120 kb of the genome encodes approximately 100
genes that are highly conserved genes among poxviruses and which encode mostly
structural and housekeeping proteins. On the terminally inverted repeats (TIR) and on the
near-terminal unique regions many immunomodulatory genes are located, which are
presumed to have evolved closely with the natural host. As they are involved in subverting
the hosts’ immune system, they may be related with inadequate host responses in the
new host, the European rabbit, eventually leading to disseminated fatal disease (Barrett et
al., 2001; Cameron et al., 1999; Kerr and McFadden, 2002; Stanford et al., 2007b;
Stanford et al., 2007c; Zuniga, 2003).
Genetic data on poxviral evolution and thus on myxoma virus evolution is scarce, mostly
due to the very large size of the viral genome. Currently the complete genome sequences
of only two strains, the virulent strain ‘‘Lausanne’’, introduced in 1952 in Europe and its
40
naturally attenuated field derivative ‘‘6918’’, obtained in 1995 in Spain are available
(Bárcena et al., 2000; Cameron et al., 1999; Morales et al., 2009). Partial sequence
information on other strains such as the Californian myxoma MSD and MSW (Jackson et
al., 1999; Labudovic et al., 2004) and two Greek isolates (Kritas et al., 2008) are also
available. Very recently, i.e. concomitantly with our work, partial sequence analysis of 97
field strains from 12 localities in Spain have shown an extremely low genetic variability of
myxoma virus (Alda et al., 2009). Altogether, current information is still scarce to allow
more accurate phylogenetic analyses and inferences about myxoma virus evolution in its
new host, the European rabbit. Additionally, horizontal gene transfer (HGT) occurs in
poxviruses including myxoma virus, potentially confounding phylogenetic inferences
based on one or few genes (Bratke and McLysaght, 2008; Gubser et al., 2004; Hughes
and Friedman, 2005; Kerr et al., 2010; Xing et al., 2006). Therefore whole-genome based
phylogenetic analyses may be considered more appropriate. Whole genome comparisons
between both myxoma virus strains as well as with shope fibroma virus have yielded
important findings. The complete genome sequencing of Lausanne has shown that it is
161773 nucleotides long and contains a total of 171 open reading frames (ORF) encoding
structural and non-structural proteins (Cameron et al., 1999). Twelve of the ORFs exist in
two copies, one at each end of the TIR of 11.5kb (Cameron et al., 1999). The genome
comparison of the virulent MV strain “Lausanne” and its attenuated field derivative “6918”
has identified a total of 73 differences consisting of 67 base substitutions, 4 deletions and
2 insertions (Morales et al., 2009). Importantly, four disrupted genes were identified as
putative determinants for the attenuation of 6918, by order of decreasing likelihood:
M135R, M148R, M009R and M036L. The comparison of virulent MV Lausanne and the
related apathogenic Shope fibroma virus has also shown significant differences. Eleven
genes are predominantly truncated or fragmented in Shope fibroma virus suggesting that
they may have possible roles in myxoma virus virulence (Cameron et al., 1999; Willer et
al., 1999). Variation at other loci is also present. The role of these genes for virulence is
difficult to assess (Cameron et al., 1999). Other techniques, based on the determination of
restriction fragment length polymorphisms (RFLPs) have been used for the
characterisation of myxoma virus field strains (Dalton et al., 2009; Kerr et al., 2010;
Russell and Robbins, 1989; Saint et al., 2001). This technique is sensible enough to
identify restriction patterns that could be linked to specific polymorphisms between strains.
Multiple genetic types of myxoma virus were found during epidemics, which apparently
were easily be replaced by others over time (Kerr et al., 2010). However, additional
studies are required to evaluate the suitability of mutations determined by this technique
for phylogenetic studies. No distinct correlation was found between RFLP typing and viral
virulence (Kerr et al., 2010). Antigenically, most strains seem to share epitopes. High
41
antigenic similarity between myxoma virus field strains have been shown by virus
neutralisation tests on the chorioallantoic membrane of developing chick embryos and by
immunodiffusion (Fenner and Marshall, 1957). But differences seem to exist, especially
between Australian field strains and the virulent strain Lausanne, as shown by challenge
experiments (Williams et al., 1973).
2.1.4 Pathogenesis and immunology
The pathogenesis of myxomatosis has been characterised in the past (Fenner and
Woodroofe, 1953 cit. by Best and Kerr, 2000) and also more recently by experimental
inoculations and comparative immunopathological studies (Best et al., 2000; Best and
Kerr, 2000). In the latter, the virulent strain SLS and its attenuated derivative Ur were
studied in genetically susceptible (laboratory) and in genetically resistant (wild) rabbits
(Best et al., 2000; Best and Kerr, 2000). Briefly, rabbits were inoculated intradermally with
100PFUs in the metatarseal region of the left hind foot. Both, laboratory and wild rabbits
inoculated with SLS developed clinical myxomatosis, however mortality was lower in the
latter. Ur infection was characterized by moderate to severe clinical signs and occasional
death in laboratory rabbits and few or no clinical signs in wild rabbits (Best and Kerr,
2000). At autopsy, several tissue samples were taken for virus titrations including the skin
of the inoculation site, skin of the equivalent site of the right hind foot (distal skin), the left
(draining lymph node) and right (contralateral) popliteal lymph nodes, blood, spleen and
lungs. There was little difference in titres of both viruses, SLS and Ur, in the skin at the
inoculation site of laboratory and wild rabbits. In the distal skin, however, virulent SLS was
present in laboratory and wild rabbits by day 4 post-inoculation (p.i.), whereas as Ur was
detected a few days later in laboratory rabbits and only in one of three inoculated wild
rabbits. In the draining lymph nodes, either SLS or Ur viruses were present by day 2 p.i. in
laboratory rabbits and by day 4 p.i. in wild rabbits. As a measure of dissemination, virus
presence was also determined in the contralateral lymph node, where it was found
approximately 2 days later than in the draining lymph node. Generally, SLS was slower to
reach this node in wild rabbits and titres remained 10-100 times lower than in laboratory
rabbits. Ur was detectable in low titres in wild rabbits only after day 15 p.i.. Neutralizing
antibody responses were detectable after day 6 p.i.. Antibody titres against virulent SLS
were higher and appeared earlier than those against Ur in both, laboratory and wild
rabbits. This work showed, that neither attenuation nor resistance were initially strongly
manifested in the skin at the inoculation site, but were more evident at the distal skin site,
and that the draining lymph node was a critical organ for amplification and dissemination
of the virus and thus for disease outcome.
42
Tissue samples of these experiments were further analysed for virus localization and
apoptosis by immunofluorescence and TUNEL reaction, respectively (Best et al., 2000).
Initial virus replication of both, SLS or Ur, in the skin was similar in resistant and
susceptible rabbits. Virus replication initiated in MHC-II positive dendritic-like cells in the
dermis, and subsequently spread to epidermal cells and lymphocytes of T cell zone of the
draining lymph node and from there to other lymphoid tissues, lungs, testis and secondary
skin sites. However, at the inoculation site an important difference in the inflammatory
response was observed. In susceptible laboratory rabbits infected with virulent SLS limited
inflammation was observed and polymorphonuclear cells, especially neutrophils,
predominated. In infections with attenuated Ur or in resistant wild rabbits an intense
cellular inflammatory response was observed with the predomination of mononuclear
cells. From the inoculation site, virus reached the draining lymph nodes within 24h in all
infections. In the lymph nodes, infection with either virus led to lymphocyte apoptosis, but
only infection with virulent SLS led to lymphocyte depletion and influx of
polymorphonuclears. In the attenuated Ur infections an influx and local proliferation of the
cells as part of an active immune response were observed, which compensated for this
loss. Dissemination of the virus from the skin and draining lymph node to distal sites
occurred in lower titres in infections with attenuated Ur or in resistant wild rabbits than in
virulent SLS infections, again, correlating with the presence of mononuclear as opposed
to polymorphonuclear cells. The authors suggested that effective constraint of virus
replication would be mediated by a type 1 cytokine response (IFN-γ, Il-12 etc) leading to
enhanced cellular immune responses, whereas a type 2 cytokine response (IL-4, IL-10
etc.), which favours humoral immune responses, predominated in disseminated
myxomatosis.
The immune responses to myxoma virus have been described in an excellent review of
Kerr and McFadden (2002). In animals that succumb to fatal nodular myxomatosis, a
severe immune dysfunction, accompanied by supervening Gram-negative bacterial
infections of the respiratory tract, is characteristic (OIE, 2009a). In animals that recover
from infection, progressive regression of signs and lesions are observed, and these
animals are generally considered resistant to subsequent disease, although
recrudescence and viral persistence in the testis has been described (Marlier et al.,
2000b). As described above, during the first encounter of a susceptible host with myxoma
virus, to date unknown factors will determine the type of innate and subsequent specific
immune responses and thus clinical outcome of infection. An effective cellular immune
response has been linked with recovery and protection. Although, to our knowledge, no
specific work has been carried out in measuring cell-mediated immunity to myxoma virus,
43
there is substantial evidence supporting this hypothesis (Best et al., 2000; Kerr et al.,
2004). The role of the humoral immune response is more difficult to evaluate. Infected
animals develop both, IgM and IgG antibodies. Rabbits that recover from myxomatosis
have antibodies basically for the rest of their lifes (Kerr, 1997). These antibodies do
neutralise the virus, but on their own may be insufficient to protect from death in virulent
infections, as similar titres were observed in survivors and animals that died from infection
(Best et al., 2000). In analogy, similar antibody titres are induced by attenuated and
inactivated vaccines, but only the former are able to provide protection. Maternally derived
antibodies play a role in providing protection to kittens, reducing clinical signs upon
infection and allowing active immunisation to take place, which will protect against
subsequent infections, especially in endemic situations with high host density and high
transmission rates (Fenner and Marshall, 1954; Fouchet et al., 2008). Crossprotection
between myxoma virus strains and as well as with the related Shope fibroma virus is
common (Fenner and Woodroofe, 1954; Gorski et al., 1994; Williams et al., 1973).
2.1.5 Immunomodulation
Poxviruses, and as such myxoma viruses, encode a large plethora of proteins which
interact with the hosts immune system. These immunomodulatory proteins may subvert
the immune responses, and thus affect pathogenesis and outcome of infection (E.g.
Cameron et al., 1999; Graham et al., 1992; Macen et al., 1996; Messud-Petit et al., 1998;
Upton et al., 1991; Upton et al., 1992). Most of these genes are located at the terminal
region of the genome (Cameron et al., 1999). They are less conserved among poxviruses
than the central region, in which most genes with housekeeping functions are located. The
sequence similarity between some of these immunomodulatory genes and the host cell
counterparts suggests that they have been acquainted from the vertebrate host reflecting
co-evolution (Johnston and McFadden, 2003). This would explain the relative apathogenic
expression of myxoma virus infection in its natural host, Sylvilagus spp.. On the contrary,
in its evolutionary recent host, the European rabbit, the expression of these gene products
could lead to a dysregulation of the elicited immune response. Thus, the acute systemic
and fatal disease observed in the European rabbit is partly mediated by
immunopathogenic and immunosuppressive mechanisms induced by the virus (Kerr and
McFadden, 2002; Kerr et al., 2010; Stanford et al., 2007b). The disease and ultimately
death is characterised by supervening bacterial infections (Kerr and McFadden, 2002).
Supporting the role of immunomodulation and -suppression in the pathogenesis of lethal
myxomatosis, is the observation that selective deletion of viral genes (“knock-out viruses”)
encoding immunomodulatory molecules produces attenuated disease in European
44
rabbits, although it should be remembered that knock-out viruses may not reflect the full
extent to which a gene product contributes to pathogenesis (Cameron et al., 1999;
Johnston and McFadden, 2004).
According to their function, the immunomodulatory proteins of poxviruses can be divided
into the following classes: a) Virostealth, in which visible signs of virus infection are
masked, for example by downregulation of MHC-I receptors by myxoma virus M135R
gene product; b) Virotransduction, by which innate antiviral mechanisms, such as
apoptosis, are inhibited, for example myxoma virus SERP-2; and c) Viromimicry, which
are viral proteins that mimic host cytokines or their receptors, virokines and viroceptors,
respectively, for example, myxoma virus M007L is a IFN-gamma receptor homologue
(Lalani et al., 1997). Many myxoma virus gene products have been studied and assigned
to these functional groups (Johnston and McFadden, 2003; Kerr and McFadden, 2002;
Stanford et al., 2007b; Stanford et al., 2007c; Zuniga, 2002, 2003).
2.1.6 Laboratory Diagnosis
Diagnosis of typical myxomatosis is generally based on clinical signs. However, in the
case of atypical or amyxomatous forms of the disease these are much less pronounced,
requiring the application of laboratory testing such as the isolation of the virus by
inoculation of sensitive cells and identification of the virus by immunological methods to
confirm infection (OIE, 2009a). In any cases, the agent can also be identified by
demonstration of nucleic acid by polymerase chain reaction. The demonstration of MV-
specific antibodies by serological tests allows the retrospective diagnosis and may be
used to determine the prevalence of infection in a population.
Virological methods allow the isolation and identification of the virus, the detection of viral
antigens or viral nucleic acid from skin or other organ material of clinically affected rabbits.
Virus can be readily isolated by cell culture using chick embryos, primary cultures of rabbit
kidney (RK) cells, or, more commonly using established cell lines, such as the RK-13 cell
line (ATCC CCL37). A cytopathic effect (CPE) usually develops after 24–48 hours, and
consists of the formation of syncytia, followed by rounding of the cells, pyknosis and
posterior detachment from the plastic support (OIE, 2009a, own observations).
Inoculation tests of rabbits also offer a means of identifying the virus and characterizing its
pathogenicity and tissue tropism, distinguishing nodular and oculo-respiratory tropisms
characteristic of the typical nodular and the atypical amyxomatous forms of the disease.
Virulence may be assessed by the type of inflammation in lesions (local or systemic
45
infection), the extent of lesions and survival time. Viral antigen can be detected by several
immunological methods such as the agar gel immunodiffusion test (OIE, 2009a) or indirect
fluorescent antibody tests applied to cell cultures (Gilbert et al., 1989). Negative-staining
electron microscopy can be applied to a sample of skin lesion (Catroxo et al., 2009). This
method, however, does not distinguish between myxoma virus and the related shope
fibroma virus (OIE, 2009a). The detection of MV-specific nucleic acids by molecular
techniques such as PCR has been described (Farsang et al., 2003), but has not been
validated for use as a diagnostic tool (OIE, 2009a).
Various serological tests have been described for the detection of a specific antibody
response (OIE, 2009a). In order of decreasing sensitivity the following may be used:
enzyme-linked immunosorbent assay (ELISA) (Gelfi et al., 1999; Kerr, 1997),
immunofluorescent antibody test based on infected fixed cell cultures, complement
fixation and agar-gel immunodiffusion. The latter can be used for the detection of both
antigen or antibody (OIE, 2009a). For epidemiological surveys, the IFA test and the
indirect ELISA can also be carried out using blood dried on blotting or filter paper: two
discs cut by paper punch are placed in each well of a 96-well plate and 100 µl PBS is
added to extract the serum. The serum dilution corresponds to about 1/30 and can be
used for testing (Gilbert et al., 1989). Antibodies develop within 8–13 days of infection,
may be detected for 6-8 months by CF and for at least 20 months by virus neutralization
and ELISA tests (Kerr, 1997; Marlier et al., 1999; OIE, 2009a).
2.1.7 Epidemiology and control
Myxoma virus spreads within rabbit populations by blood-feeding arthropod vectors, such
as fleas and mosquitoes, although limited transmission by close direct contact is possible.
Myxomatosis is currently endemic in most of Europe as well as in Australasia. Seasonal
epidemics do occur with some geographical variation, mostly depending on the availability
of vectors and a sufficient density of susceptible rabbits (Fenner and Ross, 1994; Kerr and
Best, 1998). Thus, in France and Britain, as well as on the Iberian Peninsula, epidemics
occur predominantly in late summer and autumn, but local variations may alter
epidemiological patterns, with peaks occuring in spring (Calvete et al., 2002a; Fenner and
Ross, 1994; Ferreira et al., 2009).
Control of myxomatosis is based on two main pillars: vector control and immunisation.
Vectors may be controlled physically by hygiene and nets or medically by using
ectoparasiticides such as ivermectin or selamectin, though withdrawal periods of the latter
46
need to be taken into account in meat-production. Currently, two types of vaccines, both
live modified, are available. Heterologous vaccines consist of the related Shope fibroma
virus, which is relatively apathogenic for the European rabbit, but induces good cross-
protection to myxomatosis (Fenner and Woodroofe, 1954), and homologous vaccines,
which contain attenuated strains of myxoma virus. The composition of homologous
vaccines may vary among countries and vaccine companies (Arguëllo, 1986; McKercher
and Saito, 1964). An example is the live modified strain SG33 (Saurat et al., 1978). SG33
has been attenuated by successive cell-culture passages and displays a deletion of
approximately 13kb in the Serp2 gene (Petit et al., 1996). Recently a M063-gene deleted
mutant was constructed from the attenuated Uriarra strain and tested for use as a non-
transmissible vaccine against myxomatosis (Adams et al., 2008). This vaccine would be of
interest in Australia for protecting captive and production rabbits against myxomatosis, as
other commercially available vaccine are attenuated and as such bear some risk of
spreading and inadvertently immunising wild rabbits.
Vaccines may be applied subcutaneously or intradermally, the latter commonly with a
device that applies the pressurised vaccine into the skin (E.g. Dermojet®). Recommended
vaccination schemes in commercial rabbitries include vaccinating breeding rabbits at 2.5
months of age, re-vaccinating every 6 months and to vaccinate fattening rabbits once at
the age of 30 days thus reducing interference with maternal antibodies. Generally, these
vaccines are well tolerated, but some side effects due to residual virulence may occur
especially in immunocompromised animals. The signs may include transitory palpebral
oedema and respiratory signs. These post-vaccinal reactions may be avoided if the
animals are first vaccinated with the heterologous vaccine and boosted with a
homologous vaccine 6 to 8 weeks later. To increase efficacy of the vaccines, animals
should preferentially be vaccinated in spring and autumn, when susceptibility to the
vaccine virus is better than in the hotter summer months. Generally, efficacy of these
vaccines is considered good in preventing major losses in the rabbit industry, due to
classical (virulent) myxomatosis as well as to the atypical (respiratory) form of the disease
(Marlier et al., 2000a), although vaccine failures may sporadically occur (Kritas et al.,
2008; Psikal et al., 2003).
Control of myxomatosis in free-ranging wild rabbit populations is more difficult, as the
application of medication or commercially available vaccines requires the individual
handling of animals. Nevertheless, vaccination is currently considered an important
additional tool in the management of wild rabbit populations (Ferreira et al., 2009; Garcia-
Bocanegra et al., 2010; Guitton et al., 2008), despite some evidence of a negative impact
47
caused by handling and vaccination, especially in young and subadult animals with poor
body condition (Calvete et al., 2004b). To achieve higher cost-benefit efficacy and to
decrease potential adverse effects related to the handling of individual animals, as well as
to increase vaccine coverage in the population, horizontal spread by contact and/or oral
administration by baits would be desirable. The success of oral vaccination of wildlife
species has already been shown for other diseases, such as the rabies vaccination of wild
foxes in Europe (Brochier et al., 1996), but may be difficult to achieve for myxomatosis. A
live attenuated myxoma virus vaccine capaple of horizontal spread has been developed
(see below).
Poxviruses, such as vaccinia viruses are already used as viral vectors for the construction
of recombinant vaccines (Giavedoni et al., 1991; Paoletti, 1996). The use of myxoma virus
as vector is interesting, in that it would also confer protection against the vector-induced
disease, myxomatosis. To date, three recombinant myxoma-based vaccines have been
described, in which immunogenic gene sequences from different viruses have been
inserted: one with influenza virus genes (Kerr and Jackson, 1995) and two with RHDV
(Barcena et al., 2000a; Bárcena et al., 2000; Bertagnoli et al., 1996a). Both recombinant
myxomatosis-RHD vaccines use the same gene encoding the major envelope protein
VP60 of RHDV to protect against this disease, but they differ in their myxoma virus
backbone strain. One of the vaccines uses the attenuated strain SG33 (Bertagnoli et al.,
1996a), whereas the other uses the avirulent MV field strain “6918” (Barcena et al.,
2000a; Bárcena et al., 2000). The latter strain has been tested and found suitable for
immunisation of rabbits against virulent MV strains by the subcutaneous and also the oral
routes of administration, and it retained its horizontal transmission potential even after
being passaged in cell culture. The resultant vaccine was found suitable for use in free-
ranging wild rabbits because it was found safe, i.e. did not retain residual virulence, and
efficacious, i.e. conferred protection against both diseases, and extremely practical as it
could be administered orally and could immunize in contact animals (Torres et al., 2000b;
Torres et al., 2001).
Although there is growing interest, in particular by conservationists and hunting
associations of Southern Europe, to apply this vaccine in the field, the use of it has not yet
been authorised by the European Union. Concern has been expressed on the use of
genetically modified live rabbit viruses in the field, especially as research for the
management of wild rabbits in Europe and Australia has opposing goals (Angulo and
Cooke, 2002). In other words, in Europe, a transmissible recombinant myxoma virus has
been produced to protect against myxomatosis and RHD (Bárcena et al., 2000) and in
48
Australia a transmissible recombinant myxoma virus has been produced to reduce rabbit
fertility (Gu et al., 2004; Hardy et al., 2006; van Leeuwen and Kerr, 2007). As easily
illustrated by history, myxomatosis and RHD viruses do not respect boundaries and
transboundary spread may occur. The inadvertent introduction of an immunizing myxoma
virus in Australia and a virus with immunocontraceptive properties in Europe would be
disastrous (Angulo and Cooke, 2002). Additionally, the potential interaction of field viruses
and genetically modified myxoma virus has not been assessed, as the field trial of the
transmissible recombinant myxoma vaccine, has been realised in a naïve wild rabbit
population (Torres et al., 2001).
2.1.8 Other areas of myxoma virus research
There are research lines exploring the use of myxoma virus for other purposes than those
related with the biology of myxomatosis in its host, for example as viral vector for
vaccines, or as therapeutic agents to treat cancer or inflammatory diseases. Due to their
large genome size, poxviruses lend themselves as attractive candidates for the
development of recombinant vaccines. For example, recombinant vaccines based on
canarypox viruses have been developed for diseases of veterinary importance and are
being commercially available, such as feline leukaemia vaccines. Myxoma virus has
proven safe and adequate in terms of immunogenicity, and thus represents a promising
new candidate as vector for a variety of agents. The potential of myxoma virus as vaccine
vector in non-leporid species has been explored recently for cats and small ruminants
(McCabe et al., 2002; Pignolet et al., 2008). Myxoma virus exhibits tropism for many
human tumour cells, making it an interesting candidate for oncolytic virotherapy (Lun et
al., 2005; Sypula et al., 2004; Wu et al., 2008). The tropism of myxoma virus for cancer
cells has been linked to the virus ability to activate the enzyme “Akt” by the viral protein M-
T5 (Sypula et al., 2004; Wang et al., 2006). More recent studies also focus on the
synergistic effect of immunosupressant drugs, such as rapamycin, and myxoma virus on
tumour regression (Lun et al., 2010; Stanford et al., 2007a). Similar to other viral proteins,
myxoma virus proteins are interesting candidates as novel anti-inflammatory reagents
(Reviewed in (Lucas and McFadden, 2004)). As discussed above, upon infection, some of
the myxoma virus proteins display a modulatory effect on the host’s immune system,
potentially subverting the immune response. This characteristic can be – and is starting to
be – explored for the development of new anti-inflammatory therapeutics. Some promising
results have already be obtained by testing the effect of viral proteins using animal models
(Lucas and McFadden, 2004).
49
2.2 Partial sequencing of recent Portuguese myxoma virus field isolates exhibits a high degree of genetic stabilit y.
Adapted from: Veterinary Microbiology (2010) 140, 161-166
A. Mullera,b*, E. Silvaa,b, J. Abrantesc,d,h , P. J. Estevesc,e , P. G. Ferreiraf , J. C. Carvalheiraa,c , N. Nowotnyg and G. Thompsona,b
a) Department of Veterinary Clinics, Institute of Biomedical Science Abel Salazar (ICBAS), University of Porto, P-4099-003 Porto, Portugal
b) Multidisciplinary Unit of Biomedical Investigation (UMIB), University of Porto, P-4099-003 Porto, Portugal
c) Centre of Investigation for Biodiversity and Genetic Resources (CIBIO), University of Porto, P-4485-661 Vairão, Portugal
d) Department of Zoology and Anthropology, Faculty of Sciences, University of Porto, P-4150-150 Porto, Portugal
e) Centro de Investigação em Tecnologias da Saúde (CITS), CESPU, Portugal f) Department of Anatomy, Institute of Biomedical Science Abel Salazar (ICBAS), University
of Porto, P-4099-003 Porto, Portugal g) Zoonoses and Emerging Infections Group, Clinical Virology, Department of Pathobiology,
University of Veterinary Medicine, Vienna, A-1210 Vienna, Austria h) INSERM, U892, Nantes, France; Université de Nantes, France
*Corresponding author: Phone: +351-252-660410, Fax: +351-252-661780. E-mail address: [email protected]. Postal address: ICAV–UP, Rua Padre Armando Quintas, 4485-661 Vairão, Portugal Keywords : Myxoma virus, field strains, sequence analysis, co-evolution, European rabbit
50
51
Summary
To study genetic changes underlying myxoma virus evolution in its new host, the
European rabbit (Oryctolagus cuniculus), we sequenced selected genomic regions of nine
recent virulent field strains and a live attenuated vaccine strain (“MAV”, Germany). DNA
was extracted from cell culture passaged myxoma virus. A total of 4863bp (approximately
3% of the genome) of ten regions spanning 12 genes of the myxoma viruses was
sequenced and compared to the original virulent strain “Lausanne” and its attenuated field
derivative strain “6918”. The field strains displayed a maximum of three (strains C43, C95)
and a minimum of one (strains CD01, CD05) nucleotide substitutions. These were
distributed through all analysed coding regions, except gene M022L (major envelope
protein), where all strains were identical to “Lausanne” and “6918”. Two new single
nucleotide insertions were observed in some of the field strains: within the intergenic
region M014L/M015L and within gene M009L, where it leads to a frameshift. These
insertions were located after homopolymeric regions. The vaccine strain displayed 37
nucleotide substitution, predominantly (95%) located in genes M022L and M036L.
Interestingly, regions M009L and M014L/M015L of the vaccine were not amplified
successfully, suggesting major genomic changes that could account for its attenuated
phenotype. Our results support a high degree of genetic stability of myxoma virus over the
past five decades. None of the analysed genome regions by its own seems sufficient for
the genetic characterisation of field strains.
52
Introduction
Myxoma virus (MV) is a large double stranded-DNA virus of the genus Leporipoxvirus. In
its natural hosts (Sylvilagus brasiliensis and Sylvilagus bachmani) it causes benign
cutaneous fibromas. However, its introduction in the 1950s into a new host, the European
rabbit (Oryctolagus cuniculus), resulted in devastating epizootics with mortality rates
above 99%. Interestingly, within a few years of the introduction of the virus into naïve
European wild rabbit populations in Australia and Europe, a decrease from the initial
nearly 100% mortality rates were observed. This process has been related to virus-host
adaptation consisting of the evolution of attenuated viral strains and the natural selection
of resistant rabbits (reviewed by Fenner & Ross, 1994). Extensive knowledge has been
gained on subjects related to this co-evolution, such as the determination of virulence
grades of circulating myxoma viruses (e.g.: Bárcena et al., 2000; Fenner & Ross, 1994;
Marlier et al., 1999), the pathogenesis of myxoma virus infection of different clinical
outcomes (Best & Kerr, 2000; Best et al., 2000), the rabbits’ immune response (reviewed
by Fenner & Ross, 1994), and the characterisation of virally encoded proteins able to
modulate the host’s immune response and thus clinical outcome of infection (e.g.
Johnston & McFadden, 1994; Stanford et al., 2007; Willer et al., 1999; Zúñiga, 2002).
Contrasting little is known about the genetic changes related to the evolution of myxoma
virus in its new host (Kritas et al., 2008; Morales et al., 2008; Saint et al., 2001). The
evolution of poxviruses has been studied based on whole-genome phylogenetic analyses
rather than single gene phylogeny due to the occurrence of phenomena such as
horizontal gene transfer (Bratke & McLysaght, 2008; Gubser et al., 2004; Hughes &
Friedmann, 2004; Xing et al., 2006). To date, the complete genomes of only two myxoma
viruses are available: the virulent strain “Lausanne”, introduced in 1952 in Europe, and its
attenuated field derivative “6918”, obtained in 1995 in Spain (Bárcena et al., 2000;
Cameron et al., 1999; Morales et al., 2008). The comparative analysis of both genomes
has identified 73 differences consisting of 67 base substitutions, 4 deletions and 2
insertions (Morales et al., 2008). Interestingly, events such as whole gene loss or gain
were not observed.
The understanding of genetic changes driving myxoma virus evolution in the European
rabbit requires the genetic analysis of larger numbers of field strains. The large size of the
viral genome has hampered the availability of this kind of information, and partial gene
sequences have shown little if any differences compared to the virulent strain Lausanne
(Kritas et al., 2008; Saint et al., 2001). As gene order and content remained unchanged in
the attenuated myxoma virus field strain “6918” (Morales et al., 2008), it may be sufficient
to study virus evolution by analysing specific genomic regions. Our objectives were to
53
study selected genomic regions of recent myxoma virus field isolates and to evaluate the
suitability of these as molecular marker for virus evolution within the European rabbit.
Material and Methods
1. Selection of viral genes
The genome comparison between the virulent myxoma virus strain “Lausanne” (GenBank
accession no. AF170726) and the attenuated field strain “9618” (GenBank accession no.
AF552530), suggested that the observed disruptions in ORFs M135R, M148R, M009L,
M036L may be related to loss of viral virulence (Morales et al., 2008). Thus, we included
these genome regions in our analysis (Table 2). We also partially amplified gene M020L
to confirm the insertion of the CTC codon for leucine at position 52 (Morales et al., 2008).
Further five viral genome regions were selected, which include the following partial genes:
M002L/R and M007L/R for being located in the terminal inverted repeats and encoding
immunomodulatory proteins similar to TNF receptor and to rIFN gamma receptor,
respectively (Johnston & McFadden, 1994; Stanford et al., 2007; Willer et al., 1999),
M014L and M015L, which encode a kelch-like protein and the small subunit of
ribonucleotide reductase, respectively; M022L encoding the major envelope protein, as
this protein is exposed to the immune system of the host, and may reflect the effect of
immune pressures; M137R and M138L because the corresponding sequence of the
California myxoma virus strain “MSD” (GenBank accession no. AF030894) was available
for comparison and displayed major differences when compared with “Lausanne”
(Jackson et al., 1999). The “MSD” strain naturally infects the brush rabbit (Sylvilagus
bachmani) but causes fulminant disease in the European rabbit. A further locus, M061R,
coding for the thymidine kinase gene, was selected for diagnostic purposes only (see
below). The term “genomic region” was used to describe the amplified sequences, which
correspond to either part of a single gene, or, in the case of M014L/M015L and
M137R/M138R, to two adjacent genes and their respective intergenic noncoding region.
2. Primers and sequencing
The targeted genes and used primers are shown in Table 2. A hot start Taq polymerase
(Hotstar Taq Polymerase, Qiagen) was used. The annealing conditions of the PCR
reactions varied between 50 and 65ºC. The PCR products were directly sequenced in
both directions.
54
Table 2 Selected genes and primers used for the ge netic characterisation of myxoma virus field strain s. The nucleotide positions refer to myxoma virus strain “Lausanne” (GenBank ac cession no. AF170726)
Gene
(position)
Gene description Forward primer
(position)
Reverse primer
(position)
Annealing
temperature
Size PCR
amplicon
Genomic Region:
Positions of obtained
sequence
Length of
viral protein
Positions of deduced
amino acids
M002L/R
(1665-2645;
160109-159129)
Similar to TNF receptor MT2F
(1682-1702)
MT2R
(2614-2634)
55ºC 932bp 1706-2613;
160068-159161
326 12-313
M007L/R
(7985-8776; 153789-
152998)
Similar to rIFNgamma
receptor
MT7F
(7990-8009)
MT7R
(8748-8767)
55ºC 758bp 8006-8741;
153768-153033
263 13-257
M009L
(11601-13130)
Contains kelch motifs M009F
(11859-11878)
M009R
(12383-12364)
55ºC 525bp 11859-12336 509 263-424
M014L
(15012-16565)
Kelch-like protein
NN1F= 16496F
(16496-16515)
NN1R= 16931R
(16912-16931)
65ºC
436bp
16501-16931
517 1-21
M015L
(16618-17586)
Ribonucleotide reductase,
small subunit
322 220-322
M020L
(19194-20531)
Serine/threonine protein
kinase
M020F
(20145-20164)
M020R
(20458-20439)
55ºC 314bp 20146-20413 445 38-125
M022L
(22558-23673)
Major envelope protein NN2F= 22913F
(22913-22932)
NN2F= 23298R
(23279-23298)
60ºC 386bp 22914-23298 371 126-253
M036L
(37209-39251)
Leucine zipper motif M036F
(37558-37577)
M036R
(37845-37864)
55ºC 307bp 37551-37858 680 464-564
M061R
(57797-58333)
Thymidine kinase TKU
(57822-5783)
TK3
(58375-58393)
50ºC 571bp Diagnostic PCR
M135R
(131699-132235)
IL-1/IL-6 receptor-like M135F
(131647-131668)
M135R
(131856-131876)
55ºC 230bp 131642-131871 178 1-59
M137R
(132908-133840)
Similar to vacA51R
A1F
(133767-133787)
A1R
(134405-134424)
60ºC
658bp
133788-134746
310 295-310
M138L
(133874-134746)
alpha 2,3-sialyltransferase A2F
(134340-134360)
1160R
(134938-134957)
60ºC 618bp 290 1-290
M148R
(141626-143653)
Ankyrin motif; host range M148F
(142701-142720)
M148R
(143119-143138)
55ºC 438bp 142696-143132 675 360-504
55
The obtained sequences were edited, aligned and analysed using the software Bioedit (Hall,
1999). The obtained sequences were compared to sequences available in GenBank by
performing BLAST searches. The deduced amino acid sequences were compared to the
proteins of myxoma virus strain “Lausanne” and “6918”.
3. Myxoma virus isolates
Nine field strains were obtained from European rabbits displaying signs and/or lesions
compatible with myxomatosis. They were collected between 2004 and 2007 in different
locations in Portugal: four were obtained from wild rabbits in the southern province Algarve
(C43, C95, C116, C152), three from wild rabbits in the north-eastern province Trás-os-
Montes e Alto Douro (CB31, CB32, CB191), and two from an outbreak in domestic rabbits in
the north-western province Douro Litoral (CD01, CD05). The vaccine strain “MAV” was
originally derived from a cell culture attenuated Californian myxoma MSD virus (McKercher
and Saito, 1964). It is currently used as seed for commercially available vaccines in Europe
(Gorski et al., 1994). This vaccine strain was kindly made available by the company IDT
Biologika GmbH, Dessau, Germany, through the Friedrich-Loeffler-Institut, Germany, and
was used here as reference strain.
The diagnosis of myxomatosis was made by PCR targeting the thymidine kinase gene
(M061R) using DNA extracts from eyelids (Table 2). In order to increment viral yield for the
genetic characterisation, the viruses were passaged twice in RK-13 cells. Virus was
harvested after submitting the infected cell culture twice to freeze-thaw cycles at -80ºC. Cell-
free supernatant was used for nucleic acid extraction using the QIAamp Viral RNA Mini Kit
(Qiagen, Hilden, Germany) according to the manufacturer’s instructions.
4. Nucleotide sequence accession numbers
The GenBank accession numbers of 16 sequences representing the observed nucleotide
changes are FJ970492-FJ970507.
Results
Ten genomic regions spanning 12 genes were selected for the partial genetic analysis of
nine virulent myxoma virus field isolates obtained from seven wild and two domestic rabbits
between 2004 and 2007 in Portugal, as well as from the German live attenuated vaccine
strain “MAV”. The sequence information on 4863bp (corresponding to 3% of the viral
genome) was compared to that of strains “Lausanne” and “6918”.
56
Table 3 Observed nucleotide polymorphisms and dedu ced amino acid variations in recent myxoma virus fi eld strains. The nucleotide and amino acid positions refer to myxoma virus stra in “Lausanne” (GenBank accession no. AF170726)
The GenBank accession numbers of selected sequences (FJ970492-FJ970507) are indicated in bold italics below the respective polymorphic nucleotide positions.
Terminal region Central region Terminal region
Gene M002L/R
907bp
M007L/R
735bp
M009L
477bp
M014L
M015L
430bp
M022L
384bp
M036L
307bp
M135R
229bp
M137R/M138L
958bp
M148R
436bp
NT AA NT AA NT AA NT NT AA NT AA NT AA NT AA NT AA
Strain 6918
(EU552530)
T1981
A2497
T2594
D222
F104
S18
A8064 F238 Deletion
11942-
11951
F/S after
aa395,
start Met 398
ID ID ID Insertio
n
C37687
F/S after
aa523,
start Met 542
Insertion
G131750
F/S after
aa19,
start Met
44
ID ID Deletion
C142959
F/S
after
aa446,
start
Met
505
C43 T1981 FJ970494
D222
A8261 FJ970496
ID ID ID ID*)
FJ970498 ID ID ID ID ID ID ID ID G142867
FJ970506 S416
C95 T1981 D222 ID ID Insertion
C12297 FJ970497
F/S after
aa280,
start Met 303
ID*)
ID ID T37588 FJ970500
M496 ID ID ID ID G142867 S416
C116 T1981 D222 ID ID Insertion
C12297
F/S after
aa280,
start Met 303
ID*)
ID ID ID ID ID ID ID ID G142867 S416
C152 T1981 D222 ID ID ID ID ID ID ID T37759 FJ970501
M553 ID ID ID ID ID ID
CB31 T1981 D222 ID ID Insertion
C12297
F/S after
aa280,
start Met 303
ID*)
ID ID ID ID T131772 FJ970503
C27 ID§)
FJ970504 ID ID ID
CB32 T1981 D222 ID ID Insertion
C12297
F/S after
aa280,
start Met 303
ID*)
ID ID ID ID T131772 C27 ID§)
ID ID ID
CB191 T1971 FJ970492
ID ID ID Insertion
C12297
F/S after
aa280,
start Met 303
ID*)
ID ID ID ID ID ID A133966 FJ970505
C261 ID ID
CD01 T1971 ID
ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID
CD05 C1975 FJ970495
G224
ID ID ID ID ID ID ID ID ID ID ID ID ID ID ID
Vaccine
strain “MAV”
ID ID G8492 FJ970507
ID No PCR
amplicon
(2 weak
bands 100
+ 400kb
approx.)
- No PCR
amplicon
G23118
C23296
T23212
C23218
A23235
C23236
All ID 27 nt
subst. FJ970502
L458
S491
S530
S532
S549
All other 22
ID ID ID ID T142804 FJ970493
V395
57
G23254
T23257 FJ970499
ID
ID Identical to “Lausanne”
*) Insertion (A) after nucleotide 16616 of a poly-A in the non-coding region.
§) Point mutation (C -> T) at position 133846 in the non-coding region.
F/S
58
We also confirmed the insertion of the CTC codon in gene M020L of all field strains as
well as the vaccine strain (data not shown). The results are shown in Table 3. Within gene
M002L/R (907bp) all field isolates displayed one single nucleotide substitution, albeit at
three different locations. Six of the nine field strains displayed a nonsynonymous
substitution at position 1981, which was also observed in strain “6918”. The field strains
CB191 and CD01 showed a synonymous substitution at position 1971. In field strain
CD05, which originated from the same outbreak as CD01, a nonsynonymous nucleotide
change at a different position (1975) was observed. The vaccine strain was identical to
“Lausanne”. Within gene M007L/R (735bp), two nonsynonymous nucleotide substitutions
were observed in field strain C43 and in the vaccine strain (positions 8261 and 8494,
respectively). Within gene M009L (477bp), five field strains (C95, C116, CB31, CB32,
CB191) displayed a single nucleotide insertion (C) at position 12297 after a
homopolymeric region of 5 cytosins, causing a frameshift after amino acid 280. The PCR
amplification of the vaccine strain yielded two very weak bands of approximately 100 and
400bp, inadequate for successful sequencing. Within the region spanning M014L/M015L
(430bp) a single nucleotide insertion (A) was observed at position 16616 of the intergenic
region of six field strains (C43, C95, C116, CB31, CB32, CB191) after a homopolymeric
region of 10 adenosines. PCR amplification of this region of the vaccine strain was
unsuccessful. At gene M022L (384bp) all field strains were identical to “Lausanne” and the
vaccine strain displayed eight synonymous nucleotide substitutions. Within gene M036R
(229bp), nonsynonymous nucleotide substitutions were observed at positions 37588 and
37759, of the two field strains C95 and C152, respectively. The vaccine strain displayed
27 nucleotide substitution, of which 5 were nonsynonymous. In gene M135R (229bp), the
same nonsynonymous nucleotide substitution was observed at position 131772 in the field
strains CB31 and CB32. The remaining, as well as the vaccine strain, were identical to
“Lausanne”. Within the region spanning M137R/138L (958bp), a nonsynonymous
nucleotide substitution was observed at position 133966 of field strain CB191, and a
single nucleotide substitution at position 133846 in the intergenic non-coding region of
strains CB31 and CB32. Within gene M148R (436bp), nonsynonymous nucleotide
substitutions were observed at position 142867 of isolates C43, C95, C116, and at
position 142804 of the vaccine strain.
59
Discussion
Since the introduction of Myxoma virus into its new host population, the European rabbit,
a decrease in disease mortality has been observed and myxomatosis has turned into a
frequently cited example of virus-host adaptation, but genetic information on field strains is
scarce (Kritas et al., 2008; Morales et al., 2008; Saint et al., 2001). In the present study
only virulent virus strains were included, because field evidence of attenuated or atypical
forms of disease is difficult to obtain, as these probably go undetected, e.g. we were
unable to find evidence of myxoma virus infection in eyelid samples from 30 healthy wild
rabbits hunted in southern Portugal (Pancas) and tested by PCR analysis of the TK gene
as well as by three consecutive passages on RK-13 cells (data not shown). The analysed
nucleotide sequences presented here corresponded to only approximately 3% of the
complete viral genome, but they were selected based on the above-mentioned criteria and
thus considered good candidates for detecting changes reflecting virus - host co-
evolution. Interestingly, a maximum of only three (strains C43, C95) and a minimum of
one nucleotide substitutions (strains CD01, CD05) were observed in each field strain. The
attenuated strain “6918” only displayed four nucleotide substitutions within the analysed
genome regions, one of which (position 1981 of gene M002L/R) was also found in six of
the field strains, suggesting that this mutation is being fixed in some European wild rabbit
populations. The major envelope gene (M022L) of myxoma is exposed to the rabbit’s
immune system, and expected to be a good target for identifying viral variability.
Surprisingly, the analysed gene sequences of the field isolates were identical to strain
“Lausanne”, similar to that of a pathogenic myxoma virus isolated from an outbreak in
vaccinated and non vaccinated commercial rabbits in Greece (Kritas et al., 2008). Within
M022L of the vaccine strain, eight synonymous nucleotide substitutions were found. No
equivalent sequence information on the MSD strain was found in GenBank to understand
whether these mutations are characteristic for this strain, or whether they may reflect
pressures related to its attenuation process. Although our findings support the limited
degree of genetic alteration found in recent myxoma virus field strains (Morales et al.,
2008; Saint et al., 2001), the mutations observed in the selected genome regions allowed
the individual identification and some grouping of the strains according to their geographic
origin. For example, CB31 and CB32, which were collected from wild rabbits during the
same occasion, are identical to each other but differ from CB191, which was sampled at a
different geographic location, but also in the north of Portugal. Interestingly the strains
obtained from domestic rabbits during an outbreak in a family farm (CD01, CD05)
displayed mutations at different locations of gene M002L/R, but were otherwise identical
to “Lausanne”.
60
Within myxoma viruses, whole gene gain or loss does not seem to occur, but single or
multiple base pair insertions and deletions which resulted in frameshift mutations have
been described (Morales et al., 2008). We have found two homopolymeric sites, where a
single nucleotide has been inserted in some of the virulent field strains: within gene
M009L and in the noncoding region between M014L and M015L. Thus these single
nucleotide insertions do not seem to affect virulence. However, major disruptions, at least
in M009L, may indeed play an important role in attenuation, e.g. in strain “6918” (Morales
et al., 2008). Although it has been argued that integrity of gene M009L may not be a
critical virulence factor in myxoma virus, because of its disruption in the virulent
Californian strain MSW (Labudovic et al., 2004) and its partial duplication in the
attenuated Shope fibroma virus (Willer et al., 1999), it should be remembered, however,
that these leporipoxviruses have evolved in different hosts, Sylvilagus bachmani and S.
floridanus, respectively, whereas the natural host of myxoma virus is S. brasiliensis
(Fenner & Ross, 1994). They present a considerable degree of genetic heterogeneity (84-
89%) and may not entirely be suitable for comparison with “Lausanne” and “6918”. Major
changes are likely to be present in gene M009L of the vaccine strain, hampering PCR
amplification and yielding two products of smaller sizes. The use of two other primer pairs
overlapping the site of the deletion in “6918” (positions 11937-11947) was unsuccessful
(not shown). The region spanning genes M014L/M015L of the vaccine strain could also
not be amplified successfully, suggesting the occurrence of genomic changes requiring
further investigations. Single indels in genes M135R and M148R where considered of
putative relevance for the attenuation of “6918” (Morales et al., 2008). Our results support
this hypothesis as these changes were not observed in the virulent field strains. However,
they were neither found in the vaccine strain, indicating that they are not essential for
attenuation. The disruption of another gene (M135R) was considered a potentially
important determinant for the attenuation of the field strain “6918” (Morales et al., 2008).
Again, this disruption does not seem essential for attenuation, as it did not occur in the
vaccine strain. The sequence spanning genes m137R/m138L of the vaccine strain
displayed 100% nucleotide indentity with “Lausanne”. This is rather unexpected, as the
sequence comparison with the “MSD” strain (Genbank accession no. AF030894), from
which the vaccine strain was derived, displayed only 84% nucleotide identity to strain
“Lausanne”. The vaccine strain has a long history of cell culture passaging, and it is thus
very difficult to rule out possible cross contaminations with “Lausanne”-derived isolates or
strains at any point.
61
Altogether, these results support those obtained with specific gene knockout viruses, in
that various disruptions, on their own or in synergy, may affect virulence of myxoma
viruses (Johnston & McFadden, 1994; Stanford et al., 2007; Willer et al., 1999). Further
field strains should be analysed to assess the frequency of single base substitutions and
indels as well as their importance in reflecting viral evolutionary processes, also
considering that misincorporations due to polymerase infidelity (in vivo and in vitro) may
account for some of the observed differences between strains. Although focussing on only
small parts of the viral genome, this study supports the relatively high degree of genetic
stability of myxoma field strains over the past five decades (Saint et al., 2001, Morales et
al., 2008). Based on our findings it is difficult to identify unique single gene markers of
virus attenuation or evolution, indicating that analyses of larger portions of the genome are
required.
Acknowledgements:
This study was supported by the Foundation for Science and Technology Portugal:
Project POCTI/BIA-BDE/61553/2004 and grants SFRH/BD/31093/2006,
SFRH/BD/31048/2006, SFRH/BPD/27021/2006 to A. M., J. A. and P. J. E., respectively.
Our thanks go to IDT Biologika GmbH, Dessau, Germany, in particular to Dr. Neubert for
the permission to use the vaccine strain “MAV” and for supplying information on its origin,
and to the Friedrich-Loeffler-Institut, Bundesforschungsinstitut für Tiergesundheit, Insel
Riems, Germany, in particular to Dr. Dauber and Dr. Riebe, for supplying the RK-13 cells
and the above mentioned myxoma vaccine strain. Our thanks also go to Dr. S. Bertagnoli,
École Nationale Veterinaire, Toulouse, France, for the primers and protocol for amplifying
the thymidine kinase gene of myxoma virus. We also thank the National Laboratory for
Veterinary Investigation (LNIV, Delegação do Norte) for infrastructural support.
62
63
3. Rabbit haemorrhagic disease (RHD)
64
65
3.1 Literature review
66
67
3.1.1 Introduction and brief history
Rabbit haemorrhagic disease was first reported in China in 1984. The disease spread
throughout Europe between 1987 and 1989 and is considered endemic since. In the
1990s, the etiological agent of RHD was characterised as a calicivirus (Ohlinger et al.,
1990), and the virus was introduced into Australia and subsequently New Zealand as bio-
control agent against wild European rabbit populations (Forrester et al., 2003).
In an attempt to understand the molecular epidemiology and ultimately the origins of RHD,
phylogenetic analyses based on partial sequences of the viral capsid protein VP60 of
many viral isolates from different countries were conducted (Asgari et al., 1999; Forrester
et al., 2006; Le Gall-Recule et al., 2003; Matiz et al., 2006; McIntosh et al., 2007; Moss et
al., 2002; Nowotny et al., 1997). These showed that there were up to six or more viral
groups or subgroups and that virus strains may or may not cluster according to their
geographical origin and/or the year of isolation, but that they did not always do so. Also,
evidence was gathered on the current and previous existence of RHDV-like viruses,
which may have been circulating more or less harmlessly in Europe for many years before
its first epidemic appearance in China in 1984 (Forrester et al., 2006; Moss et al., 2002;
Rodak et al., 1990). RHDV-specific signals were detected retrospectively by RT-PCR in
rabbit sera taken in the 1950s, concomitantly with the detection of RHD antibodies.
Infectiousness of viral RNA could not be proven, and recent work has shown that theses
sequences appear to be modern laboratory contaminants (Kerr et al., 2009; Moss et al.,
2002). Furthermore, rabbits with cross-reacting “pre-existing” antibodies against any
putative RHD-like viruses were not always fully protected against RHD, indicating that
antigenic differences may exist between viruses (Marchandeau et al., 2005).
New light was shed on these issues by recent extensive phylogenetic analyses (Kerr et
al., 2009; Kinnear and Linde, 2010). In these studies, four phylogenetic groups or lineages
were defined for RHDV: a) antigenic variants (RHDVa), b) strains from the Iberian
Peninsula, based on our work presented here (Muller et al., 2009), c) strains representing
the documented beginning of the epidemic, including the isolate obtained from China in
1984, and d) isolates mostly from Central Europe collected between 1989 and 2004. The
rabbit caliciviruses (RCV) displayed considerable divergence between each other and
also from all RHDV lineages, and a common ancestor has been estimated for over 200
years ago. Thus, virulent RHDV most likely did evolve from an avirulent RCV, but this
would not be a recent event and therefore would not explain the first observed epidemic in
1984 (Kerr et al., 2009). It is postulated that virulence of RHDV emerged in all RHDV
lineages on multiple occasions in the beginning of the 20th century (Kerr et al., 2009;
68
Kinnear and Linde, 2010). Various possible explanations as to why it was only in the
1980s that disease has been described were discussed (Kerr et al., 2009). The most likely
being that virulent RHDV emerged in farmed rabbits in Asia, in particular in China, aided
by a rapid expansion and intensification in that industry particularly in the second half of
the 20th century. Crossprotection conferred by co-circulating avirulent RHDV together with
concurrent socio-economical conditions would have hampered large scale disease
outbreaks earlier. Thus, the disease was not reported until 1984, when it was observed in
probably serologically naïve rabbits imported from Germany to China (Kerr et al., 2009).
3.1.2 Aetiology
Taxonomy
RHDV is a member of the Caliciviridae family (Meyers et al., 1991b; Ohlinger et al., 1990).
Based on sequence comparisons of the capsid gene, caliciviruses have been subdivided
into four genera (Green et al., 2000; ICTV, 2002). A fifth genus, Beco- or Nabovirus,
affecting cattle has been proposed (Oliver et al., 2006). The two genera Noro- and
Sapovirus include important human enteric pathogens. The genus Vesivirus comprises
San Miguel sea lion virus, vesicular exanthema virus, feline calicivirus and a recently
characterized putative new member, rabbit vesivirus (Martin-Alonso et al., 2005). The
genus Lagovirus contains RHDV and European brown hare syndrome virus (EBHSV)
(Green et al., 2000). RHDV and EBHSV are species-specific for rabbits and hares,
respectively. Despite an overall amino acid similarity of 76% of the major capsid protein,
they are serologically distinct, thus representing distinct virus species (Capucci et al.,
1991; Chasey et al., 1992; Lavazza et al., 1996; Wirblich et al., 1994). The most important
property of the genome of lagoviruses is the presence of only two ORFs as opposed to
the three ORFs observed in the other caliciviruses. Similar to other caliciviruses, RHDV is
nonenveloped with a capsid of icosaedrical symmetry. The virus is small, with a diameter
of 35-39nm. The depressions between the capsomers are cup-shaped, giving the family
its name “Calici”. The capsid is formed by the major structural protein, VP60.
Genome organization and replication The complete genome of RHDV consists of a single positive-stranded RNA of 7.437 kb
with a virus-encoded protein (VPg) covalently attached at its 5´end and a polyadenylated
3´end (Figure 1).
69
Figure 1 Monopartite, linear, single-stranded, pos itive-sense RNA genome of 7.3 to 8.3 kb. At 5’-terminus a virus protein (VPg)is cova lently linked to genome, whereas 3’-terminus is polyadenylated (Source: ViralZone ww w.expasy.ch/viralzone, Swiss Institute of Bioinformatics).
In virions and infected hepatocytes, both, genomic and a subgenomic RNA are found,
covalently linked to VPg and packaged into non-enveloped icosahedral capsids, (Meyers
et al., 1991a; Ohlinger et al., 1990; Parra and Prieto, 1990).
The genomic RNA of RHDV is composed by one long open reading frame (ORF1) that
encodes a large polyprotein of 257kDa which is proteolytically cleaved into non-structurals
proteins and a capsid protein (Gould et al., 1997; Meyers et al., 1991a; Meyers et al.,
2000; Wirblich et al., 1996). Most of the cleavage reactions are executed by the virus-
encoded trypsin-like cysteine protease (“3-C-like cysteine protease”), which is similar to
3C-proteases of picornaviruses. After cleavage, the seven non-structural proteins and the
major capsid protein are produced in the order NH2-p16-p23-p37-p29-p13-p15-p58-VP60-
COOH. Some of these proteins have larger precursor proteins, such as p60 (p23-p37),
p41 (p29+p13) and p72 (p15+p58), which are further cleaved or post-translationally
modified within the hepatocyte (see (Konig et al., 1998; Meyers et al., 2000) for review).
In RHD-infected cells a subgenomic RNA of 2.2 kb is transcribed, which is collinear with
the genomic RNA, and identical at the 3´end (Meyers et al., 1991a). The 5´end
corresponds to position 5296 of the genomic RNA. This subgenomic RNA also encodes
the viral capsid protein VP60 (Sibilia et al., 1995; Wirblich et al., 1996). It is thought that
VP60 produced by the subgenomic RNA is the type predominantly assembled into mature
virions and that it is two amino acids larger at the N-terminal than the genomic VP60.
However, both capsid proteins seem to be antigenically very similar, as shown by
monoclonal antibody reactivity and immunisation experiments (Sibilia et al., 1995). For the
generation of viral subgenomic RNA from genomic RNA template, two basic mechanisms
have been proposed, internal initiation or premature termination (Miller and Koev, 2000).
70
Recent studies suggest that internal initiation seems to be the strategy used by RHDV
(Morales et al., 2004). In any case, viral replication must occur because the RNA
dependent RNA polymerase is required for subgenomic RNA production (Miller and Koev,
2000). A second ORF (ORF2) is located at the 3´end of the genomic and subgenomic
RNA and encodes the structural protein VP10. This protein is thought to be important for
encapsidation of the viral genome with VP60, as VP60 alone is able to assemble into
virus-like but empty particles indistinguishable from those found in livers of RHDV-infected
animals (Sibilia et al., 1995; Wirblich et al., 1996).
The genomic RNA is infectious and serves as both genome and viral messenger RNA.
For replication, complementary negative sense ssRNA is synthesized from the genomic
RNA by the virally encoded RNA dependent RNA polymerase which is translated initially
from the RNA genome entering the cell. This minus strand then acts as a template for the
synthesis of new genomic RNA as well as of subgenomic RNA encoding for ORF2 protein
(Clarke and Lambden, 1997). The encapsidated nucleic acid is mainly of genomic origin,
but virions may also contain subgenomic RNA.
As RHDV cannot easily be propagated in tissue culture, many of the studies of genome
organization and viral replications have been made using different in vitro systems as RT-
PCR, ELISA and sequence analyses. However, uncertainties remain as the life cycle may
be influenced by cellular co-factors (Joubert et al., 2000; Wirblich et al., 1996). Using
cultured hepatocytes, additional proteins were detected, which were apparently not
observed in vitro, and which probably were produced by cellular post-translational
modifications (Konig et al., 1998). The results strongly suggested that virus replication had
taken place in the cultured hepatocytes, but whether infectious virus was produced
remained unanswered.
Structural proteins and antigenicity
The viral genome encodes two structural proteins, VP10, a small protein that probably
interacts with the genome during encapsidation and the major capsid protein VP60
(Wirblich et al., 1996). The major capsid protein VP60 is composed of 579 aminoacids.
This single structural protein determines functions related with capsid assembly, receptor
recognition, host specificity, strain diversity, and immunogenicity (Capucci et al., 1991;
Chen et al., 2004; Martinez-Torrecuadrada et al., 1998; Wirblich et al., 1996). The three-
dimensional structure of different caliciviruses has been studied by electron
cryomicroscopy and other methods (Chen et al., 2004; Prasad et al., 1994). Specific
information on lagoviruses are scarce, but conserved structural features across different
71
caliciviruses allow extrapolations. The RHDV capsid is composed of 90 dimers that form a
shell domain from which arch-like capsomers protrude (Prasad et al., 1994). The first 227
N-terminal amino acids form the shell domain (S), and the remaining C-terminal residues
(codons 287-579) make up the protruding domain (P) (Chen et al., 2004; Laurent et al.,
2002; Prasad et al., 1994). The S domain is the most internally, lying next to the RNA
genome. It is highly conserved among caliciviruses. This domain corresponds to the well-
conserved region B (Neill, 1992). The P domain is more variable, corresponding to the
region E (Neill, 1992). It can be further divided into the subdomains P1 and P2. The P1
domain lies more internally and is moderately conserved among caliciviruses. The P2
domain (codons 287-449) represents the most external part of the capsid protein and is
implicated with receptor and antibody interactions. This subdomain is hypervariable
between caliciviruses, also in the number of residues thus accounting for the structural
variation observed between caliciviruses (Chen et al., 2004). Antigenic determinants seem
to be located on both domains, S and P, as shown by binding studies of monoclonal
antibodies (mAb) (Capucci et al., 1995; Capucci et al., 1991; Martinez-Torrecuadrada et
al., 1998). Interestingly, mAb that reacted to internal epitopes cross-reacted with the
antigenically related but distinct EBHSV and also with so-called “smooth” RHDV particles
(s-RHDV), but were unable to inhibit haemagglutination. The other group of mAbs seemed
to react with the RHDV projections. They were able to inhibit haemagglutination, and to
confer in vivo protection. Thus, it is thought, that in the course of natural infection, the
main antigenic determinants of RHDV inducing a humoral immune response are located
on the C-terminal End of VP60 (Capucci et al., 1995; Capucci et al., 1991; Laurent et al.,
2002; Martinez-Torrecuadrada et al., 1998; Schirrmeier et al., 1999).
Only one single serotype of pathogenic RHDV is known, which contains two major
subtypes, denominated RHDV and the antigenic variants denominated RHDVa. The
antigenic variants were first detected in 1996 simultaneously in Italy and Germany
(Capucci et al., 1998a; Schirrmeier et al., 1999), but soon were described worldwide
(Farnos et al., 2007; Kerr et al., 2009; Le Gall-Recule et al., 2003; Matiz et al., 2006;
McIntosh et al., 2007). The RHDVa-specific antigenic epitope has been located to
residues 344 to 370 in the hypervariable N-terminal region E of VP60. A RHDVa strain-
specific monoclonal antibody (3B12) has been developed, which allows the detection of
these antigenic variants (Capucci et al., 1998a).
72
Types of RHDV or related caliciviruses
In the context of RHD, several types of viruses or particles have been described, such as
the virus-like particles, core-like or smooth particles, and rabbit calicivirus (RCV). Some
have been reviewed recently (Kerr et al., 2009; Lavazza and Capucci, 2008). Virus-like
particles (VLPs) result from the expression of recombinant VP60. These capsid proteins
assemble spontaneously (Laurent et al., 1994; Sibilia et al., 1995). VLPs are
morphologically and structurally similar to native RHDV particles, but are empty, i.e.
devoid of viral genome. They are highly immunogenic and able to confer protection, and
as such useful for RHD structural analyses or vaccine development (Laurent et al., 1994;
Sibilia et al., 1995). Core-like particles (CLPs), also denominated smooth particles or s-
RHDV, are detected in the liver of rabbits that die with protracted forms of the disease, or
in non-lethal intestinal infections (Capucci et al., 1991; Granzow et al., 1996). The
structural protein of CLPs has a molecular weight of 28-30kDa and particles have a
diameter of 25-27nm. Thus, they are smaller than RHDV whose structural protein is of
60kDa and that have a diameter of 32-40nm (Granzow et al., 1996). CLPs are also
described as smooth particles because the spike projections - or cup-shaped depressions
- are absent (Capucci et al., 1991). Their smaller capsid protein represents the N-terminal
fragment and thus the conserved S domain of RHDV. For that reason they cross-react
with convalescent rabbit sera as well as mAbs directed towards the inner shell. They also
lack the biological activities of the C-terminal half of VP60 such as haemagglutination
(Capucci et al., 1991; Granzow et al., 1996). Liver homogenates with these particles do
not show hemagglutinating activity (Granzow et al., 1996). Not all of the CLPs contain
nucleic acid, some may remain empty. It is not clear if they are infectious, as infection
experiments are complicated by the fact that CLP preparations do retain some complete
RHDV particles (Granzow et al., 1996). The presence of these CLPs is associated with
sub-acute cases and lower mortality, and it has been discussed that the higher
immunogenicity of these particles could enhance the specific humoral immune response
(Martinez-Torrecuadrada et al., 1998). The origin of these CLPs is unclear. They could
represent a soluble protein that either derived from the proteolytic digestion of the capsid
protein, or from a truncated genome or defective gene expression (Granzow et al., 1996;
Lavazza and Capucci, 2008). It has also been postulated by Barbieri et al. (1997), that
these particles result from the immunological clearance by its host, especially by the
interaction with RHDV specific IgM (Lavazza and Capucci, 2008). That would explain the
occurrence of these particles in the livers of rabbits with subacute or chronic forms of the
disease.
73
Rabbit caliciviruses are a group of viruses that display some similarities, but are
phylogenetically distant to RHDV (Bergin et al., 2009; Capucci et al., 1996; Forrester et
al., 2009; Forrester et al., 2007; Kerr et al., 2009; Moss et al., 2002; Strive et al., 2010;
Strive et al., 2009). The presence of a nonpathogenic virus closely related to RHDV was
already suspected at the time of the first RHD seroepidemiological surveys, when specific
RHDV antibodies were found in sera of farm and laboratory rabbits where no disease was
reported, and also in rabbit sera collected before the appearance of RHD (Moss et al.,
2002; Rodak et al., 1990). The first apathogenic calicivirus, denominated RCV, was
identified in Italy in the 1990s in rabbits from commercial farms, in which no history of
RHD had been recorded (Capucci et al., 1996). The virus was characterised antigenically
and genetically, and its infectious nature was proven by experimental inoculations.
Antigenically, this virus displayed an average amino acid identity of 91.5% to virulent
RHDV. Most of the differences were located in the C-terminal half of the capsid protein,
which constitutes the external surface of the virion. The main distinctive feature of the
RCV capsid protein was found to be a three amino acid deletion, corresponding to N-308,
A-309 and T-310 of RHDV. Importantly, despite these differences, RCV infection induced
antibodies which were cross-reactive with RHDV and able to confer protection from
challenge with pathogenic RHDV (Capucci et al., 1996). Western blot analysis using a
monoclonal antibody (mAb 5G3), that recognizes a conserved epitope on VP60 of all
lagoviruses, showed that similar to RHDV, a 60kDa protein and sometimes also a 30kDa
protein were recognized in intestinal samples of RCV infected rabbits. The latter smaller
protein is generally associated with a smooth capsid surface of the virions (Capucci et al.,
1996; Capucci et al., 1991). RCV genome organization and polyprotein processing were
found similar to RHDV (Capucci et al., 1995; Wirblich et al., 1995). A difference was found
for the putative ORF2 initiation codon, which in RCV is located 9 nucleotides downstream
as compared to RHDV(Capucci et al., 1996). In biological terms, RCV infections differed
from RHDV in that they were asymptomatic, tissue tropism was predominantly intestinal
and not hepatic, and much lower viral titres were found in internal organs. Whether the
differences on the capsid protein of RCV are directly responsible for the different virus
tropism and the lack of pathogenicity requires further clarification.
Several other RCV-like viruses have since been described. Partial or complete sequence
data is available for all, but pathogenesis studies have only been conducted for some. The
Ashington virus was obtained in the UK from a wild rabbit within a few hours of death
(Moss et al., 2002). It is assumed that the rabbit died from RHD, but certainty on the
virulence of the strain would require experimental infection. A few years later, an avirulent
RCV-like strain, denominated Lambay virus, was obtained from healthy wild rabbits on an
Irish island (Forrester et al., 2007). A high RHD seroprevalence was also observed in this
74
population, probably contributing to the absence of overt disease; however it was not
possible to isolate infectious virus. Recently an avirulent rabbit calicivirus, denominated
RCV-A1, has been characterised in Australia (Strive et al., 2010; Strive et al., 2009).
Detailed pathogenesis data is available. Viral loads have been determined by quantitative
real-time PCR for several organs. Genetically, RCV-A1 forms a branch of its own,
separating before the branches containing the Italian RCV, Ashington and Lambay
viruses, and thus possibly representing a more ancient lineage. Interestingly, strong
similarities were found between infections with RCV-A1 and those with the Italian RCV,
such as predominantly intestinal tropism, absence of clinical signs and seroconversion
capable of conferring protection against virulent RHDV (Strive et al., 2010; Strive et al.,
2009). Other novel divergent strains have been described recently from a longitudinal
study in Pitroddie, Scotland (Forrester et al., 2009). Here, healthy wild rabbits were
sampled for serology and RT-PCR on a monthly basis, during 12 months. Interestingly,
two types of viruses were obtained from liver samples, and thus were discussed to be co-
circulating. The divergent strains, RCV-like, were collectively termed Pit-WD, and strains
which clustered with other virulent RHDV strains were termed Pit-EP. Pit-WD strains were
obtained from healthy adult rabbits during months in which no RHD was observed. On the
contrary, Pit-EP strains were obtained from young seropositive rabbits, possibly survivors,
during an outbreak of RHD (Forrester et al., 2009). Noteworthy, it was not possible to
obtain viral RNA from wild rabbits that died with signs of RHD, so molecular diagnosis of
RHD remains to be confirmed. Further, pathogenesis and virulence of either Pitroddie
strains were not characterised by experimental inoculations. Whether intestinal tropism
plays a role in these infections remains unknown. Another RCV-like virus, denominated
MRCV, was reported from a clinical RHD outbreak in a commercial rabbitry in Michigan,
USA (Bergin et al., 2009). A case-fatality of 32.5% was observed in young and adult
rabbits. The virus was detected in livers, but no other organs were analysed. Interestingly,
inoculation experiments failed to reproduce disease, but viral RNA could be demonstrated
in several tissues, including the intestinal tract of inoculated rabbits. Sequence analysis
revealed similarities with the Italian RCV, especially the presence of one initiation codon
of ORF2, opposed to two observed in RHDV (Bergin et al., 2009).
3.1.3 Epidemiology
RHDV is an extremely contagious disease. The virus is very resistant to ambiental factors
(Smíd et al., 1991) and is readily transmitted by direct contact as well as by insect vectors.
The European rabbit (O. cuniculus) is the only susceptible host (OIE, 2009b).
Environmental temperature and humidity play an important role in the epidemiology of
RHD in immunologically naïve populations (Cooke and Fenner, 2002). Viral spread in wild
75
rabbit populations is slower in the hotter summer months. Viral particles are more rapidly
inactivated by temperatures above 37ºC, but they may survive up to weeks in rabbit
carcasses. Insect vectors such as flies and fleas have been shown to play a role in the
mechanical transmission of RHDV (Asgari et al., 1998). Studies in Australia have shown
that although RHD caused high mortalities in arid areas, it was less efficient in reducing
rabbit numbers in cooler areas of higher rainfall (Cooke and Fenner, 2002). The most
obvious declines in rabbit abundance were seen in Spain and Portugal and to some
extent in France, and much less in Northern Europe or Britain. On the Iberian Peninsula
(Cooke and Fenner, 2002), for example an early outbreak was observed in June 1988 in
Almeria, the arid south-east of Spain. Sequential sampling and analyses showed that
many of the surviving rabbits, both adult and subadult, had antibodies. During the
following year, the proportion of seropositive rabbits declined, as more young joined the
adult population. In May 1990, many adults were again seropositive, indicating that a
second outbreak had occurred. It took more than 5 years for RHD to reach all rabbits in
Spain. Even after 5 years of virus introduction, rabbit populations across Spain were being
held at approximately half of their former levels, but, in areas generally more favourable
for rabbits, populations recovered better than in others (Cooke and Fenner, 2002; Delibes-
Mateos et al., 2009).
Once RHD becomes established, its epidemiology changes by a variety of factors.
Rabbits that survive RHD have high levels of antibodies and are immune. Antibody titres
may decrease with time, but if animals are re-exposed to the virus, their titres may be
boosted (Cooke et al., 2000). It is unlikely that re-infection kills them, although this has
been described (Calvete et al., 2002b). So, further outbreaks depend on the presence of
susceptible individuals within given population, which most commonly arise through the
appearance of young animals. Breeding of rabbits is seasonal and associated with
pasture growth. In Southern Europe, typically, rabbits are born in the spring. Now, these
young rabbits, apart from the natural resistance during the first 4-6 weeks, may be further
protected until 13 weeks of age by passively transferred antibodies from immune mothers.
Maternal antibodies may not necessarily protect against infection, but may protect against
the lethal effect of the virus, assisting the young to become immune (Calvete et al., 2002b;
Cooke et al., 2000). This means, that there will be a whole range of susceptible to partially
or fully immune “new population” a few months after the breeding season. So, for
example, in the semi-arid Ebro Valley in northern Spain RHD outbreaks tended to occur in
the winter (Calvete et al., 2002b). Based on these observations, it has been proposed that
the pattern of RHD outbreaks was determined by the resistance of the young, and that the
impact of disease was determined by population density and hence level of contact
76
between rabbits (Calvete et al., 2002b; Cooke and Fenner, 2002). This means that, as the
contact between rabbits increases, there will be initially higher mortality, because the virus
affects a high number of animals. The higher rate of virus spread then leads to a reduction
in the median age of infection, towards an age where the young rabbits are still resistant.
This means that many will survive, so the impact on RHD on the population is reduced, as
sufficient numbers of rabbits survive to maintain the basic breeding population.
These considerations agree with mathematical concepts of infectious disease
transmission and the R0 value or basic reproductive number. R0 is defined as the
expected number of secondary cases which one case would produce in a completely
susceptible population. R0 is based on the duration of the infectious period, transmissibility
(i.e. probability of infecting a susceptible individual during one contact) and contact rates
(number of new susceptible individuals contacted per unit of time) (Anderson and May,
1982; Dietz, 1993). Therefore R0 varies not only for different infectious diseases, but also
for the same disease in different populations (Dietz, 1993). The density of susceptible
hosts is important. The threshold density for transmission is the density of susceptible
hosts at which R0 = 1. At a lower density, each infectious individual will produce less than
1 new infection and so the disease will eventually die out in the population. Outbreaks of
epidemics and the persistence of endemic levels are thus associated with R0 greater than
one. This model has been applied to RHD (Boots et al., 2004). However, in this work, the
hypothesis is laid out in a slightly different way. The authors discuss that avirulent strains
will be favoured in dense populations with high population immunity, and that more
virulent strains will tend to circulate in sparse populations (Boots et al., 2004). Laid out in a
more classical way, in high density wild rabbit populations the virus may persist creating a
high proportion of seropositive and protected animals, thus reducing RHDV impact. In low
density wild rabbit populations, the virus is unable to persist, and eventually new fully
susceptible animals will replace older ones. The introduction of RHDV into this population
is likely to have an enormous impact in terms of mortality, i.e. will be noticed as an
epidemic. Field evidence exists that supports this concept (Delibes-Mateos et al., 2009;
Santos et al., 2006). For example, RHDV epidemiology was described in a low density
population of wild rabbits in northwestern Portugal, based on serology and virology data
obtained from hunted, apparently healthy animals (Santos et al., 2006). No RHDV was
detected in 66 liver samples, whereas antibodies were detected in 2/72 sera. The authors
discussed that RHDV could become epidemic in this population. Some mathematical
modelling has been carried out for RHD (Fouchet et al., 2009; White et al., 2002; White et
al., 2001; White et al., 2004). These models are based on field observations and
assumptions such as the existence of chronic infection that is lifelong and accompanied
77
with low level viral excretion (Fouchet et al., 2009; White et al., 2002), or the existence of
persistent infection and propagation of RHDV by pathogenic and apathogenic modes
(White et al., 2004). To our knowledge however, neither has been proven, and although
the persistence of viral RNA inspite the presence of antibodies has been demonstrated,
this viral RNA does not seem to be highly infectious (Gall et al., 2007; Moss et al., 2002).
Further studies are required to elucidate and clarify the role of RHDV persistence in
recovered hosts. Regarding the discussion on non-pathogenic rabbit caliciviruses, there is
field and experimental evidence of their existence (Capucci et al., 1998b; Forrester et al.,
2009; Monteiro and Alves, 1999; Strive et al., 2009). However many open questions
pertain and require further investigations.
3.1.4 Clinico-pathological features
RHD is clinically characterised by a peracute or acute clinical disease course with high
morbidity and mortality. Infected animals typically die within 24-72 hours after infection. In
the peracute form, clinical sign may absent, and animals that die are in good body
condition. In acute forms, various signs may be present, such as fever, anorexia, apathy,
prostration, respiratory signs, nervous signs and cries (Ferreira et al., 2006c; Lavazza and
Capucci, 2008; Shien et al., 2000). Severe leukopaenia and marked increase in liver
enzymes characterise the late stages of acute RHD (Ferreira et al., 2006c). Very few
animals display subacute or chronic infection (Fuchs and Weissenbock, 1992; Gall et al.,
2007; Teifke et al., 2002). Frequently these survive the acute disease, but may exhibit
jaundice and die 1 or 2 weeks later, probably due to liver dysfunction (Lavazza and
Capucci, 2008). The most consistent pathological lesions are hepato- and splenomegaly.
The liver typically appears with friable consistency, yellow discolouration and marked
lobular pattern. The tracheal mucosa may appear hyperaemic and the lungs congested. In
subacute and chronic cases the mucosae may be icteric. Hepatocytes are the most
important cell type for viral replication in early phases of infection and characteristic
findings are severe necrotising hepatitis and disseminated intravascular coagulation
(Ferreira et al., 2006c; Fuchs and Weissenbock, 1992; Gelmetti et al., 1998; Prieto et al.,
2000). Death is considered to result from massive liver damage and associated
disseminated intravascular coagulation which causes the haemorrhages observed in
various organs.
Upon infection, viral antigen or RNA can be detected in macrophages, circulating
monocytes as well as in reticuloendothelial cells in liver, lung, spleen and lymph nodes
(Gall et al., 2007; Gelmetti et al., 1998; Gould et al., 1997; Guittre et al., 1996; Kimura et
al., 2001; Prieto et al., 2000; Shien et al., 2000; Yang et al., 2008). In situ hybridization
78
using antisense and sense probes allows the identification of sites where active virus
replication is taking place. Antisense probes detect positive sense genomic RNA
representing replicated virions, and sense probes detect negative sense template RNA,
representing intermediates of active viral replication. The application of this technique in
acute RHDV infections in adults, has shown that viral replication in the liver begins as
early as 8 hours post-infection, and that viral replication takes place in hepatocytes and
also in Kupffer cells, alveolar and splenic macrophages (Gelmetti et al., 1998; Kimura et
al., 2001). Although intestinal lesions have been described in acute RHD, viral RNA has
not been detected in intestinal epithelium (Kimura et al., 2001). By PCR, positive signals
were found in liver, bile, spleen at 18 hours post-infection, in lung, kidney, mesenteric
lymph nodes, buffy coat at 26 hours, in thymus at 30 hours and finally in urine and faeces
at 36 hours post-infection, until death of the animal (Shien et al., 2000). Subacute
infections or chronic infections in adults are characterised by a longer clinical course, of
around 10 days, with death as consequence of infection. These forms seem to be rather
uncommon under natural conditions, but may be achieved experimentally by lowering the
infectious dose of the inoculum (Teifke et al., 2002). The subacute form of RHD is
characterised by progressive icterus due to early stages of liver cirrhosis (Teifke et al.,
2002). RHDV positive sense RNA was detected by in situ hybridization mainly in
macrophages of periportal areas of the liver, those lining the sinuses and red pulp of the
spleen and also in a few alveolar macrophages, which was interpreted as possible
attempts of clearance by phagocytosis rather than as active viral replication (Teifke et al.,
2002). Another less frequent outcome of infection with virulent RHDV of adult rabbits is
survival and seroconversion. Recently, the viral loads of survivors after experimental
infection have been determined (Gall et al., 2007). These animals showed fever between
2 and 4 days p.i., but no further clinical signs or RHDV-specific lesions were observed at
5, 7 or 15 weeks post-infection. Surprisingly however, viral RNA was detected by
quantitative real-time PCR in several organs and excretions throughout the experiment,
but with levels of viral loads decreasing with time (Gall et al., 2007). The highest viral load
was found in bile. No viral antigen could be detected in bile or the different tissues,
possibly due to masking by the high antibody titres present in these animals (Gall et al.,
2007). Importantly, infectiousness of the detected viral RNA could not be proven.
Seronegative in contact rabbits did not seroconvert, neither did the rabbit that was
inoculated with concentrated RT-PCR positive liver material of a survivor (Gall et al.,
2007). The authors discussed the possible inhibitory effect of antibodies present in the
inoculum, but it is also possible, that ongoing immune clearance mechanisms in
recovering rabbits actually inactivated any virus and that the detected viral RNA does not
represent infectious particles, and that these rabbits eventually turn into RNA-negative
79
seropositive animals. The hypotheses related to RHDV persistence in these rabbits and
their epidemiological relevance through potential reactivation and viral excretion would
require further studies.
Susceptibility to disease upon RHDV exposure is strongly influenced by age. Even in the
absence of maternal antibodies, domestic rabbits less than four weeks do not develop
clinical signs or lesions upon infection (Prieto et al., 2000). Susceptibility to disease
increases from that age onwards, and by 40-50 days of age most rabbits are fully
susceptible (OIE, 2009b). Several studies have been conducted to understand possible
factors related to this innate resistance of young rabbits to RHD (Ferreira et al., 2006a;
Ferreira et al., 2004; Ferreira et al., 2005; Prieto et al., 2000; Shien et al., 2000). Clinically,
4-5 week old rabbits may show fever on the first days post-infection with virulent RHDV,
but remain otherwise asymptomatic (Shien et al., 2000). Antibodies appear from day 4 to
6 and remain for many weeks and are protective against disease in adulthood (Ferreira et
al., 2008; Lavazza and Capucci, 2008; Shien et al., 2000). Viral RNA could be detected by
RT-PCR in liver, bile and spleen from day 1 and in other organs such as lung, kidney,
mesenteric lymph node, buffy coat and faeces from day 2 p.i. (Shien et al., 2000). The
number of RNA positive organs then started to decrease after day 4 and at day 42 p.i.
viral RNA was only detected in bile and spleen, which has been related to virus clearance
by the immune system. Attempts to reactivate the infection by immunosuppressive doses
of dexamethasone were unsuccessful (Shien et al., 2000). Viral antigen detection using
immunohistochemistry, failed to observed VP60 antigen in 3 week-old infected rabbits. In
6 week-old infected rabbits a very small number of positive cells were observed in the liver
between 18 and 72 hours post-infection, but no labelling was found in lungs, spleen,
heart, intestine, thymus or brain (Prieto et al., 2000). The authors discussed that in young
rabbits only a small number of hepatocytes supported RHDV replication, possibly
indicating that changes in liver structure and function could be a determinant for RHDV
infectivity (Prieto et al., 2000). Recent studies showed that RHDV infection of young
resistant rabbits resulted in a transient decrease of blood heterophils and transient
hepatitis, characterised by an increase in liver transaminases between 18 and 72 hours
p.i. (Ferreira et al., 2004). The authors proposed that rabbits infected at a young age may
be long-term carriers for RHDV as they age. Differences in young versus adult RHDV-
infected rabbits were also found in the type of liver inflammatory reaction, which may
account for the different clinical outcomes. In the liver of young resistant rabbits, early
inflammatory cells were mostly heterophils, which were subsequently substituted by
mononuclear cells. In adult rabbits heterophils were the most predominant inflammatory
cell type, probably representing the response to the extensive hepatic cell death caused
80
by the virus (Ferreira et al., 2004; Ferreira et al., 2005). To our knowledge however, the
infectivity of the observed RHDV components in the liver of young infected but
asymptomatic rabbits were not yet assessed.
Susceptibility of rabbits to RHD has also been linked to differential receptor expression
and binding. It has been argued that young rabbits do not readily become infected with
RHDV because receptors that enable the virus to attach to the intestinal mucosa are not
yet fully developed. RHDV binds to antigens of the ABH histo-blood group family, which
occur on human erythrocytes and also in rabbits on the mucosa of the upper respiratory
tract and the intestine, where they become fully functional at about 6 weeks of age
(Ruvoen-Clouet et al., 2000). However, they seem not to be the only receptors or factors
explaining infection, as intra-muscular RHDV inoculation bypassing the mucosae did
result in infection and in liver pathology similar to that observed with intra-nasal and oral
inoculation (Ferreira et al., 2006a; Ferreira et al., 2004). Further, ABH tissue antigen
receptors do not appear to be expressed on liver cells, which are considered the main
host cell for RHDV replication (Ruvoen-Clouet et al., 2000), thus the role of other putative
receptors needs to be determined. Recent studies have shown genetic polymorphism on
Fut2 and Sec1 genes of on rabbits, which are related to the expression of the H histo-
blood group antigen binding to RHDV (Guillon et al., 2009). Different allele profiles have
been related to sensitivity to RHDV but this association was based on estimates of local
mortality rates of wild rabbits. The true status of these rabbits as to RHDV infection or
recovery was not assessed. Sophisticated technology such as nuclear magnetic
resonance has been applied to further understand RHDV binding to histo-blood group
antigens, and has shown that L-fusose is a minimal structural requirement (Rademacher
et al., 2008). Age-related changes in liver structure and function as well as the continuing
maturation of the immune system may thus contribute to pathogenicity of RHD, but further
studies are required to enhance our understanding on RHDV-receptor binding, viral entry
and, of course, resistance to disease.
3.1.5 Laboratory diagnosis
RHD can be suspected by history and clinical signs, pathological lesions and confirmed by
a variety of specific laboratory tests (Capucci et al., 1991; Lavazza and Capucci, 2008;
OIE, 2009b). Direct diagnostic methods allow the detection of viral particles, viral antigen
or viral nucleic acids. As no cell culture systems are available, the demonstration of
infectious virus requires the experimental inoculations of rabbits. The liver is considered
the target sample, as in acute infections it contains large amounts of virus. Other suitable
81
samples are spleen and serum (OIE, 2009b). Electron microscopy has been used for the
visualisation and morphological studies of RHDV particles as well as induced hepatic
lesions (Capucci et al., 1991; Ferreira et al., 2006b; Ferreira et al., 2006c; Granzow et al.,
1996; Ohlinger et al., 1990; Prasad et al., 1994). Despite being a valuable research tool, it
is time-consuming and not very sensitive and thus of limited use as diagnostic test.
RHDV antigen can be detected by several test systems. The haemagglutination (HA) test
on 10% liver or spleen homogenates was used as the first diagnostic test, and is still
widely used (Capucci et al., 1991; Nowotny et al., 1997; Shien et al., 2000). Human
erythrocytes type “O” are required, as it as the virus binds to antigens of the ABH histo-
blood group family (Ruvoen-Clouet et al., 2000), which is probably absent on erythrocytes
of other species. A small percentage of false negative HA results can be observed in
cases of protracted forms or chronic RHD, in which core-like (smooth) particles exist
(Capucci et al., 1991). Various ELISA systems have been developed to detect RHDV
antigen (Capucci et al., 1991; OIE, 2009b). Most are based on a sandwich system, using
varying types of monoclonal or polyclonal RHDV antibodies as catcher and tracer
reagents (Capucci et al., 1995; Ohlinger et al., 1990). An ELISA based on monoclonal
antibodies for distinguishing RHDV subtypes is also available (Capucci et al., 1991; OIE,
2009b). RHDV antigen can be detected in cryosections or in formalin fixed tissues by
immunofluorescence, immunohistochemistry and in situ hybridization, but these assays
are mainly used for research purposes rather than diagnosis (Gelmetti et al., 1998;
Kimura et al., 2001; OIE, 2009b; Prieto et al., 2000; Teifke et al., 2002). Since the mid
1990s, several PCR-based techniques have been described for the detection of RHDV
RNA, including single and nested PCR (Bascunana et al., 1997; Forrester et al., 2003;
Gould et al., 1997; Moss et al., 2002; Shien et al., 2000; Yang et al., 2008),
immunocapture RT-PCR (Le Gall-Recule et al., 2001) and quantitative real-time RT-PCR
(Gall et al., 2007). All these methods vary slightly in their analytical sensitivity, but are
considered more sensitive than antigen ELISA, and thus currently represent the
diagnostic test of choice (Gall et al., 2007; Guittre et al., 1995; OIE, 2009b). For example,
real-time RT-PCR allowed the detection of 10 copies of viral RNA per well, whereas
positive ELISA results corresponded to a minimum of 107 copies of viral RNA (Gall et al.,
2007). However, it should be kept in mind, that the different types of direct tests detect
different components of the virus, and thus may yield different results during the course of
infection. In particular, in the course of recovery from acute infection or in non-lethal
infections of young animals, as well as in vaccinated but infected rabbits, viral nucleic acid
has been detected (Gall et al., 2007; Gall and Schirrmeier, 2006; Shien et al., 2000). Viral
antigen or infectious virus has not always been demonstrated in these PCR positive
samples, and so PCR results may require careful interpretation (Forrester et al., 2003;
82
Gall et al., 2007; OIE, 2009b; Shien et al., 2000). There are at least two possible
explanations for this incongruence. In animals where specific RHD-antibodies are also
detectable, these may interfere with the antigen detection system. In other words, viral
structural proteins are produced but not detected by the assays. Another possible
explanation is that virus clearance mediated by specific immune responses is ongoing and
that virus replication is aborted and antigen is produced below detection threshold,
whereas remnants of viral RNA are being amplified by PCR.
Indirect or serological methods for the detection of RHD-specific antibodies include the
haemagglutination inhibition (HI) test and several ELISAs. Animals that recover from
infection develop detectable specific antibodies 4-6 days p.i., and this humoral immune
response has been correlated with protection. The HI was the first test to be developed. It
is convenient, as it uses Human erythrocytes type “O” and 4-8 haemagglutination units of
RHDV antigen, usually prepared from infected liver homogenates. Nevertheless, this
method is quite time consuming as it requires heat inactivation and/or kaolin pre-treatment
of sera to increase sensitivity (Capucci et al., 1991; OIE, 2009b). Many laboratories have
now replaced HI by ELISAs, which are quicker and much easier to perform. For routine
diagnosis, the competition ELISA (cELISA) using monoclonal antibodies detecting
antigenic determinants on the external surface of RHDV is considered highly specific and
is currently the reference test for RHD (Lavazza and Capucci, 2008). This test correlates
strongly with protection from disease. An indirect ELISA (iELISA) has been developed, in
which purified RHDV is adsorbed to the solid phase, and in which internal antigenic
determinants are exposed. This ELISA is less specific than the cELISA, as it allows to
detect cross-reactive antibodies, induced by different lagoviruses such as RCV or EBHSV
(Capucci et al., 1991; OIE, 2009b). These do not necessarily correlate with protection.
Isotype-specific ELISAs have been described which allow the detection of IgM, IgA and
IgG, and which have been used for epidemiological and pathogenesis studies (Lavazza
and Capucci, 2008; OIE, 2009b).
3.1.6 Control
There is no treatment for RHD infected rabbits, thus prophylactic measures are essential
to reduce the impact of RHD in a given population. In that context, it is useful to make
separate considerations for rabbits held in captivity, such as domestic pet or commercially
reared rabbits, and those free-living in nature, i.e. wild rabbits.
Domestic rabbits are typically regularly handled by man. This makes the application of
control measures relatively easy. Sanitary measures include vector control, appropriate
83
hygiene, good management practices and bio security which prevent the contact with wild
rabbits or other wildlife that could serve as mechanic vectors of the virus.
Immunoprophylactic measures represent the centrepiece of RHD control. Currently
several companies offer commercially available vaccines. All are of parenteral
administration. In Portugal all vaccines are based on whole inactivated RHDV, obtained
from liver homogenates of experimentally infected rabbits. All but one vaccines are
monovalent. The bivalent vaccine confers additional protection against myxomatosis.
Recommended vaccination schemes vary slightly, but centre on the following guidelines:
all animals shall be vaccinated between 8 and 10 weeks of age, fattening animals only
once and breeders shall be revaccinated yearly thereafter. In situations of high
epidemiological pressure, early vaccination may be practiced, starting at 4 weeks of age,
revaccinating 4 to 6 weeks later and thereafter annually breeders only. Several subunit
vaccines based on recombinant VP60 have been developed since the mid 1990s, but to
our knowledge none is available commercially. Different expression systems have been
used such as vaccinia virus (Bertagnoli et al., 1996b), canarypox virus (Fischer et al.,
1997), baculovirus (Laurent et al., 1994; Nagesha et al., 1995; Soledad Marín et al.,
1995), insect larvae (Pérez-Filgueira et al., 2007), myxoma virus (Barcena et al., 2000b;
Bertagnoli et al., 1996a; Torres et al., 2000a) and others. Most of these recombinant VP60
proteins or viral vectors encoding VP60 are immunogenic and successfully protect rabbits
against RHD.
The application of current RHD control measures in wild rabbit populations is, similar to
other wildlife species, hampered by several factors, such as difficult access to individual
animals, unknown populations sizes, poorly understood morbidity and mortality rates
because ill animals may die hidden and undetected, undefined responsibility as wildlife
seldom is under any ownership, etc. (Artois et al., 2001). Thus, the application of sanitary
measures and of commercially available vaccine which require parenteral application is
considered impractical and cost-inefficient for long-term and large scale control of RHD in
wild rabbits. In many areas of the Iberian Peninsula RHDV has had a major long lasting
impact on the reduction of wild rabbit densities, but other factors acting in synergy have to
be considered. Most cited examples include hunting pressures and habitat loss and
fragmentation mainly due to intensification of agriculture as well as urbanisations (Ward,
2005). Thus, RHDV control measures and in particular vaccination, form part of other
important actions aiming to increase wild rabbit populations. Habitat management
measures that can be applied to increase wild rabbit populations include improvement of
the availability of foodstuff, water and shelter, decrease of natural predators. These may
be coupled with active restocking initiatives (Delibes-Mateos et al., 2009; Letty et al.,
84
2008; Rouco et al., 2006a). As such, RHD vaccination of wild rabbits do have a
predominantly sporadic application in these local translocation and restocking events
(Cabezas et al., 2006; Calvete et al., 2004a; Moreno et al., 2004; Piorno, 2006; Rouco et
al., 2006b). Although vaccination is a reasonably common practice, depending on local
RHD infection pressures and population immunity, it may not be necessary to vaccinate
rabbits to successfully increase wild rabbit numbers (Delibes-Mateos et al., 2009; Rouco
et al., 2006a; Rouco et al., 2006b), and in one study, vaccination has even been found to
have a negative impact on the survival of wild rabbits due to the stress caused by
handling (Calvete et al., 2004b). Thus, most drawbacks of the use of RHD vaccines in wild
rabbits have been related to the need of individual delivery of the vaccine. As a
consequence, novel approaches are being explored to specifically immunise wild rabbit
populations by alternative delivery systems, such as oral uptake or horizontal spread. For
example, the immunodominant protein VP60 expressed in vaccinia virus (Bertagnoli et al.,
1996b) or transgenic potato plants (Martin-Alonso et al., 2003) has been shown to confer
protection upon oral administration. It is likely that VP60 obtained by other expression
systems are also capable to do so, but this has often not specifically been assessed
(Fischer et al., 1997; Laurent et al., 1994). The formulation of oral RHD vaccine baits for
wild rabbits in analogy to those applied for rabies and classical swine fever control in
European wild life reservoirs (Artois et al., 2001) is thus theoretically conceivable.
Horizontal spread of vaccines among wild rabbits is another attractive option, as only a
small proportion of animals would need to get actively immunized. One of the above
mentioned recombinant vaccines based on myxomavirus expressing VP60 meets this
criterion (Barcena et al., 2000b; Torres et al., 2000a). Rabbits immunised by either routes,
oral or subcutaneous, were protected against RHD and myxomatosis. This life modified
vaccine virus was capable of immunising rabbits by direct contact. Importantly other
inconvenient or risks are associated with this vaccine in particular, as has been discussed
above, in the context of myxomatosis control.
85
3.2 Evolution of Rabbit haemorrhagic disease virus (RHDV) in wild rabbits ( Oryctolagus cuniculus ) in the Iberian Peninsula.
Adapted from: Veterinary Microbiology (2009), 135, 368-373
A. Mullera,b*, J. Freitasa,b, E. Silvaa,b, G. Le Gall-Reculéc, F. Zwingelsteinc, J. Abrantesd,e, P. J. Estevesd, P. C. Alvesd,e, W. van der Lood,e, J. Kolodziejekf,g, N. Nowotnyf and G. Thompsona,b
i) Department of Veterinary Clinics, Institute of Biomedical Science Abel Salazar (ICBAS), University of Porto, P-4099-003 Porto, Portugal
j) Multidisciplinary Unit of Biomedical Investigation (UMIB), University of Porto, P-4099-003 Porto, Portugal
k) French Agency for Food Safety (AFSSA); Laboratory for studies and research on poultry, pig and fish farming; Virology, immunology, and parasitology in poultry and rabbits Unit; B.P. 53, F-22440 Ploufragan, France
l) Centre of Investigation for Biodiversity and Genetic Resources (CIBIO), University of Porto, P-4485-661 Vairão, Portugal
m) Department of Zoology and Antropology, Faculty of Sciences, University of Porto, P-4150-150 Porto, Portugal
n) Zoonoses and Emerging Infections Group, Clinical Virology, Department of Pathobiology, University of Veterinary Medicine, A-1210 Vienna, Austria
o) Animal Production Unit, FAO/IAEA Agriculture & Biotechnology Laboratory, Agency's Laboratories, Seibersdorf, International Atomic Energy Agency, Austria *Corresponding author: Phone: +351-252-660410, Fax: +351-252-661780. E-mail adress: [email protected]. Postal address: ICAV–UP, Rua Padre Armando Quintas, 4485-661 Vairão, Portugal
86
87
Abstract
To date information on rabbit haemorrhagic disease virus (RHDV) in Spain and Portugal
has been scarce, although the disease is endemic and continues to have a considerable
impact on species conservation and hunting industry. We analysed RHDVs obtained
between 1994 and 2007 at different geographic locations in Portugal (40 samples), Spain
(3 samples) and France (4 samples) from wild European rabbits (Oryctolagus cuniculus)
that succumbed to the disease. Phylogenetic analyses based on partial VP60 gene
sequences allowed a grouping of these RHDVs into three groups, termed “Iberian”
Groups IB1, IB2 and IB3. Interestingly, these three Iberian groups clustered separately,
though not far from earlier RHDVs of Genogroup 1 (containing e.g. strain “AST89”), but
clearly distinct from globally described RHDV strains of Genogroups 2-6. This result,
supported by a bootstrap value of 76%, gives rise to the hypothesis that the virus evolved
independently since its introduction to wild rabbit populations on the Iberian Peninsula,
with the Pyrenees acting as a natural barrier to rabbit and hence to virus dispersal. No
differences were observed in RHDV sequences obtained from geographic regions where
the rabbit subspecies Oryctolagus cuniculus algirus prevails compared with those
obtained from Oryctolagus cuniculus cuniculus.
Key words: RHDV; Phylogeny; Iberian Peninsula; oryctolagus cuniculus; wild rabbit
88
1. Introduction
Rabbit haemorrhagic disease (RHD) outbreaks on the Iberian Peninsula were first
described in 1988 and the disease is endemic since (Anonymous, 1989; Arguello Villares
et al., 1988). Wild rabbit abundance has declined over 30% since, raising conservational
concerns and having a negative economic impact on the hunting industry (Alves and
Ferreira, 2004; Moreno et al., 2007; Villafuerte et al., 1995). The European rabbit that
nowadays is distributed in many continents originated from the Iberian Peninsula, where
two well separated subspecies exist, O. c. cuniculus in the northeast and O. c. algirus in
the southwest, which form a contact zone in the central region (Branco et al., 2000;
Geraldes et al., 2006; Monnerot et al., 1994) (Figure 2).
Toledo1 sample 1994
Pyrénées-Orientales3 samples 2000-2
O. c. cuniculus
Northern Portugal:3 samples 1996-715 samples 2006-7
Central Portugal:33 samples 1994-7
Southern Portugal:14 samples 2004-5
O. c. algirus
O. c. cuniculus
PORTUGAL
S P A I N
Alicante1 sample 2004Albacete1 sample 2004
Contact zoneO. c. cuniculus +
O.c.algirus
F R A N C E
Manche1 sample 2005
Figure 2 Map of the Iberian Peninsula and South of France displaying the geographic origin of the RHDV samples analysed in t his study and the time period they were collected. The distribution areas of the wild rabbit subspecies Oryctolagus cuniculus algirus and Oryctolagus cuniculus cuniculus as well as the contact zone across the Iberian Peninsula are indic ated.
The subspecies O. c. algirus is endangered due to various factors, but, most importantly,
due to high mortality rates of RHD epizootics (Alves and Ferreira, 2004; Moreno et al.,
2007).
89
Surprisingly, the available genetic information on rabbit haemorrhagic disease virus
(RHDV) in Spain and Portugal is scarce (Boga et al., 1994; Nowotny et al., 1997; Parra
and Prieto, 1990), although many studies have been conducted in other countries
(Forrester et al., 2007; Le Gall-Recule et al., 2003; Le Gall et al., 1998; Matiz et al., 2006;
Moss et al., 2002; Nowotny et al., 1997). These phylogenetic analyses focus
predominantly on sequences located on the viral capsid protein VP60 gene, and although
inferences could be made in some studies, linking RHDV genetic groups to variables such
as the years of sampling, geographic origin, or virulence of strains, these relations were
not always observed and therefore cannot be generalized.
Our objectives were to characterise RHDV strains obtained from wild rabbits presumed to
have died from RHD in different years and geographic locations in the Iberian Peninsula
as well as to characterise RHDV strains obtained from rabbits in distribution areas of O. c.
algirus.
2. Materials and Methods
2.1. Samples
In Portugal, a total of 65 wild rabbits that were found dead during known epidemics of
RHD were collected and immediately stored at -20ºC. The animals were collected from
different geographic areas in different years (Figure 2). Thirty-six samples were collected
between 1994 and 1997 for a study aiming to determine the presence of RHDV as cause
of death in wild rabbits. These had previously tested positive by antigen capture ELISA
(Capucci et al., 1991). These and the remaining liver samples (collected 2004 - 2007)
were processed in the Laboratory of the University of Porto.
Seven RHDV sequences were obtained from wild rabbits from Spain and France (Table 4;
Figure 2). The sequences of the two Spanish RHDVs collected in Alicante and Albacete in
2004 were kindly provided by Dr. Ramon Soriguer (CSIC). The sequence from the Toledo
specimen was obtained in the Laboratory of the University of Porto. It was the only nested
RT-PCR positive sample out of 39 hunted wild rabbits collected in 1994. The four recent
RDHV sequences from France corresponded to three strains (“2000-08”, “2001-23” and
“2002-20”) that had been collected in 2000, 2001 and 2002, respectively, in the
Department “Pyrénées-Orientales”, and to strain “2005-01” that was obtained in 2005 in
the Department “Manche”. These sequences were obtained in the Laboratory of AFSSA,
Ploufragan.
90
Table 4 Genbank accession numbers of RHDV sequence s included in the phylogenetic analysis
RHDV Group Strain GenBank Reference
Group IB3 2004-03 EU192134
France_2001-23 AM746980
Spain_Alicante_2004 AM884394
Spain_Albacete_2004 AM884395
2006-01 EF571322
2006-04 EF571325
2006-09 EF571330
2005-01 EU192140
France_2000-08 AJ319594
France_2002-20 AM746981
2007-01 EU192135
Group IB2 1995-01 EU192132
1994-02 EU192136
1997-03 EU192139
Spain_Toledo_1994 EU192137
1996-08 EU192138
Group IB1 1997-02 EU192133
1994-07 EU192131
Genogroup 1 Eisenhuettenstadt Y15440
AST89 Z49271
France_SD Z29514
Spain_MC-89 L48547
Genogroup 2 China_WX/1984 AF402614
Mexico89_ AF295785
Germany_FRG M67473
Czech_V351 U54983
Genogroups 3-5 France_00-13 AJ495856
France_2005-01 AM085133
Wriezen Y15427
Hagenow Y15441
Meiningen Y15426
Frankfurt Y15424
France_95-10 AJ535094
Genogroup 6 CUB5-04 DQ841708
France_03-24 AJ969628
France_99-05 AJ302016
Root RCV X96868
2.2. RT-PCR and sequencing
RNA was extracted from liver homogenates and cDNA was synthesized using random
priming and M-MLV reverse transcriptase (Invitrogen). Nested PCR was used to amplify
partially the RHDV VP60 capsid protein gene (Moss et al. 2002), corresponding to
positions 6157 to 6703 of strain AST89 (GenBank accession number Z49271). The
91
amplicons of 547bp were directly sequenced in both directions employing the nested PCR
forward and reverse primers.
2.3. Sequence analysis
From Portugal only the 40 non-identical sequences were further analysed. For
phylogenetic analysis, different methods (minimum evolution, maximum parsimony,
maximum likelihood and neighbour-joining) were applied using the software package
MEGA3.1 (Kumar et al., 2004). The obtained trees showed similar clustering of the
sequences. The neighbor-joining tree was presented as considered adequate for
comparing relatively short sequences (Takahashi and Nei, 2000). The nucleotide
substitution model of Kimura-2-parameter was used, and the reliability of the tree was
tested by bootstrap analysis of 1000 replicates. The obtained sequences were compared
with published homologues from GenBank database (NCBI). Eighteen sequences
representing previously described RHDV genogroups were selected and included (Table
1). These sequences were grouped into Genogroup1 to 6, adapted to the classification
used by Le Gall-Reculé et al. (2003). The Italian non-pathogenic rabbit calicivirus “RCV”
(GenBank accession number X96868) was used to root the tree. The amino acid
sequences and the consensus sequences of each group were deduced and aligned.
Results
The phylogenetic tree estimated by the neighbor-joining method (Figure 3) shows the
clusters formed by RHDV strains from the Iberian Peninsula and the south of France,
which have been termed “Iberian” Groups IB1 to IB3, together with the clusters containing
“known” RHDV strains representing Genogroup 1, Genogroup 2, Genogroups 3-5 and
Genogroup 6 antigenic variants or “RHDVa” strains (Capucci et al., 1998). The Groups
IB1 and IB2 contain sequences collected between 1994 and 1997, whereas Group IB3
includes more ones collected between 2000 and 2007. Each group contains sequences
from different geographic locations, except Group IB1, that contains five sequences
obtained in 1994 and 1997 from Santarém district of central Portugal. Group IB2 contains
strains collected between 1994 and 1997 from northern and central Portugal as well as
the virus obtained in 1994 from Toledo, Spain. Group IB3 includes the more recent (2004-
2007) Portuguese strains collected in the southern province Algarve (2004-2005) as well
as in the North (2006-2007). Also included in Group IB3 are the sequences from three
French RHDVs that had been identified between 2000 and 2002 in the Department
“Pyrénée-Orientales”, and the two Spanish strains “Albacete” and “Alicante” collected in
2004.
92
Figure 3 RHDV strains from Portugal cluster separa tely from known genogroups based on phylogenetic analysis of partial VP60 gene sequences. The neighbour joining tree was rooted with RCV. Bootstrap probabi lity values above 75% for 1000 replicate runs are indicated at the nodes.
Group IB 32000-2007
Group IB 21994-1997
Genogroup 1
Group IB 11994-1997
Genogroup 2
Genogroups 3-5
Genogroup 6
2004-02 2004-10
2004-07 2004-03 2004-01 2004-09 2004-05
France 2001-23 Spain Alicante 2004
Spain Albacete 2004 2006-01 2006-04 2006-09
2004-08 2005-03
2005-01 2005-04
France 2000-08 France 2002-20 2007-01 2007-02
1995-01 1994-10 1995-09
1994-02 1995-05
1996-01 1997-03 Spain Toledo 1994
1996-04 1997-01
1995-04 1996-05 1997-05 1994-12
1995-02 1995-12
1996-07 1996-08
1995-10 1995-11
Eisenhuettenstadt AST89
France SD Spain MC-89
1997-02 1994-01
1994-03 1994-04
1994-07 France 88
China WX/1984 Mexico89
Germany FRG Czech V351
France 00-13 France 2005-01
Wriezen Hagenow
Meiningen Frankfurt
France 95-10 Saudi Arabia
CUB5-04 France 99-05 France 03-24
RCV
100
100
100
99
99
9199
9699
78
99
99
98
8698
94
93
97
85
77
76
82
94
87
84
82
90
0.02
93
All described RHDV sequences from Portugal, Spain and the South of France
represented in Groups IB1, IB2 and IB3 formed, together with Genogroup 1 sequences, a
distinct cluster separated from all previously described RHDV genogroups, supported by a
bootstrap value of 76%. Group IB2 and IB3 viruses share a common ancestor with
Genogroup 1 viruses (bootstrap 82%). Group IB1, which contains five sequences from
central Portugal (bootstrap 97%), separated before the known RHDV Genogroup 1. The
recent French strain “2005-01” obtained in the Department “Manche” clustered within
Genogroups 3-5, close to another French strain collected in 2000 (“00-13”).
The grouping of the RHDVs was supported by the bootstrap values as well as a
comparison of nucleotide proximities. Nucleotide similarities of 97%, 98% (excluding strain
“1996-08”) and 99-94% were observed within groups IB1, IB2 and IB3, respectively.
Lower values were observed between groups and genogroups. Group IB2 strain “1996-
08” displayed a higher genetic distance proportionally to all other strains, but was still
closer to RHDVs of its own group IB2 (96-95%) than to Genogroup 1 strains (94%) or
others (less than 94%).
The comparison of the group consensus sequences of the deduced RHDV VP60
polymorphic amino acid composition showed that, in comparison to Genogroup 1, Group
IB1 presents three replacements: A2176N, N2178S and S2194N. The strains contained in
Groups IB2 and 3 are characterised by five amino acid replacements when the respective
group consensus sequences are compared to those of Genogroups 1 to 6: R2062Q, L2152P,
T2163I, A2176T and V2230I. The more recent Iberian and French RHDV strains of Group IB3
are further characterised by the residues P2069N, N2071G and I2092V, which is not a feature
of the other described strains.
4. Discussion
In Spain and Portugal, rabbit mass mortality due to RHD was observed in the late 1980s
and early 1990s, coinciding with the observation of the epidemic in other European
countries, suggesting that the origin of the virus was the same. Accordingly, Genogroup 1
sequences were obtained from RHD outbreaks in 1989 not only in Spain (Boga et al.,
1994; Parra and Prieto, 1990), but also in France (“France SD”) and Germany
(“Eisenhuettenstadt”). No genetic information has ever been published on more recent
RHDVs circulating in wild rabbits in Spain, and none ever from Portugal. Here, forty-seven
RHDV strains from wild rabbits (Oryctolagus cuniculus) obtained between 1994 and 2007
at different geographic locations in Portugal, Spain and France (Fig. 2) were characterised
based on their partial VP60 gene sequences and grouped into three groups, termed
“Iberian” Groups IB1, IB2 and IB3. All these “Iberian” Groups sequences formed, together
94
with those of Genogroup 1, a distinct cluster separated from all other described RHDV
genogroups. Group IB2 and IB3 viruses share a common ancestor with Genogroup 1
viruses, whereas Group IB1 strains separated before Genogroup 1 RHDV.
In geographically neighbouring France, virulent RHDVs of two distinct Genotypes (1 and
2) were initially present between 1987 and 1990, but were subsequently replaced by other
RHDV strains (Le Gall-Reculé et al., 2003). Despite the lack of data between 1989 and
1994, none of the RHDV sequences from Spain and Portugal clustered within Genogroup
2, suggesting that only Genogroup 1-like virulent RHDV strains predominated initially and
that these were subsequently replaced by strains here grouped as IB2 and IB3, indicating
that RHDV could have evolved separately in the Iberian Peninsula since. Alongside the
nucleotide sequence analysis, the observed amino acid polymorphisms suggest that the
substitutions observed in Groups IB2 and IB3 seem to have become fixed around 1994
and are still present in RHDVs circulating in wild rabbits in the Iberian Peninsula, but not
elsewhere. It is therefore tempting to speculate that the Pyrenees may act as a natural
barrier, constraining wild rabbit and hence virus dispersal and evolution, similar to what
was observed on Lambay island or in New Zealand (Forrester et al., 2007; Forrester et al.,
2003).
Phylogenetic, serological and epidemiological studies related to RHD have led to the
hypothesis that attenuated or avirulent forms of the virus have been circulating in Europe
before the 1980s (Forrester et al., 2003; Moss et al., 2002; Nowotny et al., 1992; Rodak et
al., 1990). The drastic reduction in wild rabbit numbers observed on the Iberian Peninsula
has been historically unprecedented, suggesting that, if any RHDV-like viruses were
circulating in wild rabbit populations at that time, they must have been highly host-adapted
but not cross-protective. Among the 39 wild rabbits obtained from hunters in 1994 from
the Toledo region, only one tested positive by nested RT-PCR (2-3% of the total). Also,
more recently in 2006, liver samples obtained from 30 healthy wild rabbits hunted in 2006
in Pancas (Lisbon district) tested negative by nested RT-PCR (data not shown). This data
is different from the high percentage (40-60%) of PCR positive healthy wild rabbits found
in New Zealand (Forrester et al., 2003), suggesting that in the Iberian Peninsula RHDV-
like viruses are either not present or are present at a very low incidence. Climatic
differences together with potentially circulating avirulent “RHDV-like” strains in cooler and
more humid countries (Cooke, 2002) may explain the observed differences.
The categorisation of the samples obtained in Portugal between 1994 and 1997 in two
distinct groups (IB1 and IB2) was quite surprising, as all were collected during the same
time period, and because the five RHDVs that formed Group IB1 originated from the same
district (Santarém) as others that grouped within IB2 (RHDV strains “1994-10”, “1995-01”,
“1995-10”, “1995-11”), suggesting that two different RHDVs were circulating concomitantly
95
in the presence of disease and mortality. The alignment of the amino acid sequence group
consensus sequences further strengthens this hypothesis, as Group IB1 differed in eight
positions when compared to Group IB2, but in only three when compared to Genogroup 1.
Bearing in mind, that RHDV infection can perpetuate in rabbit holdings due to virus
persistence (Gall et al., 2007; Moss et al., 2002), i.e. without repeated introduction of the
virus from the environment, the question arises whether the detected subgroups are
typical for wild rabbits of this region. Our data seem to support this hypothesis, as e.g.
shown by the proximity of all recent wild rabbit RHDVs collected on the Iberian Peninsula
and South of France forming Group IB3. This does not necessarily mean that the same
RHDV circulate in wild and farmed or pet rabbits. We characterised a RHDV from an
outbreak that occurred in January 2007 in a commercial rabbit farm in the North of
Portugal, which was classified as an antigenic variant RHDVa, based on partial VP60
gene sequence analysis (own observations) and on antigenic characterisation using a
panel of monoclonal antibodies performed by the OIE Reference Laboratory (Dr. L.
Capucci).
Phylogenetic analyses of RHDV strains are commonly based on sequences representing
only a fragment of the capsid VP60 protein gene, however, discrepancies between
authors in relation to the number of RHDV groups and subgroups and also in tree
topology, warrant harmonisation of RHDV typing. Due to recombination events
contributing to RHDV variability, it may be more appropriate to investigate the complete
sequence encoding VP60, or ideally, the full length genome, rather than partial capsid
gene sequences (Abrantes et al., 2008b; Forrester et al., 2008).
In this study we report the genetic characterisation of RHDV strains which have been
obtained in Portugal, where the rabbit subspecies O. c. algirus is prevalent, from locations
in Spain within the contact zone, and from France where only O. c. cuniculus has been
described. No significant epidemiological, clinical or pathological differences have been
observed between the rabbit subspecies, suggesting that O. c. algirus is as susceptible to
RHDV as O. c. cuniculus, and that the virus is equally virulent for both rabbit subspecies.
No significant differences have been observed in RHDV partial VP60 gene sequences
obtained from wild rabbit specimens in either region. To our knowledge this is the first
genetic characterisation and molecular epidemiology of RHDV sequences obtained from
O. c. algirus.
Acknowledgements
This study was supported by the Foundation for Science and Technology Portugal:
Project POCTI/BIA-BDE/61553/2004 and grants SFRH/BD/31093/2006,
SFRH/BD/31048/2006, SFRH/BPD/27021/2006 to A.M., J. A. and P. J. E., respectively.
96
We are grateful to Dr. R. Soriguer (CSIC, Spain) for providing the RHDV sequences from
Albacete and Alicante, and to Oporto City Council, in particular to Dr. A. Pereira, for
providing the samples of the RHD outbreak of 2006. We thank the OIE Reference
Laboratory in Brescia and in particular Dr. L. Capucci for the antigenic characterisation of
the RHDV strain “Viseu”. We also thank the National Laboratory for Veterinary
Investigation (LNIV, Delegação do Norte) for infrastructural support.
Addendum
Detailed information on the samples and respective sequences referred to in this chapter
can be found in Appendices 1 and 2.
97
3.3 Evolution of RHDV in the Iberian Peninsula: A b rief review of recent findings .
Adapted from: II Seminario Internacional sobre el Conejo Silvest re. Córdoba 28-30
Abril 2010 (in press)
Muller, A. and Thompson, G. Departamento de Clínicas Veterinárias, Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto Adress: R. Padre Armando Quintas, P- 4485-661, Vairão-Portugal Telef.: ++351-252-660400, Email: [email protected] and [email protected]
98
99
Abstract
Since the early 1990s, rabbit haemorrhagic disease (RHD) has caused high mortality
rates in wild rabbit populations in the Iberian Pensinsula. It is now considered endemic
and continues to have considerable impact on species conservation and hunting industry.
Here we review current knowledge on the evolution of rabbit haemorrhagic disease virus
(RHDV) in the Iberian Peninsula. Our previous work (Muller et al. 2009, Vet. Microbiol.
135: 368-373) as well as recent work on the origin and phylodynamics of RHD (Kerr et al.,
2009, J. Virol. 83, 12129-12138; Kinnear and Linde, 2010, J. Gen. Virol. 91, 174-181) is
presented and discussed. Currently available sequence data of RHDV of the Iberian
Peninsula derive from the beginning of RHD outbreaks (AST89, MC89) and from different
geographic locations in Portugal (40 samples) and Spain (3 samples), as well as Southern
France (3 samples) obtained between 1994 and 2007. Phylogenetic analyses based on
partial VP60 gene sequences allowed a grouping of these RHDVs into three groups,
termed “Iberian” Groups IB1, IB2 and IB3. Interestingly, these three Iberian groups
clustered separately, though not far from earlier RHDVs of Genogroup 1 (containing e.g.
strain “AST89”), but clearly distinct from globally described RHDV strains. This result gave
rise to the hypothesis that the virus evolved independently on the Iberian Peninsula, with
the Pyrenees acting as a natural barrier to rabbit and virus dispersal (Muller et al 2009).
No differences were observed in RHDV sequences obtained from geographic regions
where the rabbit subspecies O. c. algirus prevails compared with those obtained from O.
c. cuniculus. The distinct clustering of these same Iberian RHDV sequences was
confirmed by more sophisticated phylogenetic analyses (Kerr et al., 2009). Times to most
common recent ancestor (TMRCA) for the different RHDV branches were estimated.
These gave a mean date of 1948 for the origin of “Iberian” strains. Both studies also
estimated that virulent RHDV probably emerged in the early 1900s, and that multiple virus
lineages were already circulating before the first reports of disease in 1984 (Kerr et al.,
2009; Kinnear and Linde, 2010). Both studies relate the emergence of virulent RHDV to
the intensification of rabbit production. We discuss these findings and conclude that if
virulent RHDV already existed in the Iberian Peninsula in the 1950s, their impact could
have been masked by mortalities due to the concomitant recent introduction of
myxomatosis. Despite evidence of genetic differences between RHDV field strains
currently circulating in the Iberian Peninsula and those circulating elsewhere; there is no
evidence that these affect protection induced by current commercially available vaccines.
Antigenic variants (RHDVa) have been found in a commercial rabbit farm in Portugal, but
not yet in wild rabbits. To our knowledge, no avirulent forms of RHDV or RCV-like viruses
have yet been found in Iberian wild rabbit populations, but further investigations are
100
warranted to address these issues. Also, more strains, especially from different locations
in Spain, should be analysed to enhance current understanding of RHDV evolution on the
Iberian Peninsula. Work was funded by FCT: SFRH/BD/31093/2006.
101
Introduction
Similar to other European countries, myxomatosis and rabbit haemorrhagic disease
(RHD) have been introduced into the Iberian Peninsula in the 1950s and early 1990s,
respectively (Anonymous, 1989; Monteiro, 1999; Muñoz, 1960; Villafuerte et al., 1995).
Within a few years of their introduction in wild rabbit populations, a severe decline in rabbit
abundance was recorded in the Iberian Peninsula to the extent that the wild rabbit is
currently considered “near threatened” by the World Conservation Union in 2008 (Smith
and Boyer, 2008). RHD is now considered endemic in Spain and Portugal, and despite
many efforts, rabbit numbers have not fully recovered (Delibes-Mateos et al., 2008b,
2009; Dias-Pereira et al., 2004; Moreno et al., 2007; Muller et al., 2004; Santos et al.,
2006; Villafuerte et al., 1995; Ward, 2005). The objective of the present manuscript is to
review current knowledge on the evolution of rabbit haemorrhagic disease virus (RHDV) in
the Iberian Peninsula. We will briefly present our previous work (Muller et al., 2009) as
well as recent work on the origin and phylodynamics of RHD (Kerr et al., 2009; Kinnear
and Linde, 2010) and discuss the practical implications of these findings.
1. Brief history
RHD was first reported in China in 1984. The disease spread throughout Europe, also
reaching the Iberian Peninsula, between 1987 and 1989. In the 1990s, the etiological
agent of RHD was characterised as a calicivirus (Ohlinger et al., 1990), and the virus was
introduced into Australia and subsequently New Zealand as bio-control agent against the
wild European rabbit population (Forrester et al., 2003). In an attempt to understand the
molecular epidemiology and ultimately the origins of RHD, phylogenetic analyses based
on partial sequences of the viral capsid protein VP60 of many viral isolates from different
countries were conducted (Asgari et al., 1999; Forrester et al., 2006; Le Gall-Recule et al.,
2003; Matiz et al., 2006; McIntosh et al., 2007; Moss et al., 2002; Nowotny et al., 1997).
These showed that there were up to six or more viral groups or subgroups and that virus
strains may or may not cluster according to their geographical origin and/or the year of
isolation, but that they did not always do so. Also, evidence was gathered on the current
and previous existence of RHDV-like viruses, collectively denominated rabbit caliciviruses
(RCV), which may have been circulating more or less harmlessly in Europe for many
years before the first epidemic appearance in China in 1984 (Forrester et al., 2006; Moss
et al., 2002; Rodak et al., 1990). RHDV-specific signals were detected by RT-PCR in
rabbit sera taken in the 1950s, concomitantly with the detection of RHD antibodies, but
infectiousness of viral RNA could not be proven (Moss et al., 2002). So, until recently, a
102
lot of information on the molecular epidemiology of RHDV in Europe and other countries
was gathered. However, detailed information on RHDV in the Iberian Peninsula was still
lacking, and further questions on the origin of RHD remained.
2. Evolution of rabbit haemorrhagic disease virus ( RHDV) in the European rabbit
(Oryctolagus cuniculus ) from the Iberian Peninsula
RHDV strains obtained from wild rabbits in different years and geographic locations in the
Iberian Peninsula were recently characterised (Muller et al., 2009). Briefly, 47 partial
RHDV sequences were analysed, that were obtained from wild rabbits that were found
dead during known epidemics of RHD in Portugal, Spain and France between 1994 and
2007. The majority, 40 viral sequences, were obtained from different geographic locations
of Portugal. Three RHDV sequences were obtained from wild rabbits from Spain: two from
Alicante and Albacete collected in 2004 (Dr. Ramon Soriguer, CSIC), and one from
Toledo collected in 1994 (CIBIO). Three of the four recent RDHV sequences from France
were collected between 2000 and 2002 in the Department “Pyrénées-Orientales”, and the
fourth in 2005 in the Department “Manche” (Dr. Le Gall-Recoulé, AFSSA). Nested PCR
was used to amplify partially the RHDV VP60 capsid protein gene (Moss et al. 2002). The
amplicons of 547bp were directly sequenced in both directions. The phylogenetic tree was
estimated by the neighbor-joining method as considered adequate for comparing relatively
short sequences (Takahashi and Nei, 2000). The obtained sequences were compared
with published homologues from GenBank database (NCBI). Eighteen sequences
representing previously described RHDV genogroups were selected and included. These
sequences were grouped into Genogroup 1 to 6, adapted to the classification used by Le
Gall-Reculé et al. (2003). The results of this phylogenetic analysis allowed a grouping of
these RHDV strains into three groups, termed “Iberian” Groups IB1, IB2 and IB3.
Interestingly, these three Iberian groups clustered separately, though not far from earlier
RHDVs of Genogroup 1 (containing e.g. strain “AST89”), but clearly distinct from globally
described RHDV strains. The Groups IB1 and IB2 contained sequences collected
between 1994 and 1997, whereas Group IB3 included those collected between 2000 and
2007. Each group contained sequences from different geographic locations, except Group
IB1, that contained five sequences obtained in Santarém district of central Portugal.
Interestingly, Group IB2 also included the virus obtained in 1994 from Toledo, Spain, and
Group IB3 also included the three sequences from the French Department “Pyrénée-
Orientales”, as well as the Spanish strains “Albacete” and “Alicante”. On the contrary, the
sequence obtained in 2005 from the Departement Manche in the North of France,
clustered amidst other European RHDV sequences of Genogroups 3-5. These findings
103
led to the hypothesis that virus evolution occurred independently in wild rabbit populations
on the Iberian Peninsula, with the Pyrenees acting as a natural barrier to rabbit and hence
to virus dispersal
3. The origin and phylodynamics of RHDV
Recently, two detailed and sophisticated phylogenetic analyses on RHDV were published
(Kerr et al., 2009; Kinnear and Linde, 2010). Importantly, Bayesian Markov Chain Monte
Carlo analyses were applied, allowing the estimation of viral nucleotide substitution rates,
as well as times to most common recent ancestors (MCRA), adding a temporal dimension
to the evolutionary reconstruction of RHDV. Despite some differences in methodology and
results, both studies agree on the identification of four distinct monophyletic groups or
clades of RHDV. Although contrasting previous studies (Forrester et al., 2003; Le Gall-
Recule et al., 2003; Moss et al., 2002), these findings are contributing substantially to the
warranted harmonisation of RHDV classification. Group 1 (Clade D) contained the
antigenic variants. Group 2 (Clade C) contained predominantly strains from the Iberian
Peninsula and South of France. Group 3 (Clade A) contains the “original strain” dating to
China 1984 as well as viruses from central Europe between 1987 and 1993, Korea and
Mexico. Group 4 (Clade B) contained strains from central Europe between 1989 and 2004
and Bahrein. The estimated dates for MRCA of the different groups of RHDV indicated
that virulent RHDV probably emerged in the early 1900s, and that multiple lineages were
likely circulating long before the first reports of disease in 1984. Both studies related the
evolution of RHDV with the intensification of rabbit production. Importantly, one of the
studies included some of our recent sequence data on Iberian RHDV, and confirmed our
findings of distinct clustering of Iberian strains (Kerr et al., 2009). Times to MRCA
indicated a mean date of 1948 for the origin of “Iberian” strains. Within this predominantly
“Iberian” group, two subgroups were described: viruses isolated between 1989 and 1997
and those isolated between 2000 to 2007, which have a mean TMRCA of around 1962.
The rabbit caliciviruses (RCV) displayed considerable divergence between each other and
also from all RHDV lineages, and a common ancestor was estimated to fall in 19th or early
20th century (Kerr et al., 2009; Kinnear and Linde, 2010). Thus, virulent RHDV most likely
did evolve from an avirulent RCV, but this would have occurred approximately 300 years
ago, and therefore would not explain the first observed epidemic in 1984 (Kerr et al.,
2009).
104
4. Discussion and Conclusions
Genetic differences have been found between current RHDV field strains of the Iberian
Peninsula and those elsewhere (Kerr et al., 2009; Muller et al., 2009). We hypothesized
that virus evolution occurred independently in wild rabbit populations on the Iberian
Peninsula (Muller et al., 2009). A mean date of 1948 for the origin of “Iberian” strains has
been estimated recently (Kerr et al., 2009). This suggests that virulent RHDV must have
been circulating already before the first recorded rabbit mass mortality in the late 1980s
and early 1990s in Spain and Portugal. The following question arises: is it possible that
RHD outbreaks already occurred in wild rabbit populations well before the 1980s, e.g. in
the 1950s and 1960s? We think it is possible and that they would likely have gone
unnoticed. Rabbit mortalities from the 1950s onwards coincided with the known
introduction of myxomatosis. RHD is an acute infection that induces discrete if any visible
signs and lesions, requiring necropsy for diagnosis. Other co-factors may have played a
role in incrementing the impact of RHD in wild rabbit populations between the 1950s and
1980s. Maybe the most notorious being major changes in agricultural practices, leading to
an increase in rabbit habitat defragmentation. Finally, only with the first description of RHD
in 1984, investigations on this new disease exploded and the disease was subsequently
actively searched for and thus reported from many countries, including Spain and Portugal
(Anonymous, 1989; Monteiro, 1999; Villafuerte et al., 1995). Current sequence data
consists mostly of strains obtained in Portugal, and it is unclear whether these are
representative for the whole of the Iberian Peninsula. Analyses of more RHDV field strains
especially from Spain and South of France are required to strengthen current findings and
to gain further insight into viral evolution and hopefully origins of RHD in the Iberian
Peninsula.
Only one single serotype of pathogenic RHDV is known, which contains two major
subtypes, denominated RHDV and the antigenic variants denominated RHDVa (Capucci
et al., 1998a; Schirrmeier et al., 1999), which have by now been described worldwide
(Farnos et al., 2007; Kerr et al., 2009; Le Gall-Recule et al., 2003; Matiz et al., 2006;
McIntosh et al., 2007). Although antigenic characterisations of current Iberian RHDV has
not been carried out, to our knowledge there is no evidence of antigenic variation. Current
vaccines are thus expected to be fully protective. Interestingly, although antigenic variants
(RHDVa) have been found in a commercial rabbit farm in Portugal (Muller et al., 2009),
these have not yet been found in wild rabbits in the Iberian Peninsula. Rabbit caliciviruses
(RCV) are a group of predominantly apathogenic viruses that display some antigenic
similarities, but are phylogenetically distant to RHDV (Bergin et al., 2009; Capucci et al.,
105
1996; Forrester et al., 2009; Forrester et al., 2007; Kerr et al., 2009; Moss et al., 2002;
Strive et al., 2010; Strive et al., 2009). The presence of a nonpathogenic virus closely
related to RHDV was already suspected at the time of the first RHD seroepidemiological
surveys, when specific RHDV antibodies were found in sera of farm and laboratory rabbits
where no disease was reported, and also in rabbit sera collected before the appearance
of RHD (Moss et al., 2002; Rodak et al., 1990). The drastic reduction in wild rabbit
numbers observed on the Iberian Peninsula has been historically unprecedented,
suggesting that RHDV-like apathogenic viruses were either not circulating, or, if they did,
they were probably not fully cross-protective. Active investigations on the presence of
avirulent RCV-like viruses on the Iberian Peninsula seem limited. We have analysed 68
samples from 2 healthy wild rabbit populations by nested RT-PCR. All samples were
negative, however serology was not performed (Muller et al., 2009). Thus to our
knowledge, no avirulent forms of RHDV nor RCV-like viruses have been found in Iberian
wild rabbit populations, but further investigations are warranted to address these issues as
they are expected to significantly add to current understanding of RHDV epidemiological
history.
Acknowledgements
This study was supported by the FCT grant SFRH/BD/31093/2006 to A.M.
106
107
3.4 Real-time PCR for the detection of rabbit haemo rrhagic disease virus (RHDV) - Preliminary results
Manuscript in preparation
108
109
Introduction
Rabbit haemorrhagic disease (RHD) is a contagious disease associated with high
mortality rates due to acute liver necrosis caused by a calicivirus, termed rabbit
haemorrhagic disease virus (RHDV) (Meyers et al., 1991b; Ohlinger et al., 1990). Since its
first description in the 1980s, RHD has established endemicity in wild rabbits in many
European countries (Anonymous, 1989; Calvete et al., 2002b; Le Gall-Recule et al., 2003;
Nowotny et al., 1997). Recent studies have shown that RHDV strains obtained from wild
rabbits in the Iberian Peninsula are genetically different from most others, forming a group
of its own (Kerr et al., 2009; Muller et al., 2009). Despite genetic variability, Iberian strains
are antigenically similar to other virulent strains, and distinct from the antigenic variants,
RHDVa. Current diagnostic methods include conventional PCR (Bascunana et al., 1997;
Moss et al., 2002) and antigen ELISA (OIE, 2009b). Recently, a real-time PCR was
developed for the detection and quantification of viral RNA of rabbits infected with RHDV
(Gall et al., 2007). This assay allowed the demonstration of viral RNA loads in different
organs at different time points after infection, as well as RNA persistence during at least
15 weeks in recovered and also in vaccinated and subsequently challenged rabbits (Gall
et al., 2007; Gall and Schirrmeier, 2006). Whether infectious virus is present in these
animals requires further investigations (Gall et al., 2007). Here, we describe a new real-
time PCR for the detection of RHDV strains, aiming a more sensitive detection of RHDV
circulating in the Iberian Peninsula as well as to quantify viral loads in experimental
infections using the Spanish strain AST89 (Genbank accession number Z49271).
Materials and methods
A total of 45 liver samples from 43 wild and 2 domestic European rabbits (Oryctolagus
cuniculus) from the Iberian Peninsula were tested. Twenty-one samples have previously
tested positive by convention nested PCR (Moss et al., 2002). Of these, nineteen were
obtained from wild rabbits and have recently been characterized genetically based on
sequence analysis of the partial major capsid VP60 gene (Muller et al. 2008) and two
(CD09 and CD10) derived from an outbreak in a commercial rabbit farm near Viseu, North
Portugal. The latter were characterized as antigenic variants or RHDVa strains by genetic
(HM450410) and antigenic analysis (L. Capucci, personal communication). Twenty four
samples were obtained from clinically healthy wild rabbit populations: five samples were
obtained 1994 near Toledo, Spain, ten samples were obtained 2006 in a hunting estate in
Pancas, Portugal and nine samples were obtained in 1992 near Santarém, Portugal. The
latter were obtained before the observation of RHD related mortality in that region (P.C.
110
Alves, personal communication). As positive control, liver homogenate was used from a
domestic rabbit that succumbed to RHD following experimental infection with the Spanish
strain AST89 (kindly made available by P. G. Ferreira, ICBAS-UP). The negative control
consisted of the mastermix with double distilled DEPC-treated water instead of RNA
template.
RNA was extracted from 10% w/v liver homogenates in DEPC-treated double distilled
water using QIAamp viral RNA extraction kit (Qiagen) according to the instructions of the
manufacturer. For the real-time PCR, a dual labeled probe, using FAM as fluorophor and
TAMRA as quencher was designed using the software Primer Express version 2 (Applied
Biosystems) based on the sequence encoding the partial VP60 gene sequence of the
spanish RHDV strain AST89 (Genbank accession number Z49271). After analysis of the
primer-probe pairs in light of the alignment of 60 international partial RDHV capsid
sequences available on GenBank (Appendix 3), the following degenerate primer probe
pair was designed to accommodate single nucleotide substitutions observed among
strains: probe rhdv_fam: 5´- FAM-TGGCATGCAGTTYCGCTTCATAGTTGC-TAMRA-3´
covering nucleotide positions 5649-5675 on AST89, forward primer rhdv_for: 5´-
GCCGTGCTGAGCCAGAT-3´ covering nucleotide positions 5613-5630 on AST89 and
reverse primer rhdv_rev: 5´-CGATGCCYGGTGGTATCA-3´ covering nucleotide positions
5731-5714 on AST89.
The qPCR mastermix was prepared using the SuperscriptTM Platinum One Step
Quantitative RT-PCR System (Invitrogen) in a final volume of 25µl, consisting of 20µl
mastermix and 5µl template RNA. Primers and probes at a concentration of 10µM were
added to each reaction at a volume of 0.5µl of each primer and of 0.25µl of the probe. The
thermocycling reaction was carried out in a Applied Biosystems Step One Thermocycler
with the following protocol: Reverse transcription: 50ºC for 15 minutes, activation of the
Taq enzyme: 95ºC for 2 minutes and 40 cycles at 95ºC for 15 seconds and 60ºC for 30
seconds. The performance of this real-time PCR was compared with an established fully
validated assay (Gall et al., 2007).
111
Results
A total of 45 samples were tested by a real-time PCR using the newly designed primer-
probe pair spanning nucleotide positions 5613 to 5731 of the RHDV AST89 capsid. These
samples were also tested by an established assay whose primer-probe pair spans
nucleotide positions 6941-7044 (Gall et al., 2007). The samples were classified as positive
or negative according to previous results obtained by a nested RT-PCR (Moss et al.,
2002; Muller et al., 2009) and partly by antigen ELISA (Monteiro, 1999).
The cycle threshold (Ct) values obtained by real-time PCR of the 21 positive samples are
shown in Table 5. Sequence information spanning nucleotide positions 6157 to 6703 of
the RHDV AST89 capsid were available for all samples and Genbank references are
indicated of those submitted. All except the two samples containing the antigenic variants
(CD09 and CD10) were included in a previous phylogenetic analysis, and are
representative of Iberian groups 2 and 3 (Muller et al., 2009). Sixteen of the samples were
detected by both real time assays. Six samples yielded a higher Ct value in the assay
described by Gall et al. 2007, six yielded higher values in the assay described here, and
four samples had very similar values. The positive control (strain AST89) had a slightly
lower Ct value in the assay described here. Five of the samples were not amplified in
either or both of the real-time PCRs. These include the four samples from a virulent RHD
outbreak observed in 2006 in Porto City Park and one sample obtained in Loulé, Algarve,
in 2005.
The twenty four negative samples as well as the no template control tested negative in the
assay described by Gall et al. 2007, and one sample (CB08 Pancas) gave a Ct value of
33.93 in the new real-time PCR assay described here.
112
Table 5 Cycle threshold (Ct) values obtained by th e application of two different primer-probe pairs in a real-time PCR assay of posi tive samples as determined by conventional nested RT-PCR (Moss et al., 2002)
Sample/Origin Comment Genbank
reference Geno-group Muller et al. 2009
Ct value Probe “VP60” Gall et al. 2007
Ct value Probe “RHD” this paper
CD09 Antigenic variant
HM450410 Geno-group 6
7.39 11.85
CD10 Antigenic variant
As HM450410 (Sample CD09)
Geno-group 6
7.68 11.32
2007-03 Virulent RHD
Sequence not submitted
IB 3 20.66 14.72
2007-04 Virulent RHD
Sequence not submitted
IB 3 19.94 13.31
CB98 Porto Virulent RHD
As EF571322 (Sample 2006_01)
IB 3 7.76 Below threshold
CB99 Porto Virulent RHD
As EF571322 (Sample 2006_01)
IB 3 Below threshold Below threshold
CB102 Porto Virulent RHD
As EF571322 (Sample 2006_01)
IB 3 31.03 Below threshold
2006-09 Porto Virulent RHD
EF571330 IB 3 Below threshold Below threshold
2005-01 Loulé Virulent RHD
EU192140 IB 3 Below threshold 17.78
2004-10 Loulé Virulent RHD
Sequence not submitted
IB 3 17.31 28.36
1995-01 Santarém
Virulent RHD
EU192132 IB 2 12.29 12.21
1994-02 Coruche
Virulent RHD
EU192136 IB 2 9.7 10.45
1997-03 Fornos
Virulent RHD
EU192139 IB 2 11.0 10.38
1997-01 Bragança
Virulent RHD
Sequence not submitted
IB 2 10.96 23.98
CB168 1996-08
Virulent RHD
EU192138 IB 2 10.67 10.61
1997-02 Santarém
Virulent RHD
EU192133 IB 2 11.91 15.33
1995-10 Coruche
Virulent RHD
Sequence not submitted
IB 2 14.52 14.34
1995-11 Coruche
Virulent RHD
Sequence not submitted
IB 2 10.93 10.18
1996-05 Guarda
Virulent RHD
Sequence not submitted
IB 2 34.71 27.81
1997-05 V. Conde
Virulent RHD
Sequence not submitted
IB 2 34.26 30.66
CB66 TOLEDO94
Unknown EU192137 IB 2 28.47 24.89
Control C15 - AST89
Positive control
Z49271 Geno-group 1
23.51 21.98
113
Discussion and conclusions
Here we show preliminary findings on the performance of a new real-time PCR for the
dual purpose of diagnostic detection of RHDV circulating in the Iberian Peninsula as well
as quantification of viral loads in infections using the Spanish strain AST89. A primer-
probe pair was designed based on nucleotide positions 5613-5731, which was compared
to a previously described, spanning nucleotides further downstream (positions 6941-7044)
of the major capsid protein gene (Gall et al., 2007). These positions were chosen, as the
region appears slightly more conserved, justifying the use of less wobble bases in the
primer-probe. Initially, an attempt was made to design a primer-probe pair for capsid
region typically targeted for sequencing, especially spanning nucleotides 6157-6703,
which were available for the RHDV obtained in wild rabbits in Portugal. The options given
by the primer design software were inspected visually on an alignment of 60 international
partial RDHV capsid sequences available on GenBank. The high variability in this region
did not allow succeeding, and none was found suitable. Hence, a different region from the
already described by Gall et al., 2007 was targeted, and is here presented.
Twenty one positive and 24 negative samples as classified by conventional PCR were
tested by real time PCR using the herein described primer-probe pair as well as the
previously described by Gall et al., 2007. A high agreement between both assays was
observed with the negative samples. Only one sample (CB08 Pancas) gave a Ct-value of
33.93 in the new real-time PCR. Interpretation of this sample is difficult, especially taking
into account that high Ct-values could be indicative of minimal amounts of target nucleic
acid which could represent an infection state or otherwise environmental contamination.
Further investigations would be necessary to clarify the true status of this sample as this
sample was taken from a healthy wild rabbit population. For example, the real-time assay
could be repeated with a larger amount of RNA template. Unfortunately serum was not
available for the determination of RHDV antibodies. If antibodies were present, viral RNA
persistence could be a possibility (Gall et al., 2007). Otherwise, seronegativity would not
rule out an early incubation period, so other methods should be used. A lower agreement
between tests was observed with the positive samples. Sixteen samples tested positive by
both assays, despite some variability between the individual ct-values. Only one well was
tested per sample, and pipetting errors are likely to account for this difference. Hence, the
use of two or more wells per sample must be considered during the validating of this
assay. Three samples were discordant, i.e. positive by one primer-probe pair but not the
other. And two samples were not detected by either real time PCR. Interestingly, the two
of the discordant as well as the two false negative samples corresponded to samples from
114
a virulent RHD outbreak in Porto City Park. These results suggest a rather lower
sensitivity of real-time PCR in comparison to conventional PCR. Although positive
samples have been used that have been genetically characterised, the sequence
information does not cover the genetic region targeted by the real-time PCR, so is of
limited value. The sequences targeted by both primer-probe pairs should be determined at
least for the samples that were not detected.
In conclusion, further studies are required to determine the tests performance. Especially
if intended for diagnostic screening, more samples of known status as determined by
conventional PCR should be tested, and the apparent low sensitivity be clarified. For the
quantification of viral loads in RHDV “AST89”-infections, the existent validated assay may
be used (Gall et al., 2007). Alternatively, the herein described primer-probes may be used,
as sequence alignments show high complementarity and ct-values are similar between
both tests. Ideally, the herein described primer-probe pairs should also be calibrated with
an internal control.
115
3.5 Real-time PCR for the detection of European bro wn hare syndrome virus (EBHSV) - Preliminary results
Manuscript in preparation
116
117
Introduction
European Brown hare syndrome (EBHS) affects wild and farmed hares and has been
described since the 1980s in many European countries (Billinis et al., 2005; Frolich et al.,
2001; Frolich et al., 2003; Frolich et al., 1996; Gavier-Widen and Morner, 1993; Le Gall-
Recule et al., 2006; Nowotny et al., 1997; Syrjala et al., 2005). The syndrome is
characterized by an acute and severe contagious necrotizing hepatitis with varying levels
of associated mortality. It is caused by a calicivirus termed European Brown hare
syndrome virus (EBHSV), which is similar to but distinct from rabbit haemorrhagic disease
virus (RHDV) which naturally infects the European rabbit (Oryctolagus cuniculus) (Wirblich
et al., 1994). Mortality rates of EBHS are difficult to estimate in nature as there are other
factors that may influence the density of hare populations such as climate, agricultural and
hunting practices or concurrent diseases such as tularaemia. Therefore, despite
associated morbidity and mortality, EBHS epidemics may not necessarily have any
negative effect on free living hare populations, and could remain unnoticed if the virus´
presence was not actively searched for (Gavier-Widen and Morner, 1993). Mortality rates
of EBHS are considered to be lower than for RHDV, thus it is possible, that more
attenuated or even avirulent EBHSV circulate in hare populations, similar to what has
been postulated for RHDV (Forrester et al., 2003; Moss et al., 2002). To date, the virus
has been found to cause death in two hare species, the European hare (Lepus
Europaeus) and the Mountain hare (Lepus timidus) (Frolich et al., 2001; Gavier-Widen
and Morner, 1993; Syrjala et al., 2005). To our knowledge, however, neither EBHS-related
mortality nor seroconversion has ever been reported in the Iberian or Granada hare
(Lepus granatensis). The Iberian hare occupies a large variety of habitats in the central
and southern Iberian Peninsula (Alves et al., 2008; Melo-Ferreira et al., 2005). Just a
small fringe from Galicia and Asturias in the Northwest of Spain over to Catalonia in the
east is occupied by the European hare. In these, EBHS has been documented (P. C.
Alves, personal communication). The habitat of both hare species overlap in a contact
zone, so virus spread can be expected (Alves et al., 2008; Melo-Ferreira et al., 2005).
Further studies are required to clarify the presence of EBHSV in Iberian hare populations.
Different diagnostic methods have been validated for EBHS, such as histopathology
(Fuchs and Weissenbock, 1992), haemagglution tests and antigen ELISA (OIE, 2009b),
an immunocapture RT-PCR (Le Gall-Recule et al., 2006) and a nested RT-PCR
(Bascunana et al., 1997). For its ease of use and high sensitivity, the latter is frequently
used, either in its nested form (Syrjala et al., 2005) or using the external primer pair only
(Billinis et al., 2005). Recently, quantitative real-time assays have become available for
the detection and quantification of viral genomes, including the related RHDV (Gall et al.,
118
2007). Advantages of these assays are that they are even more rapid than conventional
molecular techniques, they reduce laboratory contaminations and are potentially more
sensitive, facilitating higher sample throughput. Here we describe the development of a
real-time PCR assay for the detection of EBHSV in hares, and its applications in field
samples of Iberian hares.
Materials and Methods
A total of 22 liver samples from wild hares and 1 liver sample of a domestic rabbit
(Oryctolagus cuniculus) infected with RHDV were tested. Five samples were from
European hares from Austria that had died with clinical signs and lesions suggestive of
EBHS (kindly made available by Dr. Nowotny, Department of Clinical Virology, University
of Veterinary Medicine, Vienna). These samples have previously tested positive by the
haemagglutination test using human group O red blood cells as described (OIE, 2009b).
The remaining samples were obtained from the Iberian hare (Lepus granatensis) in
Portugal. Five specimens were obtained from a hunting bag of healthy hares in
Benavente, in the North of Portugal, whereas 12 were taken from animals that were found
dead in the southern Province Algarve. The latter were subjected to necropsy and
displayed heavy infestation with the parasite cysticercus pisiformis. Gross pathological
and histopathological lesions did not suggest EBHS infection (RIPAC, 2004).
RNA was extracted from 10% w/v liver homogenates in DEPC-treated double distilled
water using QIAamp viral RNA extraction kit (Qiagen) according to the instructions of the
manufacturer. Conventional nested PCR was carried out as described (Bascunana et al.,
1997) using a one step RT-PCR kit (Qiagen). PCR amplicons were visualized under UV
light after GelRedTM (Biotium) nucleic acid gel staining.
For the real-time PCR, a dual labeled probe, with FAM as fluorophor and TAMRA as
quencher, was designed using the software Primer Express version 2 (Applied
Biosystems) based on the sequence encoding the partial VP60 gene sequence of the
EBHSV strain Austria 94b (Genbank accession number U65359). A multiple sequence
alignment of 52 international partial EBHSV capsid sequences available at GenBank was
carried out (Figure 4) using the software Bioedit Version 7 (Hall, 1999). The following
degenerate primer probe pair was designed to accommodate single nucleotide
substitutions observed among strains: Probe ebhs_fam: 5´- FAM- TGC RAT TGT YAC
AAC ACC TGG RAC ACC-TAMRA-3´, forward primer ebhs_for: 5´- CCA CAT AYA CCC
CAC AAC CA-3´ and reverse primer ebhs_rev: 5´- RCC AAT RGG TGC RGC RA . The
119
qPCR mastermix was prepared using the SuperscriptTM Platinum One Step Quantitative
RT-PCR System (Invitrogen) in a final volume of 25µl, consisting of 20µl mastermix and
5µl template RNA. Primers and probes at a concentration of 10µM were added to each
reaction at a volume of 0.5µl of each primer and of 0.25µl of the probe. The thermocycling
reaction was carried out in a Applied Biosystems Step One Thermocycler with the
following protocol: Reverse transcription: 50ºC for 15 minutes, activation of the Taq
enzyme: 95ºC for 2 minutes and 40 cycles at 95ºC for 15 seconds and 60ºC for 30
seconds.
120
Figure 4 Alignment of EBHSV partial capsid gene se quences and primer-probe pairs selected for real-ti me PCR. The shown nucleotide positions correspond to positions 1332-1 421 of the VP60 capsid gene and to positions 6563-6 652 of the complete EBHSV genome (examples strain “GD”, Genbank accession num bers Z32526 and Z69629, respectively)
111 111 111 122 222 222 223 333 333 333 444 444 444 455 555 555 556 666 666 666 777 777 777 788 888 888 889 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 U65359_Austria_94b ggc cgc cac cac ata cac ccc aca acc aag tgc aat tgt cac aac acc tgg aac acc tgt tgc tgc acc cat tgg caa gaa tac acc gat U65365_Germany_89b ... t.. ... ... ... ... .. . ... ... ... ... ... ... t.. ... ... ... ... ... . .. ... ... ... ... ... ... ... c.. ... ... U65371_Sweden_93 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... U65363_Finland_90 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z32526_EBHSV-GD ... t.. ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. ... ... U65362_Czech_R_91 ... t.. ... ... ... ... ... ... g.. ... ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... U65361_Belgium_90 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... t.. U65358_Austria_94a ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... t.. U65357_Austria_93 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... t.. U65367_Germany_90b ... t.. ... ... ... t.. ... ... ... ... ... ... ... t.. ... ... c.. ... ... ... c.. ... ... ... ... ... ... ... ... ... U65356_Austria_92 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... t.. X98002_Italy_BS89 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... U65366_Germany_90a ... t.. ... ... ... t.. ... ... ... ... ... ... ... t.. ... ... c.. ... ... ... c.. ... ... ... ... ... ... ... ... ... U65364_Germany_89a ... t.. ... ... ... ... ... c.. ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... ... ... ... ... c.. ... ?.. U09199_pEB-2_and_pEB-4 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... ... ... ... ... ... ... t.. ... ... ... c.. ... ... U65372_UK_91 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... ... ... ... ... ... ... t.. ... ... ... c.. ... ... U65360_Belgium_89 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... ... ... ... ... ... ... t.. ... ... ... c.. ... ... U65368_Sweden_81 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... ... ... ... ... ... ... ... U65370_Sweden_82b ... t.. ... ... ... ... ... g.. ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... ... ... ... ... ... ... ... U65369_Sweden_82a ... t.. ... ... ... ... ... g.. ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... ... ... ... ... ... ... ... Z69620_France_GD ... t.. ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. ... ... AJ971300_France_9101 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... c.. ... ... DQ862478_Slovakia_DV1 ... t.. ... ... ... ... t.. ... ... ... ... g.. ... t.. ... ... ... ... g.. ... ... ... ... ... ... ... ... c.. ... ... AJ971311_France_0102 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... g.. ... ... ... c.. ... c.. ... ... ... ... ... ... ... t.. AJ971299_France_9005 ... t.. ... ..a t.. ... ... ... ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... t.. ... ... ... c.. ... ... AJ971310_France_0022 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... g.. ... ... ... c.. ... c.. ... ... ... ... ... ... ... t.. AJ971302_France_9930 ... t.. ... ... ... t.. t.. ... ... ... ... g.. ... t.. ... ... ... ... ... ... ... ... g.. ... ... ... ... ... ... ... AJ971308_France_9917 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. ... t.. AJ971314_France_0257 ... t.. ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... c.. c.. c.. ... ... ... ... a.. ... ... t.. AJ971313_France_0149 ... t.. ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. c.. ... ... ... ... ... ... ... t.. AJ971309_France_0006 ... t.. ... ... ... ... ... ... ... ... ... c.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. ... t.. AJ971305_France_0101 ... t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... c.. ... ... AJ971301_France_0252 a.. t.. ... ... ... ... ... ... ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... t.. ... ... ... c.. ... ... AJ971304_France_0251 ... t.. ... ... ... ... ... ... ... ... ... g.. ... t.. t.. ... ... ... ... ... ... ... ... ... ... t.. ... c.. ... ... AJ971303_France_0004 ... t.. ... ... ... ... ... ... ... ... ... g.. ... t.. t.. ... ... ... ... ... ... ... ... ... ... t.. ... c.. ... ... AJ584643_Greece ... t.. t.. ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. c.. ... ... ... t.. ... ... ... c.. AJ971315_France_0305 ... t.. ... ... ... t.. ... ... ... ... ... ... ... t.. ... ... ... ... ... ... c.. c.. ... ... ... ... ... ... ... t.. AJ971312_France_0129 ... t.. t.. ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. c.. ... ... ... ... a.. ... ... t.. AJ971306_France_0256 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. ... ... AJ971307_France_0303 ... t.. ... ... ... ... ... ... ... ... ... ... ... a.. ... ... ... ... ... ... ... ... ... ... ... ... ... c.. ... ... DQ862480_Slovakia_N8k ... t.. ... ... ... ... ... ... ... ... ... g.. ... ... ... g.. ... ... ... ... ... ... ... ... c.. t.. ... ... ... ... DQ862478_Slovakia_DV1(2) ... t.. ... ... ... ... t.. ... ... ... ... g.. ... t.. ... ... ... ... g.. ... ... ... ... ... ... ... ... c.. ... ... AM048854_Greece_GRE-8 ... t.. t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .a. ... ... ... ... ... ... ... U80981_Sweden_77 ... t.. ... ... ... ... ... g.. ... ... ... ... ... t.. ... ... ... g.. ... ... ... ... ... ... ... ... ... ... ... ... DQ862479_Slovakia_bc3 ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... t.. ... c.. ... t.. AM048851_Greece_GRE-5 ... t.. ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. c.. ... ... ... ... ... ... ... c.. AM048853_Greece_GRE-7 ... t.. t.. ... ... t.. ... ... ... ... ... ... ... ... ... ... ..a ... ... ... c.. ... ... ... ... ... ... c.. ... ... AM048849_Greece_GRE-3 ... t.. t.. ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. c.. ... ... ... t.. ... ... ... c.. AM048848_Greece_GRE-2 ... t.. ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... g.. ... c.. c.. ... ... ... t.. ... c.. ... c.. AM048850_Greece_GRE-4 ... t.. ... ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... g.. ... c.. c.. ... ... ... t.. ... c.. ... c.. AM048847_Greece_GRE-1 ... t.. t.. ... ... t.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... c.. c.. ... ... ... t.. ... ... ... c.. AM048852_Greece_GRE-6 ... t.. ... ... ... tt. ... ... t.. ... ... ... ... ... ... ... ... ... ... ... c.. c.. ... ... ... ... ... ... ... c.. PRIMER-PROBE ggc cgc cac cac ata yac ccc aca acc aag tgc rat tgt yac aac acc tgg rac acc tgt rgc rgc acc rat tgg raa gaa tac acc gat
121
Results
Of the five samples from European hares obtained from Austria, four tested positive by
conventional PCR and yielded ct-values between 22 and 25 by real-time PCR, and one
tested negative by both, conventional and real-time PCR (Table 6). These five samples
had been found positive by the haemagglutination test. The 17 samples obtained from
Iberian hares were found negative by the conventional nested PCR as well as by real-time
PCR (Table 6). The sample of a RHDV-positive rabbit tested negative by real-time PCR.
Table 6 Comparison of diagnostic tests for the det ection of European brown hare syndrome virus (EBHSV)
Sample Host History PCR-I PCR-II qPCR
(Ct value) 594/04 Wien Lepus Europeus Died, EBHS POSITIVE not tested 22,94 684/04 Wien Lepus Europeus Died, EBHS POSITIVE not tested 22,78 273/04 Wien Lepus Europeus Died, EBHS negative negative undetermined*) 685/04 Wien Lepus Europeus Died, EBHS POSITIVE not tested 25,92 717/04 Wien Lepus Europeus Died, EBHS POSITIVE not tested 24,96 Benavente 1 Lepus granatensis Healthy, hunted negative negative undetermined Benavente 2 Lepus granatensis Healthy, hunted negative negative undetermined Benavente 3 Lepus granatensis Healthy, hunted negative negative undetermined Benavente 4 Lepus granatensis Healthy, hunted negative negative undetermined Benavente 5 Lepus granatensis Healthy, hunted negative negative undetermined Algarve L8 Lepus granatensis Found dead negative negative undetermined Algarve L10 Lepus granatensis Found dead negative negative undetermined Algarve L11 Lepus granatensis Found dead negative negative undetermined Algarve L12 Lepus granatensis Found dead negative negative undetermined Algarve L17 Lepus granatensis Found dead negative negative undetermined Algarve L18 Lepus granatensis Found dead negative negative undetermined Algarve L19 Lepus granatensis Found dead negative negative undetermined Algarve L20 Lepus granatensis Found dead negative negative undetermined Algarve L21 Lepus granatensis Found dead negative negative undetermined Algarve L22 Lepus granatensis Found dead negative negative undetermined Algarve L23 Lepus granatensis Found dead negative negative undetermined Algarve L24 Lepus granatensis Found dead negative negative undetermined RHD AST89 Oryctolagus
cuniculus Rabbit with RHD not tested not tested undetermined
*) undetermined means ct-value below threshold
Ten-fold dilution series of two positive samples were tested by simple and nested
conventional PCR assay (Table 7). The threshold of detection for the nested reaction was
the same as the observed after a single PCR. Positive reactions were obtained at dilutions
of 10-5 and 10-7 of samples 685/04 and 684/04, respectively.
122
Table 7 Comparison of simple and nested PCR for th e detection of European brown hare syndrome virus (EBHSV) in 10-fold diluti ons of samples 684/04 and 685/04
Sample Dilution PCR-I PCR-II 685/04 Neat + +
10-1 + + 10-2 + + 10-3 + + 10-4 + + 10-5 + + 10-7 - - 10-8 - - 10-9 - -
684/04 Neat + + 10-1 + + 10-2 + + 10-3 + + 10-4 + + 10-5 + + 10-6 + + 10-7 + + 10-8 - - 10-9 - -
Discussion
Since the 1980s mortalities have been described in wild hares in many European
countries. Interestingly, in the Iberian hare (Lepus granatensis), which occupies most
areas of central and south of the Iberian Peninsula, to our knowledge, neither unusual
mortalities due to EBHS nor the presence of the virus have been reported. This may partly
be due to the lack of active diagnostic investigations. In order to be able to engage in
further investigations on the presence of EBHS in the Iberian Peninsula, we developed an
EBHS-specific real time PCR. Here, we present preliminary findings on its performance.
As the virus has not yet been detected in the Iberian hare, we used five samples from
European hares obtained in 2004 in Austria. These samples had previously tested
positive by the haemagglutination test, and thus were considered positive for EBHSV.
Interestingly one of these samples tested negative by both PCR assays. The reasons for
this discrepancy have not been determined. Both situations are possible: a false positive
result by the agglutination test, or alternatively, a false negative result by the molecular
methods. The former may be induced by any unspecific agglutination reaction and the
latter by viral strains not detected by the specific primers. The assessment of the
sensitivity of the real-time PCR requires the testing of larger numbers of positive samples
123
by haemagglutination as well as both PCR assays. Serial dilutions of two positive samples
were tested by a single and nested PCR reaction. No differences were observed in the
detection threshold of either. This suggests that the nested reaction may be omitted for
diagnostic purposes. These dilutions should also be tested by real-time PCR to allow
estimation of the detection thresholds of both assays. Typically, the development and
validation of real-time PCR includes the testing of dilution series of a positive control
consisting of a vector containing the appropriate template (Gall et al., 2007). This was not
performed as we pretend to use the EBHS real-time PCR for diagnostic purposes and not
for the measurement of viral loads in infected animals. Thus we consider the
determination of performance of the presented real-time PCR satisfactory by comparing it
to currently established assays. Seventeen samples from Iberian hares were available.
Five samples were obtained from healthy hares during hunting, and twelve samples were
obtained from hares found dead in the field. The lesions observed in the latter were not
considered typical of EBHS. These samples were tested by conventional and real-time
PCR, and found negative by both, suggesting good agreement. However, considering the
possibility of virus variants going undetected by the specific primers, these samples
should also be tested by the more robust haemagglutination test. A sample of a RHDV
infected rabbit tested by real-time PCR, suggesting no cross-reactivity between viruses,
similar to the observed for the conventional PCR (Bascunana et al., 1997). To obtain a
more accurate estimation of the specificity of the real-time PCR, more samples should be
tested, ideally by the three assays.
In conclusion, our preliminary studies on the performance of a real-time PCR for the
detection of EBHSV in liver samples suggest that this test may be a valuable tool for the
rapid screening of large numbers of samples. More samples need to be tested to
determine the sensitivity and specificity of this real-time PCR. Further studies on the
putative presence or absence of EBHS in the Iberian hare will also require the application
of complementary diagnostic tools, such as serology to rule out asymptomatic infections.
124
125
4. Discussion
126
127
Myxomatosis and rabbit haemorrhagic disease (RHD) are highly infectious diseases
which have emerged in wild European rabbit populations (Oryctolagus cuniculus) in the
1950s and 1980s, respectively. In the first years after their appearance, high mortality
rates were observed, but in subsequent years, the impact of these infections seemed to
have decreased, and the hypothesis was postulated that these viruses were co-evolving
with their hosts, leading to adaptation by the selection of less virulent strains and more
resistant hosts (Fenner and Ross, 1994; Kerr and Best, 1998; Villafuerte et al., 1995). It is
within this context, that the present studies were designed, aiming to contribute to the
current knowledge on virus-host adaptation and co-evolution of MV and RHDV in their
natural host, by analysing the (partial) genetic variability of the viruses.
Four specific objectives were initially outlined, but as work was being carried out, some
modifications were made. The first and second objectives, to genetically characterize viral
strains of myxoma virus and RHDV obtained from wild rabbits from Portugal and to
compare findings with those obtained for other international strains, were considered to be
completed successfully, and two research papers were published (Muller et al., 2009;
Muller et al., 2010). The third objective, to correlate our findings with those obtained of the
genetic variation of host cell receptors in order to approach the question related to viral
and/or host adaptation and co-evolution was not achieved in form of a research paper and
will form the centrepiece of this discussion. The fourth objective, to development of real
time PCR assays for RHDV and EBHS was added in the course of progressing work, as it
was increasingly being considered a priority for our research group, as collaborations with
other research groups and new research projects were being developed. Primers and
probes were developed and the preliminary findings on the performance of these real time
assays were presented. In addition, an invite was received from the “Junta de Andalucia”
to participate in the “2nd International Seminar on the Wild Rabbit” with an oral
presentation on the evolution of RHD in the Iberian Peninsula. This Seminar was held in
the context of the Project “Conservation and Reintroduction of the Iberian Lynx in
Andalucia”, LIFE 06/NAT/000209. A more detailed manuscript written for inclusion into the
Seminar´s Report is therefore also presented in this thesis.
Within each publication or chapter on original work of this thesis, discussions on the
respective subjects have been presented. Here we shall integrate all recent findings on
the current knowledge of virus-host adaptation of myxomatosis and RHD.
128
4.1 Virus-host adaptation and co-evolution of myxom a virus in the European rabbit
Several studies and models have led to the following hypothesis on virus-host co-
evolution for myxomatosis (Anderson and May, 1982; Fenner, 1994; Fenner and Chapple,
1965; Kerr and McFadden, 2002; Ross and Sanders, 1987). Within the first years of the
introduction of highly virulent MV into wild rabbit populations, high case-fatality rates were
observed. The following years, viral virulence dropped and attenuated strains appeared,
that allowed the rabbits to survive for longer. Rabbits with high innate resistance to
disease survived initial epidemics, raising the proportion of resistant rabbits over time. In
these resistant rabbits, viruses of moderate or low virulence would be too attenuated to be
successfully transmitted and thus, more strains of intermediate to high virulence started
again to be selected for and to become more prevalent.
The first question requiring analysis on the virus-host adaptation and co-evolution of
myxoma virus in the European rabbit in the Iberian Peninsula is: What evidence do we
currently have, to support that there has been a change in viral virulence of the virus since
its introduction? Recent information in Europe is scarce, and mostly relates to studies in
Great Britain. For example, between 1962 and 1981, similar proportions (62-67%) of
moderately virulent grade III viruses were observed, together with a slight increase in
grade II viruses since from 1962 (17.6%) to 1981 (35.8%) (Fenner and Chapple, 1965;
Ross and Sanders, 1987). Information on the virulence of field strains in the Iberian
Peninsula relates to only one study, carried out in the 1990s (Bárcena et al., 2000). Here,
the virulence of twenty field strains from different locations in Spain was assessed in
inoculated and in-contact rabbits. Interestingly, three quarter of the viruses were classified
as highly virulent grades I (50%) and II (25%). The remaing strains were graded as
moderately virulent grade III (10%), and attenuated grades IV (5%) and V (10%).
However, very stringent experimental conditions using very high inoculation doses in very
young animals were employed, not following the established protocol (Fenner and
Marshall, 1957). This experiment included transmission to other rabbits by contact.
Interestingly, the average survival time recorded in the contact-infected rabbits allowed
the classification of over half (55%) of the field strains as moderately virulent grade III, and
none as grades I and II. The results obtained by the in-contact animals were considered
more suitable for comparison to previous studies in Great Britain (Bárcena et al., 2000). In
our study we present the partial genetic characterisation of nine myxoma virus field strains
obtained from rabbits with signs and/or lesions of myxomatosis. Based on the presence of
signs and/or lesions of myxomatosis, we classified the analysed strains as virulent and
129
discussed, that the genetic changes found on these strains were compatible with a
virulent phenotype. Field evidence of attenuated or atypical forms of disease is very
difficult to obtain, as these may go undetected. In an attempt to detect less virulent strains,
we also tested eyelid samples from 30 apparently healthy wild rabbits by three
consecutive passages on the highly susceptible cell line RK-13 as well as PCR, but
results were negative. Strictly speaking however, inoculation experiments and virulence
grading (Fenner and Marshall, 1957) would have to be performed with our field samples.
This would be of particular importance, as strains of virulence grades III and IV also
induce signs and lesions, but average survival times are longer than for strains of higher
virulence grades. Mortality rates are also higher for the former, so a varying proportion of
infected and symptomatic animals may actually recover, which is not the case for
infections with viruses of virulence grades I and II, where mortality is above 95%. So, the
possibility does exist, that the nine field strains herein analysed, actually pertained to
different virulence grades. On the other hand, the difficulty in standardizing the
experimental conditions for the assessment of virulence grades has been described
(Bárcena et al., 2000; Parer, 1995; Parer et al., 1994). Factors such as ambient
temperature, age, dose and route of challenge influence outcome of infection (Bárcena et
al., 2000; Fenner and Ross, 1994). Reliable and more simple systems of measuring viral
virulence would be extremely utile for the evaluation of current field strains aiming to
further corroborate the above described hypothesis on virus-host co-evolution for
myxomatosis. To bypass ethical concerns and reduce potencial variability related to the in
vivo virulence testing, the development of an equivalent in vitro assay, would be highly
desirable. Attempts have been made using diverse assays, including pock counts on the
allantoic membrane of chick embryos (Fenner and Marshall, 1957) or RFLP assays (Kerr
et al., 2010; Saint et al., 2001), but no consistent correlation has been found with virulence
grades. Futher studies are required to address this subject, for example, by using different
cell cultures and/or measuring the production of cytokines induced by different viruses in
cell cultures, or assessing other putative molecular markers of virulence.
What are the molecular mechanisms underlying myxoma virus virulence? A whole
genome comparison of the virulent myxoma strain “Lausanne”, and its attenuated field
derivative “6918” mapped the attenuated phenotype to potentially four disrupted genes
(Morales et al., 2009). Inoculation experiments of genetically engineered “knock-out”
viruses have shown that many unrelated gene deletions are also related with an
attenuated phenotype (Johnston and McFadden, 2003, 2004; Stanford et al., 2007c;
Willer et al., 1999). In other words, the disruption of many different genes may lead to
attenuated phenotypes, suggesting that attenuation is not a ”site-specific” genetic event,
130
but that many different disruptions may have that consequence. This raises yet another
question. Are the attenuated myxoma viruses observed in the field a consequence of
evolutionary pressures imposed by adaptation to its new host, or are they due to
stochastic events related, for example, to “errors” during virus replication? In a recent
study in Australia, up to three different genetic types were found in epidemics, suggesting
that multiple viruses may co-exist in a given area at given time-point (Kerr et al., 2010).
Further studies attempting to clarify this subject are necessary for the European context,
first, because different circulating strains derived from a different ancestor, and second,
because in Australia multiple virus introductions were realized. Whole genome or at least
RFLP analyses should be carried out on field viruses, as partial genetic approaches, e.g.
as taken in our study and elsewhere (Alda et al., 2009; Kritas et al., 2008; Muller et al.,
2010) are likely to miss important changes.
Summarizing, myxoma virus evolution over the past six decades, in particular in the
Iberian Peninsula, is difficult to assess. Data on virus strains shortly after the introduction
of the virus is lacking, but as the same strain was introduced elsewhere in Europe,
information from other countries may be extrapolated. Recent studies on the virulence and
the genetic characterisation of circulating field strains have been carried out (Alda et al.,
2009; Bárcena et al., 2000; Muller et al., 2010). The interpretation on the virulence
gradings may be somewhat ambiguous, but ultimately suggests that virus strains of
intermediate virulence are predominating in the field (Bárcena et al., 2000). Our findings
did not specifically address the virulence gradings of field strains, but we were only able to
include field strains from animals with signs and/or lesions, as no virus could be isolated
from apparently healthy animals (Muller et al., 2010). Similar to other viruses, evolution of
myxoma viruses is expected to be reflected by genetic changes in the viral genome. The
genetic characterisation of poxviruses is difficult due to the large size of the virus and
different approaches have been taken to detect genetic changes either reflecting
attenuation and/or evolution (Alda et al., 2009; Kerr et al., 2010; Muller et al., 2010; Saint
et al., 2001). Our data on the partial genetic characterisation has shown little differences
between field strains (Muller et al., 2010). A recent study on field strains from different
locations in Spain has obtained similar findings, further strengthening the idea of a
relatively high genetic stability of myxoma virus over time (Alda et al., 2009). Although this
this is quite expected for large DNA viruses such as poxviruses (Gubser et al., 2004; Xing
et al., 2006), it seems to contradict the hypothesized evolutionary pressures suffered by
myxoma virus in its new host, which are reflected by changes in virulence.
131
The second question on virus-host adaptation and co-evolution of myxoma virus in the
European rabbit in the Iberian Peninsula is related to the putative selection of
myxomatosis-resistant rabbits within the past 5-6 decades. As above, this subject is also
difficult to address, because it typically requires animal inoculation experiments. Most
older studies relied on the capture of young rabbits in the field and the selection of
seronegative individuals in challenge experiments with viruses of known virulence. The
immunodiffusion test was initially widely used to determine if rabbits were immunologically
naïve prior to experimental inoculation, but this test was later shown to be rather
inconsistent and substituted by others such as ELISA (Kerr and McFadden, 2002; Kerr,
1997; Williams et al., 1973). So, initial data may carry some bias due to the inclusion of
immunised animals. Most studies were carried out either in Australia or in Great Britain
(Edmonds et al., 1975; Ross and Sanders, 1984). We are not aware of studies addressing
this subject in the Iberian Peninsula, where two different subspecies of the wild rabbit
exist, displaying a higher genetic diversity than elsewhere (Branco et al., 2000; Ferrand,
2008; Ferrand and Branco, 2007). Theoretically it would be conceivable that selection of
resistant rabbits would be a slower process in the Iberian Peninsula and that currently a
much smaller proportion of resistant rabbits would be present than elsewhere. But specific
studies are required to detect and characterise the proportion of resistant rabbits in the
field. The genetic basis for resistance of rabbits to myxomatosis remains unknown. Some
work has focussed on the identification and characterisation of putative viral receptors. In
particular chemokine receptors such as CCR-5 and CXCR4, that present features unique
to Oryctolagus may be related with the species´ susceptibility to infection (Abrantes et al.,
2010; Abrantes et al., 2008a; Abrantes et al., 2008b; Carmo et al., 2006). Others have
based on the characterisation of microsatellites (Surridge et al., 1999). In whichever, in
vivo and/or in vitro infection assays are required to consolidate these hypotheses. Another
possible explanation for resistance are differences in tissue tropism or an enhanced
immune response (Kerr and McFadden, 2002). Differences may sometimes but not
always be found in the virus tropism for lymphocytes of different rabbits (Best and Kerr,
2000; Kerr and McFadden, 2002). This issue merits further investigations.
The investigation of a putative enhanced immune response is complex, because during
successful myxoma virus replication, many different proteins may be secreted that may
interact in different ways, modulating the hosts’ immune responses, affecting clinical
outcome (Johnston and McFadden, 2003; Kerr and McFadden, 2002; Messud-Petit et al.,
1998; Stanford et al., 2007c; Zuniga, 2002). Current knowledge on the in vivo secretion
and physiological effect of these proteins is scarce. The up or down regulation of the
secretion of these proteins may be triggered by complex, to date unknown, host factors
132
present in some rabbits but not others. The interaction between myxoma virus and the
hosts immune system is more difficult to assess than putative viral receptors, and may
require the study of complete host genomes as proposed in the context of susceptibility to
infectious disease in general (Schnappinger and Ehrt, 2006; Tuite and Gros, 2006; Vidal
et al., 2008).
4.2 Virus-host adaptation and co-evolution of RHDV in the European rabbit
In analogy to myxomatosis, the following questions on virus-host adaptation and co-
evolution of RHDV in the European rabbit require attention. What evidence do we
currently have, to support that there has been attenuation of the virus? Not much, really.
Actually, the contrary hypothesis prevails. Virulent RHDV strains appear to have resulted
from avirulent strains which probably have been circulating in wild rabbit populations for
decades before the first description of RHD (Forrester et al., 2006; Forrester et al., 2007;
Kerr et al., 2009; Kinnear and Linde, 2010; Moss et al., 2002). The molecular base related
to this switch in virulence has yet to be defined. The presence of avirulent strains similar
to RHDV, denominated rabbit caliciviruses or RCV-like viruses, has been described in
some countries, but generally seem difficult detect consistently (Forrester et al., 2009;
Forrester et al., 2007; Strive et al., 2010; Strive et al., 2009). In an attempt to detect
avirulent RHDV or RHDV-like viruses, we analysed 30 liver samples from a healthy wild
rabbit population by nested RT-PCR, but found no evidence of virus infection (Muller et
al., 2009). Further studies are required to amplify these preliminary findings, bearing in
mind that RCV-like viruses, which are genetically different from RHDV, may also be
circulating in the Iberian Peninsula, but have not yet been described there. Hence,
sampling should include intestine as well as liver, and diagnostic assays should include
serology as well as RCV and RHDV-specific (or crossreactive) methodology.
Pathogenesis studies must be carried out to determine if detected viruses are virulent or
not. This is essential, because viral RNA but apparently not infectious virus may persist for
several weeks after recovery from acute RHDV infection or even upon challenge of
vaccinated rabbits (Gall et al., 2007; Gall and Schirrmeier, 2006).
We have genetically characterised so called “virulent” RHDV, obtained from wild rabbits
that died from RHD in different locations of the Iberian Peninsula (Muller et al., 2009).
Similar work has previously been carried out for many other European RHDV field strains
(Asgari et al., 1999; Forrester et al., 2006; Le Gall-Recule et al., 2003; Le Gall-Recule et
al., 2006; Matiz et al., 2006; McIntosh et al., 2007; Moss et al., 2002; Nowotny et al.,
133
1997). Surprisingly, our results appointed a distinct grouping of field strains from the
Iberian Peninsula. We hypothesized that field strains from the Iberian Peninsula and
South of France may have evolved distinctly from most other European or worldwide
RHDV, probably due to a physical barrier to wild rabbit dispersal formed by the Pyrenees
(Muller et al., 2009). Two recent independent studies now agree on the identification of
four distinct monophyletic clades of RHDV (Kerr et al., 2009; Kinnear and Linde, 2010).
Importantly, one of these four RHDV clades is formed predominantly by the sequences of
the Iberian Peninsula and South of France (Kerr et al., 2009). Our study is mostly based
on samples from Portugal. To further corroborate the hypothesis of distinct RHDV
evolution on the Iberian Peninsula, strains from other geographical areas, especially the
central and eastern Spain, must be characterised.
Two recent publications on RHDV evolution introduced a temporal dimension to the
reconstruction of RHDV evolution (Kerr et al., 2009; Kinnear and Linde, 2010). This
prompted us to review our current knowledge on RHD evolution in the Iberian Peninsula in
the light of these studies (Chapter 3.3). Briefly, the year 1948 was estimated as mean time
to most common recent ancestor for Iberian strains (Kerr et al., 2009). This suggests that
virulent RHDVs were already emerging in the Iberian Peninsula long before 1984, maybe
already in the 1950s or 1960s. The emergence of virulent RHDV would probably be a
gradual process, by in large obscured by the then observed mass mortality caused by
myxomatosis. This hypothesis contrasts with some field reports on the drastic reduction of
rabbit numbers in some locations presumably due to RHD observed in the 1980s and
1990s (Delibes-Mateos et al., 2008b, 2009; Villafuerte et al., 1995). On one hand these
observations may reflect true incidence of RHD and variability in local epidemiological
circumstances, as they are still observed today (Villafuerte et al., 1995). On the other
hand, as they resulted after the enlarged awareness on RHD, they may to some extent be
biased, as more objective rabbit population census and surveillance schemes were
implemented a posteriori, so pre-RHD information on rabbit densities is in many cases
lacking or merely empirical. Ultimately, there is no factual evidence that RHDV-like viruses
have really been circulating before the 1980s in the Iberian Peninsula. This may partly
because wild rabbit sera taken before 1980s are not available, so retrospective analyses
are not possible. Further studies are required to test this hypothesis and to clarify the
origin of RHD in wild rabbits of the Iberian Peninsula and elsewhere. The genetic
characterisation of larger numbers of field samples of different geographic areas of the
Iberian Peninsula are required to corroborate our findings (Muller et al., 2009) and to
support statistical inferences on viral evolution and, potentially, its origins.
134
A few considerations on the putative selection of RHD-resistant rabbits shall also be
made. Recent studies have determined ABH tissue antigen as putative RHDV cellular
receptor (Ruvoen-Clouet et al., 2000). But these are not expressed on liver cells, so other
receptors need to be identified. Different allele profiles of Fut2 and Sec1 genes have been
identified in wild rabbits (Guillon et al., 2009). Functional alleles are thought to be present
in so-called “secretor phenotypes” which are thought to be present in individuals
susceptible to RHD. However, this hypothesis is based on empirical observations of the
donor populations and requires testing by infection experiments. To our knowledge,
virulence grading assays by rabbit inoculations similar to those realised for myxomatosis
have not been carried out for RHDV. We are also not aware of the identification of
resistant rabbits, excluding young animals in the phase of natural resistance (Ferreira et
al., 2006a; Ferreira et al., 2004; Ferreira et al., 2005; Prieto et al., 2000; Shien et al.,
2000). If the “virus-host co-evolution” hypothesis is to be maintained as representing a
major force driving rabbit evolution, further studies are required to determine a) if, and in
which proportions, either disease- or infection-resistant rabbits do exist in the field, and b)
what the underlying molecular mechanisms are.
4.3 Development of real-time PCR assays for RHDV an d EBHSV
The development of real-time PCR has had a major impact not only in the rapid and more
sensitive diagnosis of infectious diseases, but importantly also on current knowledge on
the respective pathogenesis. For example, the application of real-time PCR to different
tissues has allowed the quantification of viral RNA sequentially after RHDV infection (Gall
et al., 2007). Real-time PCR has the further advantage of reducing cross-contaminations
which may occur during the process of traditional and in particular nested PCR, which is
currently a widely used diagnostic assay for RHD (Bascunana et al., 1997; Moss et al.,
2002; Nowotny et al., 1997). In order to improve diagnosis of RHD and also to detect viral
RNA in experimental inoculation experiments using the Spanish RDHV strain AST89, a
new primer-probe pair was designed and compared to a previously described assay (Gall
et al., 2007). The preliminary results on the performance of this new real-time PCR were
obtained using RHDV field strains, for which partial genetic information was available
(Muller et al., 2009). However, the available sequence information does not cover the
regions targeted by the primer-probe pair annealing. This is due to the fact that variable
regions are required for the study of viral evolution and that more conserved regions are
usually targeted for diagnostic purposes. Our preliminary results showed good
agreements between tests using negative samples. However, some positive samples, in
135
particular those obtained in the recent RHD outbreak of Oporto City Park, were not
unanimously detected by both real-time assays. The underlying causes require further
analysis, such as sequencing of the regions targeted by both real-time assays. Further
work is also required to compare both primer-probes for the detection of the strain AST89
in samples from experimental infections. It may be considered necessary to contruct an
internal control to allow proper RNA quantification.
A real-time PCR assay was also developed for EBHSV and the preliminary findings on the
performance of this test are presented. To our knowledge, this is the first description of
such assay for EBHS. This assay should ideally substitute current traditional PCR assays
for diagnostic purposes (Bascunana et al., 1997; Nowotny et al., 1997), which are more
time-consuming and, as mentioned above for RHD, bear considerable risks of cross
contaminations. A primer-probe pair was designed and the performance tested on positive
and negative samples as determined by conventional PCR and haemagglutination test.
The agreement between tests on the 17 negative samples was excellent, however, more
samples should be tested to give a more accurate estimate on the tests specificity. Only
five positive samples were available from Austria (kindly made available by Dr. Nowotny,
Department of Clinical Virology, University of Veterinary Medicine, Austria). No positive
samples from the Iberian Peninsula were available, because the EBHS has not been
described in the Iberian hare (Lepus granatensis), and further investigations shall be
carried out by our group, ideally using a real time as screening tool. Of the five positive
samples as determined by the haemagglutination test, one was neither detected by
conventional nor real time PCR. The reason for this incongruence should be investigated.
Also, more positive samples from different geographical origins should be tested to give a
more accurate estimate on the tests sensitivity.
Summarizing, real-time PCR for the detection of EBHS and RHD remain attractive and
potentially sensitive tools, but further work is required to validate and optimize their
performance, and before allowing their application in diagnostic or experimental settings.
136
137
5. Conclusions and perspectives
138
139
In the present thesis original studies on the partial characterisation of myxoma virus and
RHDV strains obtained from wild rabbits in the Iberian Peninsula, in particular from
Portugal, and on the preliminary results of newly developed real-time PCR assays for the
detection of RHDV and EBHSV were presented and discussed in the light of current
knowledge, allowing the following conclusions to be made:
• The analysis of selected genomic regions corresponding to approximately 3% of the
viral genome suggests a high genetic stability of myxoma virus field strains over the
past five decades. Based on our findings it is difficult to identify unique single gene
markers of virus attenuation or evolution, indicating that analyses of larger proportions
of the genome or even the whole genome may be required.
• The phylogenetic analysis based on the partial VP60 sequences of the RHDV capsid
gene of field strains from Portugal, Spain and South of France allowed the grouping of
these into three groups, determined “Iberian Groups” IB1 to IB3. These Iberian groups
clustered separately from most globally described RHDV, giving rise to the hypothesis
of independent viral evolution on the Iberian Peninsula, with the Pyrenees acting as
natural barrier to rabbit and thus viral dispersion.
• Two real-time PCR assays for the detection of RHDV and EBHSV have been
developed and preliminary assessment of its performance suggests high specificity
but less satisfactory sensitivity.
• The frequently cited hypothesis on virus-host coevolution for both myxomatosis and
RHDV was assessed in the light of current knowledge. According to this hypothesis,
the co-evolution of viruses and their host would lead to the emergence of attenuated
viruses and more resistant hosts. We found that further field and experimental
evidence is required to maintain and further support this hypothesis in the case of both
infectious diseases. We also highlight the complexity of these subjects requiring the
integration of field and experimental studies at different levels.
140
Perspectives
The work presented in this thesis allowed the identification of several questions that may
be investigated in the near future, such as:
1. What evidence do we have that attenuated strains of myxomatosis occur in the
field and what is their importance? Is it possible to develop an in vitro method for
the assessment of virulence grades and/or host genetic resistance to the virus?
The latter question could be addressed with inoculation experiments using field
viruses and targetting primary lymphocyte cultures from different rabbits.
2. What are the origins of RHDV in the Iberian Peninsula? Do avirulent RHDV or
RCV-like strains exist in healthy wild rabbit populations? This topic shall be
approached by a joint project already approved for funding, and that also covers
assessing the role of EBHS in the Iberian Peninsula (see below).
3. To complete the development of real-time PCR assays for the detection of RHDV
and EBHSV: to fully validate and optimize their performance, and to apply these
assays in diagnostic or experimental settings. This topic shall be addressed within
two joint projects. One is already ongoing and includes the detection of RHDV-
specific RNA in AST89-infected young rabbits. Another joint project on the
screening of Iberian hares for EBHS has recently been approved for funding (see
above).
141
6. References
142
143
Abrantes, J., Carmo, C., Matthee, C., Yamada, F., van der Loo, W., Esteves, P., 2010. A shared
unusual genetic change at the chemokine receptor type 5 between Oryctolagus,
Bunolagus and Pentalagus. Conservation Genetics.
Abrantes, J., Esteves, P.J., Carmo, C.R., Müller, A., Thompson, G., Loo, W.v.d., 2008a. Genetic
characterization of the chemokine receptor CXCR4 gene in lagomorphs: comparison
between the families Ochotonidae and Leporidae. International Journal of
Immunogenetics 35, 111-117.
Abrantes, J., Esteves, P.J., van der Loo, W., 2008b. Evidence for recombination in the major capsid
gene VP60 of the rabbit haemorrhagic disease virus (RHDV). Archives of Virology 153,
329-335.
Adams, M.M., van Leeuwen, B.H., McFadden, G., Kerr, P.J., 2008. Construction and testing of a
novel host-range defective myxoma virus vaccine with the M063 gene inactivated that is
non-permissive for replication in rabbit cells. Veterinary Research 39, 60.
Alda, F., Gaitero, T., Suárez, M., Doadrio, I., 2009. Molecular characterisation and recent evolution
of myxoma virus in Spain. Archives of Virology 154, 1659-1670.
Altizer, S., Harvell, D., Friedle, E., 2003. Rapid evolutionary dynamics and disease threats to
biodiversity. Trends in Ecology & Evolution 18, 589-596.
Alves, P.C., Ferreira, C. 2004. Revisão do Livro Vermelho dos Vertebrados de Portugal.
Determinação da abundância relativa das populações de coelho-bravo (Oryctolagus
cuniculus) em Portugal Continental. Relatório Final., CIBIO-ICETA, ed. (Universidade do
Porto).
Alves, P.C., Melo-Ferreira, J., Freitas, H., Boursot, P., 2008. The ubiquitous mountain hare
mitochondria: multiple introgressive hybridization in hares, genus Lepus. Philosophical
Transactions of the Royal Society B: Biological Sciences 363, 2831-2839.
Anderson, R.M., May, R.M., 1982. Coevolution of Hosts and Parasites. Parasitology 85, 411-426.
Angulo, E., Cooke, B., 2002. First synthesize new viruses then regulate their release? The case of
the wild rabbit. Molecular Ecology 11, 2703-2709.
Angulo, E., Villafuerte, R., 2004. Modelling hunting strategies for the conservation of wild rabbit
populations. Biological Conservation 115, 291-301.
Anonymous, 1989. Doença hemorrágica a vírus do coelho em Portugal. Revista Portuguesa de
Ciências Veterinárias 489, 57-58.
Arguëllo, J.L., 1986. Contribución a la profilaxis de la mixomatosis del conejo mediante uso de una
cepa homóloga. Medicina Veterinária 3, 91-103.
Arguello Villares, J.L., Llanos Pellitero, A., Perez Ordoyo Garcia, L.M., 1988. Enfermedad vírica
hemorrágica del conejo en España. Medicina Veterinária 5, 645-650.
Artois, M., Delahay, R., Guberti, V., Cheeseman, C., 2001. Control of infectious diseases of wildlife
in Europe. Veterinary Journal 162, 141-152.
Asgari, S., Hardy, J.R.E., Cooke, B.D., 1999. Sequence analysis of rabbit haemorrhagic disease virus
(RHDV) in Australia: alterations after its release. Archives of Virology 144, 135-145.
Asgari, S., Hardy, J.R.E., Sinclair, R.G., Cooke, B.D., 1998. Field evidence for mechanical
transmission of rabbit haemorrhagic disease virus (RHDV) by flies (Diptera: Calliphoridae)
among wild rabbits in Australia. Virus Research 54, 123-132.
Barcena, J., Morales, M., Vazquez, B., Boga, J.A., Parra, F., Lucientes, J., Pages-Mante, A., Sanchez-
Vizcaino, J.M., Blasco, R., Torres, J.M., 2000a. Horizontal transmissible protection against
myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus. J
Virol 74, 1114-1123.
Barcena, J., Morales, M., Vazquez, B., Boga, J.A., Parra, F., Lucientes, J., Pages-Mante, A., Sanchez-
Vizcaino, J.M., Blasco, R., Torres, J.M., 2000b. Horizontal transmissible protection against
myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus.
Journal of Virology 74, 1114-1123.
144
Bárcena, J., Pagès-Manté, A., March, R., Morales, M., Ramírez, M.A., Sánchez-Vizcaíno, J.M.,
Torres, J.M., 2000. Isolation of an attenuated myxoma virus field strain that can confer
protection against myxomatosis on contacts of vaccinates. Archives of Virology 145, 759-
771.
Barrett, J.W., Cao, J.-X., Hota-Mitchell, S., McFadden, G., 2001. Immunomodulatory proteins of
myxoma virus. Seminars in Immunology 13, 73-84.
Bartrip, P.W., 2008. Myxomatosis in 1950s Britain. 20th Century British History 19, 83-105.
Bascunana, C.R., Nowotny, N., Belak, S., 1997. Detection and differentiation of rabbit hemorrhagic
disease and European brown hare syndrome viruses by amplification of VP60 genomic
sequences from fresh and fixed tissue specimens. Journal of Clinical Microbiology 35,
2492-2495.
Bergin, I.L., Wise, A.G., Bolin, S.R., Mullaney, T.P., Kiupel, M., Maes, R.K., 2009. Novel calicivirus
identified in rabbits, Michigan, USA. Emerging Infectious Diseases 15, 1955-1962.
Bertagnoli, S., Gelfi, J., LeGall, G., Boilletot, E., Vautherot, J.F., Rasschaert, D., Laurent, S., Petit, F.,
BoucrautBaralon, C., Milon, A., 1996a. Protection against myxomatosis and rabbit viral
hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic
disease virus capsid protein. Journal of Virology 70, 5061-5066.
Bertagnoli, S., Gelfi, J., Petit, F., Vautherot, J.F., Rasschaert, D., Laurent, S., Le Gall, G., Boilletot, E.,
Chantal, J., Boucraut-Baralon, C., 1996b. Protection of rabbits against rabbit viral
haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine 14, 506-510.
Best, S.M., Collins, S.V., Kerr, P.J., 2000. Coevolution of host and virus: cellular localization of virus
in myxoma virus infection of resistant and susceptible European rabbits. Virology 277, 76-
91.
Best, S.M., Kerr, P.J., 2000. Coevolution of host and virus: the pathogenesis of virulent and
attenuated strains of myxoma virus in resistant and susceptible European rabbits.
Virology 267, 36-48.
Biju-Duval, C., Ennafaa, H., Dennebouy, N., Monnerot, M., Mignotte, F., Soriguer, R.C., Gaaïed,
A.E., Hili, A.E., Mounolou, J.-C., 1991. Mitochondrial DNA evolution in lagomorphs: Origin
of systematic heteroplasmy and organization of diversity in European rabbits. Journal of
Molecular Evolution 33, 92-102.
Billinis, C., Psychas, V., Tontis, D.K., Spyrou, V., Birtsas, P.K., Sofia, M., Likotrafitis, F., Maslarinou,
O.M., Kanteres, D., 2005. European brown hare syndrome in wild European brown hares
from Greece. Journal of Wildlife Diseases 41, 783-786.
Boga, J.A., Casais, R., Marin, M.S., Martinalonso, J.M., Carmenes, R.S., Prieto, M., Parra, F., 1994.
Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein
gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). Journal of General
Virology 75, 2409-2413.
Boon, A.C., deBeauchamp, J., Hollmann, A., Luke, J., Kotb, M., Rowe, S., Finkelstein, D., Neale, G.,
Lu, L., Williams, R.W., Webby, R.J., 2009. Host Genetic Variation Affects Resistance to
Infection with a Highly Pathogenic H5N1 Influenza A Virus in Mice. Journal of Virology,
JVI.00514-00509.
Boots, M., Hudson, P.J., Sasaki, A., 2004. Large shifts in pathogen virulence relate to host
population structure. Science 303, 842-844.
Branco, M., Ferrand, N., Monnerot, M., 2000. Phylogeography of the European rabbit
(Oryctolagus cuniculus) in the Iberian Peninsula inferred from RFLP analysis of the
cytochrome b gene. Heredity 85, 307-317.
Branco, M., Monnerot, M., Ferrand, N., Templeton, A.R., 2002. Postglacial dispersal of the
European rabbit (Oryctolagus cuniculus) on the Iberian Peninsula reconstructed from
nested glade and mismatch analyses of mitochondrial DNA genetic variation. Evolution
56, 792-803.
Bratke, K., McLysaght, A., 2008. Identification of multiple independent horizontal gene transfers
into poxviruses using a comparative genomics approach. BMC Evolutionary Biology 8, 67.
145
Brochier, B., Aubert, M.F., Pastoret, P.P., Masson, E., Schon, J., Lombard, M., Chappuis, G.,
Languet, B., Desmettre, P., 1996. Field use of a vaccinia-rabies recombinant vaccine for
the control of sylvatic rabies in Europe and North America. OIE Revue Scientifique et
Technique 15, 947-970.
Brotherstone, S., White, I.M.S., Coffey, M., Downs, S.H., Mitchell, A.P., Clifton-Hadley, R.S., More,
S.J., Good, M., Woolliams, J.A., 2010. Evidence of genetic resistance of cattle to infection
with Mycobacterium bovis. Journal of dairy science 93, 1234-1242.
Cabezas-Díaz, S., Lozano, J., Virgós, E., 2005. El declive del conejo en España: evidencias a partir de
las estadísticas de caza. Quercus 236, 16-20.
Cabezas, S., Calvete, C., Moreno, S., 2006. Vaccination Success and Body Condition in the
European Wild Rabbit: Applications for Conservation Strategies. Journal of Wildlife
Management 70, 1125-1131.
Calvete, C., Estrada, R., Lucientes, J., Osacar, J.J., Villafuerte, R., 2004a. Effects of vaccination
against viral haemorrhagic disease and myxomatosis on long-term mortality rates of
European wild rabbits. Veterinary Record 155, 388-392.
Calvete, C., Estrada, R., Osacar, J.J., Lucientes, J., Villafuerte, R., Morrison, 2004b. Short-term
negative effects of vaccination campaigns against myxomatosis and viral hemorrhagic
disease (VHD) on the survival of European wild rabbits. Journal of Wildlife Management
68, 198-205.
Calvete, C., Estrada, R., Villafuerte, R., Osacar, J.J., Lucientes, J., 2002a. Epidemiology of viral
haemorrhagic disease and myxomatosis in a free-living population of wild rabbits. Vet
Rec. 150, 776-782.
Calvete, C., Estrada, R., Villafuerte, R., Osacar, J.J., Lucientes, J., 2002b. Epidemiology of viral
haemorrhagic disease and myxomatosis in a free-living population of wild rabbits.
Veterinary Record 150, 776-782.
Calvete, C., Villafuerte, R., Lucientes, J., Osacar, J.J., 1997. Effectiveness of traditional wild rabbit
restocking in Spain. Journal of Zoology 241, 271-277.
Cameron, C., Hota-Mitchell, S., Chen, L., Barrett, J., Cao, J.X., Macaulay, C., Willer, D., Evans, D.,
McFadden, G., 1999. The complete DNA sequence of myxoma virus. Virology 264, 298-
318.
Capucci, L., Fallacara, F., Grazioli, S., Lavazza, A., Pacciarini, M.L., Brocchi, E., 1998a. A further step
in the evolution of rabbit hemorrhagic disease virus: the appearance of the first
consistent antigenic variant. Virus Research 58, 115-126.
Capucci, L., Frigoli, G., Ronshold, L., Lavazza, A., Brocchi, E., Rossi, C., 1995. Antigenicity of the
Rabbit Hemorrhagic-Disease Virus Studied by Its Reactivity with Monoclonal-Antibodies.
Virus Research 37, 221-238.
Capucci, L., Fusi, P., Lavazza, A., Pacciarini, M.L., Rossi, C., 1996. Detection and preliminary
characterization of a new rabbit calicivirus related to rabbit hemorrhagic disease virus but
nonpathogenic. Journal of Virology 70, 8614-8623.
Capucci, L., Fusi, P., Nardin, A., Pacciarini, M.L., Rossi, C., Lavazza, A., 1998b. Identification in
rabbits and preliminary characterization of a non-pathogenic calicivirus correlated to
Rabbit Haemorrhagic Disease Virus (RHDV). Proceedings of the 6th World Rabbit
Congress, Vols 1-3, C39-C45.
Capucci, L., Scicluna, M.T., Lavazza, A., 1991. Diagnosis of viral haemorrhagic disease of rabbits
and the European brown hare syndrome. OIE Revue Scientifique et Technique 10, 347-
370.
Carmo, C., Esteves, P., Ferrand, N., van der Loo, W., 2006. Genetic variation at chemokine
receptor CCR5 in leporids: alteration at the 2nd extracellular domain by gene conversion
with CCR2 in Oryctolagus, but not in Sylvilagus and Lepus species. Immunogenetics 58,
494-501.
146
Catroxo, M.H.B., Bersano, J.G., Martins, A.M.C.P.F., Petrella, S., Portugal, M.A.S.C., Souza, O.S.,
2009. Ultrastructural Study of Poxvirus Causing Myxomatosis in Rabbits, in São Paulo and
Santa Catarina, Brazil. International Journal of Morphology 27, 543-552.
Chasey, D., Lucas, M., Westcott, D., Williams, M., 1992. European Brown Hare Syndrome in the Uk
- a Calicivirus Related to but Distinct from That of Viral Hemorrhagic-Disease in Rabbits.
Archives of Virology 124, 363-370.
Chen, R., Neill, J.D., Noel, J.S., Hutson, A.M., Glass, R.I., Estes, M.K., Prasad, B.V., 2004. Inter- and
intragenus structural variations in caliciviruses and their functional implications. Journal of
Virology 78, 6469-6479.
Clarke, I.N., Lambden, P.R., 1997. The molecular biology of caliciviruses. Journal of General
Virology 78 ( Pt 2), 291-301.
Cooke, B.D., Fenner, F., 2002. Rabbit haemorrhagic disease and the biological control of wild
rabbits, Oryctolagus cuniculus, in Australia and New Zealand. Wildlife Research 29, 689-
706.
Cooke, B.D., Robinson, A.J., Merchant, J.C., Nardin, A., Capucci, L., 2000. Use of ELISAs in field
studies of rabbit haemorrhagic disease (RHD) in Australia. Epidemiology and Infection
124, 563-576.
Dalton, K.P., Ringleb, F., Martin Alonso, J.M., Parra, F., 2009. Rapid identification of myxoma virus
variants by long-range PCR and restriction fragment length polymorphism analysis.
Journal of Virological Methods 161, 284-288.
Daszak, P., Cunningham, A.A., Hyatt, A.D., 2000. Emerging infectious diseases of wildlife--threats
to biodiversity and human health. Science 287, 443-449.
Delibes-Mateos, M., Delibes, M., Ferreras, P., Villafuerte, R., 2008a. Key Role of European Rabbits
in the Conservation of the Western Mediterranean Basin Hotspot. Conservation Biology
22, 1106-1117.
Delibes-Mateos, M., Ferreras, P., Villafuerte, R., 2008b. Rabbit populations and game
management: the situation after 15 years of rabbit haemorrhagic disease in central-
southern Spain. Biodiversity and Conservation 17, 559-574.
Delibes-Mateos, M., Ferreras, P., Villafuerte, R., 2009. European rabbit population trends and
associated factors: a review of the situation in the Iberian Peninsula. Mammal Review 39,
124-140.
Dias-Pereira, P., Faustino, A., Lemos, A., Muller, A., Thompson, G., Alves, P.C., 2004. Sanitary
Surveillance Program in wild rabbits and hares in Algarve (Southern Portugal). Preliminary
results. In: 2nd World Lagomorph Conference, Vairão, Portugal, July 26-31, p. P 70.
Dietz, K., 1993. The estimation of the basic reproduction number for infectious diseases.
Statistical Methods in Medical Research 2, 23-41.
Edmonds, J.W., Nolan, I.F., Shepherd, R.C., Gocs, A., 1975. Myxomatosis: the virulence of field
strains of myxoma virus in a population of wild rabbits (Oryctolagus cuniculus L.) with high
resistance to myxomatosis. Journal of Hygiene (London) 74, 417-418.
Esteves, P.J., Alves, P.C., N., F., 2006. O uso de marcadores genéticos na gestão e conservação de
populações de coelho-bravo (Oryctolagus cuniculus), In: Ferreira, C., Alves, P.C. (Eds.)
Gestão de populações de coelho-bravo (Oryctolagus cuniculus algirus). Federação
Alentejana de Caçadores, Loulé, pp. 13-30.
Farnos, O., Rodriguez, D., Valdes, O., Chiong, M., Parra, F., Toledo, J.R., Fernandez, E., Lleonart, R.,
Suarez, M., 2007. Molecular and antigenic characterization of rabbit hemorrhagic disease
virus isolated in Cuba indicates a distinct antigenic subtype. Archives of Virology 152,
1215-1221.
Farsang, A., Makranszki, L., Dobos-Kovács, M., Virág, G., Fábián, K., Barna, T., Kulcsár, G., Kucsera,
L., Vetési, F., 2003. Occurrence of atypical myxomatosis in Central Europe: Clinical and
virological examinations. Acta Veterinaria Hungarica 51, 493-501.
147
Fenner, F. 1994. Chapter 9. Myxoma virus. In Virus Infections of Vertebrates. Vol. 5. Virus
infections of rodents and lagomorphs., Horzinek, M.C., Osterhaus, A.D.M.E., eds. (Elsevier
Science B. V., Amsterdam).
Fenner, F., Chapple, P.J., 1965. Evolutionary Changes in Myxoma Virus in Britain. An Examination
of 222 Naturally Occurring Strains Obtained from 80 Counties during the Period October-
November 1962. Journal of Hygiene (London) 63, 175-185.
Fenner, F., Marshall, I.D., 1954. Passive Immunity in Myxomatosis of the European Rabbit
(Oryctolagus-Cuniculus) - the Protection Conferred on Kittens Born by Immune Does.
Journal of Hygiene 52, 321-336.
Fenner, F., Marshall, I.D., 1957. A comparison of the virulence for European rabbits (Oryctolagus
cuniculus) of strains of myxoma virus recovered in the field in Australia, Europe and
America. Journal of Hygiene (London) 55, 149-191.
Fenner, F., Marshall, I.D., Woodroofe, G.M., 1953. Studies in the Epidemiology of Infectious
Myxomatosis of Rabbits I. Recovery of Australian Wild Rabbits (Oryctolagus cuniculus)
from Myxomatosis under Field Conditions. Journal of Hygiene Cambridge 51, 225-244.
Fenner, F., Ratcliffe, F.N. 1965. Myxomatosis (Cambridge University Press, Cambridge), p. 379.
Fenner, F., Ross, J. 1994. Chapter 7. Myxomatosis. In The European Rabbit: History and Biology of
a Successful Colonizer, Thompson, H.V., King, C.M., eds. (Oxford University Press, USA
(March 24, 1994)), p. 264.
Fenner, F., Woodroofe, G.M., 1954. Protection of Laboratory Rabbits against Myxomatosis by
Vaccination with Fibroma Virus. Australian Journal of Experimental Biology and Medical
Science 32, 653-668.
Ferrand, N. 2008. Inferring the evolutionary history of the European rabbit (Oryctolagus cuniculus)
from molecular markers. In Lagomorph Biology: Evolution, Ecology, and Conservation,
Alves, P.C., Ferrand, N., Hackländer, K., eds. (Berlin Heidelberg, Springer), pp. 47-63.
Ferrand, N., Branco, M., 2007. The evolutionary history of the European rabbit (Oryctolagus
cuniculus): major patterns of population differentiation and geographic expansion
inferred from protein polymorphism. Phylogeography of Southern European Refugia, 207-
235.
Ferreira, C., Ramirez, E., Castro, F., Ferreras, P., Alves, P.C., Redpath, S., Villafuerte, R., 2009. Field
experimental vaccination campaigns against myxomatosis and their effectiveness in the
wild. Vaccine 27, 6998-7002.
Ferreira, P.G., Costa-e-Silva, A., Aguas, A.P., 2006a. Liver disease in young rabbits infected by
calicivirus through nasal and oral routes. Research in Veterinary Science 81, 362-365.
Ferreira, P.G., Costa-e-Silva, A., Monteiro, E., Oliveira, M.J.R., Aguas, A.P., 2004. Transient
decrease in blood heterophils and sustained liver damage caused by calicivirus infection
of young rabbits that are naturally resistant to rabbit haemorrhagic disease. Research in
Veterinary Science 76, 83-94.
Ferreira, P.G., Costa-e-Silva, A., Monteiro, E., Oliveira, M.J.R., Aguas, A.P., 2006b. Liver enzymes
and ultrastructure in rabbit haemorrhagic disease (RHD). Veterinary Research
Communications 30, 393-401.
Ferreira, P.G., Costa-E-Silva, A., Oliveira, M.J.R., Monteiro, E., Aguas, A.P., 2005. Leukocyte-
hepatocyte interaction in calicivirus infection: differences between rabbits that are
resistant or susceptible to rabbit haernorrhagic disease (RHD). Veterinary Immunology
and Immunopathology 103, 217-221.
Ferreira, P.G., Costa-e-Silva, A., Oliveira, M.J.R., Monteiro, E., Cunha, E.M., Aguas, A.P., 2006c.
Severe leukopenia and liver biochemistry changes in adult rabbits after calicivirus
infection. Research in Veterinary Science 80, 218-225.
Ferreira, P.G., Dini, M., Costa-E-Silva, A., Aguas, A.P., 2008. Adult rabbits acquire resistance to
lethal calicivirus infection by adoptive transfer of sera from infected young rabbits.
Veterinary Immunology and Immunopathology 121, 364-369.
148
Fischer, L., Le Gros, F.-X., Mason, P.W., Paoletti, E., 1997. A recombinant canarypox virus protects
rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge. Vaccine 15, 90-
96.
Flowerdew, J.R., Trout, R.C., Ross, J., 1992. Myxomatosis: population dynamics of rabbits
(Oryctolagus cuniculus Linnaeus, 1758) and ecological effects in the United Kingdom. OIE
Revue Scientifique et Technique 11, 1109-1113.
Forrester, N.L., Abubakr, M.L., Abu Elzein, E.M.E., al-Afaleq, A.L., Housawi, F.M.T., Moss, S.R.,
Turner, S.L., Gould, E.A., 2006. Phylogenetic analysis of Rabbit haemorrhagic disease virus
strains from the Arabian Peninsula: Did RHDV emerge simultaneously in Europe and Asia?
Virology 344, 277-282.
Forrester, N.L., Boag, B., Buckley, A., Moureau, G., Gould, E.A., 2009. Co-circulation of widely
disparate strains of Rabbit haemorrhagic disease virus could explain localised epidemicity
in the United Kingdom. Virology 393, 42-48.
Forrester, N.L., Boag, B., Moss, S.R., Turner, S.L., Trout, R.C., White, P.J., Hudson, P.J., Gould, E.A.,
2003. Long-term survival of New Zealand rabbit haemorrhagic disease virus RNA in wild
rabbits, revealed by RT-PCR and phylogenetic analysis. Journal of General Virology 84,
3079-3086.
Forrester, N.L., Moss, S.R., Turner, S.L., Schirrmeier, H., Gould, E.A., 2008. Recombination in rabbit
haemorrhagic disease virus: Possible impact on evolution and epidemiology. Virology 376,
390-396.
Forrester, N.L., Trout, R.C., Gould, E.A., 2007. Benign circulation of rabbit haemorrhagic disease
virus on Lambay Island, Eire. Virology 358, 18-22.
Fouchet, D., Guitton, J.-S., Marchandeau, S., Pontier, D., 2008. Impact of myxomatosis in relation
to local persistence in wild rabbit populations: The role of waning immunity and the
reproductive period. Journal of Theoretical Biology 250, 593-605.
Fouchet, D., Le Pendu, J., Guitton, J.S., Guiserix, M., Marchandeau, S., Pontier, D., 2009. Evolution
of microparasites in spatially and genetically structured host populations: The example of
RHDV infecting rabbits. Journal of Theoretical Biology 257, 212-227.
Frolich, K., Haerer, G., Bacciarini, L., Janovsky, M., Rudolph, M., Giacometti, M., 2001. European
brown hare syndrome in free-ranging European brown and mountain hares from
Switzerland. Journal of Wildlife Diseases 37, 803-807.
Frolich, K., Kujawski, G.E.J.G., Rudolph, M., Ronsholt, L., Speck, S., 2003. European brown hare
syndrome virus in free-ranging European brown hares from Argentina. Journal of Wildlife
Diseases 39, 121-124.
Frolich, K., Meyer, H.H.D., Pielowski, Z., Ronsholt, L., vonSeckLanzendorf, S., Stolte, M., 1996.
European brown hare syndrome in free-ranging hares in Poland. Journal of Wildlife
Diseases 32, 280-285.
Fuchs, A., Weissenbock, H., 1992. Comparative Histopathological Study of Rabbit Hemorrhagic-
Disease (RHD) and European Brown Hare Syndrome (EBHS). Journal of Comparative
Pathology 107, 103-113.
Gall, A., Hoffmann, B., Teifke, J.P., Lange, B., Schirrmeier, H., 2007. Persistence of viral RNA in
rabbits which overcome an experimental RHDV infection detected by a highly sensitive
multiplex real-time RT-PCR. Veterinary Microbiology 120, 17-32.
Gall, A., Schirrmeier, H., 2006. Persistence of rabbit haemorrhagic disease virus genome in
vaccinated rabbits after experimental infection. Journal of Veterinary Medicine Series B-
Infectious Diseases and Veterinary Public Health 53, 358-362.
Garcia-Bocanegra, I., Astorga, R.J., Napp, S., Casal, J., Huerta, B., Borge, C., Arenas, A., 2010.
Myxomatosis in wild rabbit: design of control programs in Mediterranean ecosystems.
Preventive Veterinary Medicine 93, 42-50.
Gavier-Widen, D., Morner, T., 1993. Descriptive epizootiological study of European brown hare
syndrome in Sweden. Journal of Wildlife Diseases 29, 15-20.
149
Gelfi, J., Chantal, J., Phong, T.T., Py, R., Boucraut-Baralon, C., 1999. Development of an ELISA for
detection of myxoma virus-specific rabbit antibodies: test evaluation for diagnostic
applications on vaccinated and wild rabbit sera. Journal of Veterinary Diagnostic
Investigation 11, 240-245.
Gelmetti, D., Grieco, V., Rossi, C., Capucci, L., Lavazza, A., 1998. Detection of rabbit haemorrhagic
disease virus (RHDV) by in situ hybridisation with a digoxigenin labelled RNA probe.
Journal of Virological Methods 72, 219-226.
Geraldes, A., Ferrand, N., 2006. A 7-bp insertion in the 3 ' untranslated region suggests the
duplication and concerted evolution of the rabbit SRY gene. Genetics Selection Evolution
38, 313-320.
Geraldes, A., Ferrand, N., Nachman, M.W., 2006. Contrasting patterns of introgression at X-linked
loci across the hybrid zone between subspecies of the European rabbit (Oryctolagus
cuniculus). Genetics 173, 919-933.
Geraldes, A., Rogel-Gaillard, C., Ferrand, N., 2005. High levels of nucleotide diversity in the
European rabbit (Orydolagus cuniculus) SRY gene. Animal Genetics 36, 349-351.
Giavedoni, L., Jones, L., Mebus, C., Yilma, T., 1991. A vaccinia virus double recombinant expressing
the F and H genes of rinderpest virus protects cattle against rinderpest and causes no
pock lesions. Proceedings of the National Academy of Sciences of the United States of
America 88, 8011-8015.
Gilbert, Y., Picavet, D.P., Chantal, J., 1989. Diagnosis of myxomatosis: development of an indirect
immunofluorescence technique. OIE Revue Scientifique et Technique 8, 209-220.
Goncalves, H., Alves, P.C., Rocha, A., 2002. Seasonal variation in the reproductive activity of the
wild rabbit (Oryctolagus cuniculus algirus) in a Mediterranean ecosystem. Wildlife
Research 29, 165-173.
Gorski, J., Mizak, B., Chrobocinska, M., 1994. Control of Rabbit Myxomatosis in Poland. OIE Revue
Scientifique et Technique 13, 869-879.
Gould, A.R., Kattenbelt, J.A., Lenghaus, C., Morrissy, C., Chamberlain, T., Collins, B.J., Westbury,
H.A., 1997. The complete nucleotide sequence of rabbit haemorrhagic disease virus
(Czech strain V351): Use of the polymerase chain reaction to detect replication in
Australian vertebrates and analysis of viral population sequence variation. Virus Research
47, 7-17.
Graham, K.A., Opgenorth, A., Upton, C., McFadden, G., 1992. Myxoma virus M11L ORF encodes a
protein for which cell surface localization is critical in manifestation of viral virulence.
Virology 191, 112-124.
Granzow, H., Weiland, F., Strebelow, H.G., Liu, C.M., Schirrmeier, H., 1996. Rabbit hemorrhagic
disease virus (RHDV): Ultrastructure and biochemical studies of typical and core-like
particles present in liver homogenates. Virus Research 41, 163-172.
Green, K.Y., Ando, T., Balayan, M.S., Berke, T., Clarke, I.N., Estes, M.K., Matson, D.O., Nakata, S.,
Neill, J.D., Studdert, M.J., Thiel, H.J., 2000. Taxonomy of the caliciviruses. Journal of
Infectious Diseases 181, S322-S330.
Gu, W., Holland, M., Janssens, P., Seamark, R., Kerr, P., 2004. Immune response in rabbit ovaries
following infection of a recombinant myxoma virus expressing rabbit zona pellucida
protein B. Virology 318, 516-523.
Gubser, C., Hue, S., Kellam, P., Smith, G.L., 2004. Poxvirus genomes: a phylogenetic analysis.
Journal of General Virology 85, 105-117.
Guillon, P., Ruvoen-Clouet, N., Le Moullac-Vaidye, B., Marchandeau, S., Le Pendu, J., 2009.
Association between expression of the H histo-blood group antigen, alpha
1,2fucosyltransferases polymorphism of wild rabbits, and sensitivity to rabbit
hemorrhagic disease virus. Glycobiology 19, 21-28.
Guitton, J.-S., Devillard, S., Guénézan, M., Fouchet, D., Pontier, D., Marchandeau, S., 2008.
Vaccination of free-living juvenile wild rabbits (Oryctolagus cuniculus) against
myxomatosis improved their survival. Preventive Veterinary Medicine 84, 1-10.
150
Guittre, C., Baginski, I., Legall, G., Prave, M., Trepo, C., Cova, L., 1995. Detection of Rabbit
Hemorrhagic-Disease Virus Isolates and Sequence Comparison of the N-Terminus of the
Capsid Protein Gene by the Polymerase Chain-Reaction. Research in Veterinary Science
58, 128-132.
Guittre, C., RuvoenClouet, N., Barraud, L., Cherel, Y., Baginski, I., Prave, M., Ganiere, J.P., Trepo, C.,
Cova, L., 1996. Early stages of rabbit haemorrhagic disease virus infection monitored by
polymerase chain reaction. Journal of Veterinary Medicine Series B-Zentralblatt Fur
Veterinarmedizin Reihe B-Infectious Diseases and Veterinary Public Health 43, 109-118.
Hall, T.A., 1999. BioEdit: a user-friendly biological sequence alignment edito and analysis program
for Windows 95/98/NT. Nucleic Acids Symposium Series 41, 95-98.
Hardy, C.M., Hinds, L.A., Kerr, P.J., Lloyd, M.L., Redwood, A.J., Shellam, G.R., Strive, T., 2006.
Biological control of vertebrate pests using virally vectored immunocontraception. Journal
of Reproductive Immunology 71, 102-111.
Hobbs, J.R., 1928. Studies on the nature of infectious myxoma of rabbits. American Journal of
Epidemiology 8, 800-839.
Hughes, A.L., Friedman, R., 2005. Poxvirus genome evolution by gene gain and loss. Molecular
Phylogenetics and Evolution 35, 186-195.
Hurst, E.W., 1937. Myxoma and the Shope fibroma. I. The histology of myxoma. British Journal of
Experimental Pathology 18, 1–15.
ICNB 2005. Livro vermelho dos vertebrados de Portugal. (Instituto de Conservação da Natureza e
da Biodiversidade).
ICTV 2002. Caliciviridae (International Committee on Taxonomy on Viruses).
ICTVdB 2006. 00.058. Poxviridae. In ICTVdB - The Universal Virus Database, version 4., Büchen-
Osmond, C., ed. (Columbia University, New York, USA).
Jackson, R.J., Hall, D.F., Kerr, P.J., 1999. Myxoma Virus Encodes an alpha 2,3-Sialyltransferase That
Enhances Virulence. Journal of Virology 73, 2376-2384.
Johnston, J.B., McFadden, G., 2003. Poxvirus Immunomodulatory Strategies: Current Perspectives.
Journal of Virology 77, 6093-6100.
Johnston, J.B., McFadden, G., 2004. Technical knockout: understanding poxvirus pathogenesis by
selectively deleting viral immunomodulatory genes. Cellular Microbiology 6, 695-705.
Joubert, P., Pautigny, C., Madelaine, M.F., Rasschaert, D., 2000. Identification of a new cleavage
site of the 3C-like protease of rabbit haemorrhagic disease virus. Journal of General
Virology 81, 481-488.
Kerr, P., McFadden, G., 2002. Immune Responses to Myxoma Virus. Viral Immunology 15, 229-
246.
Kerr, P.J., 1997. An ELISA for epidemiological studies of myxomatosis: persistence of antibodies to
Myxoma virus in European Rabbits (Oryctolagus cuniculus) Wildlife Research, 53-65.
Kerr, P.J., Best, S.M., 1998. Myxoma virus in rabbits. Rev. sci. tech. 17, 256-268.
Kerr, P.J., Hone, J., Perrin, L., French, N., Williams, C.K., 2010. Molecular and serological analysis of
the epidemiology of myxoma virus in rabbits. Veterinary Microbiology 143, 167-178.
Kerr, P.J., Jackson, R.J., 1995. Myxoma virus as a vaccine vector for rabbits: antibody levels to
influenza virus haemagglutinin presented by a recombinant myxoma virus. Vaccine 13,
1722-1726.
Kerr, P.J., Kitchen, A., Holmes, E.C., 2009. Origin and Phylodynamics of Rabbit Hemorrhagic
Disease Virus. Journal of Virology 83, 12129-12138.
Kerr, P.J., Perkins, H.D., Inglis, B., Stagg, R., McLaughlin, E., Collins, S.V., van Leeuwen, B.H., 2004.
Expression of rabbit IL-4 by recombinant myxoma viruses enhances virulence and
overcomes genetic resistance to myxomatosis. Virology 324, 117-128.
Kimura, T., Mitsui, I., Okada, Y., Furuya, T., Ochiai, K., Umemura, T., Itakura, C., 2001. Distribution
of rabbit haemorrhagic disease virus RNA in experimentally infected rabbits. Journal of
Comparative Pathology 124, 134-141.
151
Kinnear, M., Linde, C.C., 2010. Capsid gene divergence in rabbit hemorrhagic disease virus. Journal
of General Virology 91, 174-181.
Konig, M., Thiel, H.J., Meyers, G., 1998. Detection of viral proteins after infection of cultured
hepatocytes with rabbit hemorrhagic disease virus. Journal of Virology 72, 4492-4497.
Kritas, S.K., Dovas, C., Fortomaris, P., Petridou, E., Farsang, A., Koptopoulos, G., 2008. A
pathogenic myxoma virus in vaccinated and non-vaccinated commercial rabbits. Research
in Veterinary Science 85, 622-624.
Kumar, S., Tamura, K., Nei, M., 2004. MEGA3: Integrated software for molecular evolutionary
genetics analysis and sequence alignment. Briefings in Bioinformatics 5, 150-163.
Labudovic, A., Perkins, H., van Leeuwen, B., Kerr, P., 2004. Sequence mapping of the Californian
MSW strain of Myxoma virus. Archives of Virology 149, 553-570.
Lalani, A.S., Graham, K., Mossman, K., Rajarathnam, K., Clark-Lewis, I., Kelvin, D., McFadden, G.,
1997. The purified myxoma virus gamma interferon receptor homolog M-T7 interacts
with the heparin-binding domains of chemokines. Journal of Virology 71, 4356-4363.
Laurent, S., Kut, E., Remy-Delaunay, S., Rasschaert, D., 2002. Folding of the rabbit hemorrhagic
disease virus capsid protein and delineation of N-terminal domains dispensable for
assembly. Archives of Virology 147, 1559-1571.
Laurent, S., Vautherot, J.F., Madelaine, M.F., Legall, G., Rasschaert, D., 1994. Recombinant Rabbit
Hemorrhagic-Disease Virus Capsid Protein Expressed in Baculovirus Self-Assembles into
Virus-Like Particles and Induces Protection. Journal of Virology 68, 6794-6798.
Lavazza, A., Capucci, L. 2008. How Many Caliciviruses are there in Rabbits? A Review on RHDV and
Correlated Viruses. In Lagomorph Biology: Evolution, Ecology, and Conservation, Alves,
P.C., Ferrand, N., Hackländer, K., eds. (Berlin Heidelberg, Springer).
Lavazza, A., Scicluna, M.T., Capucci, L., 1996. Susceptibility of hares and rabbits to the European
brown hare syndrome virus (EBHSV) and rabbit haemorrhagic disease virus (RHDV) under
experimental conditions. Journal of Veterinary Medicine Series B-Zentralblatt Fur
Veterinarmedizin Reihe B-Infectious Diseases and Veterinary Public Health 43, 401-410.
Le Gall-Recule, G., Zwingelstein, F., Laurent, S., de Boisseson, C., Portejoie, Y., Rasschaert, D.,
2003. Phylogenetic analysis of rabbit haemorrhagic disease virus in France between 1993
and 2000, and the characterisation RHDV antigenic variants. Archives of Virology 148, 65-
81.
Le Gall-Recule, G., Zwingelstein, F., Laurent, S., Portejoie, Y., Rasschaert, D., 2006. Molecular
epidemiology of European brown hare syndrome virus in France between 1989 and 2003.
Archives of Virology 151, 1713-1721.
Le Gall-Recule, G., Zwingelstein, F., Yves, P., Le Gall, G., 2001. Immunocapture-RT-PCR assay for
detection and molecular epidemiology studies of rabbit haemorrhagic disease and
European Brown Hare Syndrome viruses. Journal of Virological Methods 97, 49-57.
Le Gall, G., Arnauld, C., Boilletot, E., Morisse, J.P., Rasschaert, D., 1998. Molecular epidemiology of
rabbit haemorrhagic disease virus outbreaks in France during 1988 to 1995. Journal of
General Virology 79, 11-16.
Letty, J., Aubineau, J., Marchandeau, S. 2008. Improving rabbit restocking success: a review of
field experiments in France. In Lagomorph Biology: Evolution, Ecology, and Conservation,
Alves, P.C., Ferrand, N., Hackländer, K., eds. (Berlin Heidelberg, Springer).
Lopez-Martinez, N. 2008. The lagomorph fossil record and the origin of the European rabbit. In
Lagomorph Biology: Evolution, Ecology, and Conservation, Alves, P.C., Ferrand, N.,
Hackländer, K., eds. (Berlin Heidelberg, Springer), pp. 27-43.
Lucas, A., McFadden, G., 2004. Secreted immunomodulatory viral proteins as novel
biotherapeutics. Journal of Immunology 173, 4765-4774.
Lun, X., Alain, T., Zemp, F.J., Zhou, H., Rahman, M.M., Hamilton, M.G., McFadden, G., Bell, J.,
Senger, D.L., Forsyth, P.A., 2010. Myxoma Virus Virotherapy for Glioma in
Immunocompetent Animal Models: Optimizing Administration Routes and Synergy with
Rapamycin. Cancer Research 70, 598-608.
152
Lun, X., Yang, W., Alain, T., Shi, Z.-Q., Muzik, H., Barrett, J.W., McFadden, G., Bell, J., Hamilton,
M.G., Senger, D.L., Forsyth, P.A., 2005. Myxoma Virus Is a Novel Oncolytic Virus with
Significant Antitumor Activity against Experimental Human Gliomas. Cancer Research 65,
9982-9990.
Macen, J.L., Graham, K.A., Lee, S.F., Schreiber, M., Boshkov, L.K., McFadden, G., 1996. Expression
of the Myxoma Virus Tumor Necrosis Factor Receptor Homologue and M11L Genes Is
Required to Prevent Virus-Induced Apoptosis in Infected Rabbit T Lymphocytes. Virology
218, 232-237.
Marchandeau, S., Le Gall-Recule, C., Bertagnoli, S., Aubineau, J., Botti, G., Lavazza, A., 2005.
Serological evidence for a non-protective RHDV-like virus. Veterinary Research 36, 53-62.
Marlier, D., Cassart, D., Boucraut-Baralon, C., Coignoul, F., Vindevogel, H., 1999. Experimental
Infection of Specific Pathogen-free New Zealand White Rabbits with Five Strains of
Amyxomatous Myxoma Virus. Journal of Comparative Pathology 121, 369-384.
Marlier, D., Mainil, J., Boucraut-Baralon, C., Linden, A., Vindevogel, H., 2000a. The Efficacy of Two
Vaccination Schemes Against Experimental Infection with a Virulent Amyxomatous or a
Virulent Nodular Myxoma Virus Strain. Journal of Comparative Pathology 122, 115-122.
Marlier, D., Mainil, J., Sulon, J., Beckers, J.F., Linden, A., Vindevogel, H., 2000b. Study of the
Virulence of Five Strains of Amyxomatous Myxoma Virus in Crossbred New Zealand
White/Californian Conventional Rabbits, with Evidence of Long-term Testicular Infection
in Recovered Animals. Journal of Comparative Pathology 122, 101-113.
Marshall, I.D., 1959. The influence of ambient temperature on the course of myxomatosis in
rabbits. Journal of Hygiene (London) 57, 484-497.
Marshall, I.D., Douglas, G.W., 1961. Studies in Epidemiology of Infectious Myxomatosis of Rabbits
.8. Further Observations on Changes in Innate Resistance of Australian Wild Rabbits
Exposed to Myxomatosis. Journal of Hygiene 59, 117-&.
Marshall, I.D., Fenner, F., 1958. Studies in the epidemiology of infectious myxomatosis of rabbits:
V. Changes in the innate resistance of Australian Wild rabbits exposed to myxomatosis.
Epidemiology and Infection 56, 288-302.
Martin-Alonso, J.M., Castanon, S., Alonso, P., Parra, F., Ordas, R., 2003. Oral immunization using
tuber extracts from transgenic potato plants expressing rabbit hemorrhagic disease virus
capsid protein. Transgenic Research 12, 127-130.
Martin-Alonso, J.M., Skilling, D.E., Gonzalez-Molleda, A., del Barrio, G., Machin, A., Keefer, N.K.,
Matson, D.O., Iversen, P.L., Smith, A.W., Parra, F., 2005. Isolation and characterization of a
new Vesivirus from rabbits. Virology 337, 373-383.
Martinez-Torrecuadrada, J.L., Cortes, E., Vela, C., Langeveld, J.P.M., Meloen, R.H., Dalsgaard, K.,
Hamilton, W.D.O., Casal, J.I., 1998. Antigenic structure of the capsid protein of rabbit
haemorrhagic disease virus. Journal of General Virology 79, 1901-1909.
Matiz, K., Ursu, K., Kecskemeti, S., Bajmocy, E., Kiss, I., 2006. Phylogenetic analysis of rabbit
haemorrhagic disease virus (RHDV) strains isolated between 1988 and 2003 in eastern
Hungary. Archives of Virology 151, 1659-1666.
McCabe, V.J., Tarpey, I., Spibey, N., 2002. Vaccination of cats with an attenuated recombinant
myxoma virus expressing feline calicivirus capsid protein. Vaccine 20, 2454-2462.
McIntosh, M.T., Behan, S.C., Mohamed, F.M., Lu, Z.Q., Moran, K.E., Burrage, T.G., Neilan, J.G.,
Ward, G.B., Botti, G., Capucci, L., Metwally, S.A., 2007. A pandemic strain of calicivirus
threatens rabbit industries in the Americas. Virology Journal 4.
McKercher, D.G., Saito, J.K., 1964. An Attenuated Live Virus Vaccine for Myxomatosis. Nature 202,
933-934.
Melo-Ferreira, J., Boursot, P., Suchentrunk, F., Ferrand, N., Alves, P.C., 2005. Invasion from the
cold past: extensive introgression of mountain hare (Lepus timidus) mitochondrial DNA
into three other hare species in northern Iberia. Molecular Ecology 14, 2459-2464.
153
Messud-Petit, F., Gelfi, J., Delverdier, M., Amardeilh, M.-F., Py, R., Sutter, G., Bertagnoli, S., 1998.
Serp2, an Inhibitor of the Interleukin-1beta -Converting Enzyme, Is Critical in the
Pathobiology of Myxoma Virus. Journal of Virology 72, 7830-7839.
Meyers, G., Wirblich, C., Thiel, H.J., 1991a. Genomic and subgenomic RNAs of rabbit hemorrhagic
disease virus are both protein-linked and packaged into particles. Virology 184, 677-686.
Meyers, G., Wirblich, C., Thiel, H.J., 1991b. Rabbit hemorrhagic disease virus - molecular cloning
and nucleotide sequencing of a calicivirus genome. Virology 184, 664-676.
Meyers, G., Wirblich, C., Thiel, H.J., Thumfart, J.O., 2000. Rabbit hemorrhagic disease virus:
Genome organization and polyprotein processing of a calicivirus studied after transient
expression of cDNA constructs. Virology 276, 349-363.
Miller, W.A., Koev, G., 2000. Synthesis of subgenomic RNAs by positive-strand RNA viruses.
Virology 273, 1-8.
Mims, C.A., Dimmock, N.J., Nash, A., Stephen, J. 1995. Mims´Pathogenesis of Infectious Disease.
(London, Academic Press).
Monnerot, M., Vigne, J.D., Bijuduval, C., Casane, D., Callou, C., Hardy, C., Mougel, F., Soriguer, R.,
Dennebouy, N., Mounolou, J.C., 1994. Rabbit and Man - Genetic and Historic Approach.
Genetics Selection Evolution 26, S167-S182.
Monteiro, A.S., Alves, P.C., 1999. Incidência da doença hemorrágica viral (DHV) em populações
selvagens de coelho. In: I Colóquio sobre Fauna Silvestre, Paredes de Coura, Portugal, 19-
20 Junho.
Monteiro, A.S.A., 1999. Incidência da doença hemorrágica viral em populações portuguesas de
coelho-bravo (Oryctolagus cuniculus algirus). Faculdade de Ciências da Universidade do
Porto,
Morales, M., Barcena, J., Ramirez, M.A., Boga, J.A., Parra, F., Torres, J.M., 2004. Synthesis in vitro
of rabbit hemorrhagic disease virus subgenomic RNA by internal initiation on (-)sense
genomic RNA - Mapping of a subgenomic promoter. Journal of Biological Chemistry 279,
17013-17018.
Morales, M., Ramirez, M.A., Cano, M.J., Parraga, M., Castilla, J., Perez-Ordoyo, L.I., Torres, J.M.,
Barcena, J., 2009. Genome Comparison of a Nonpathogenic Myxoma Virus Field Strain
with Its Ancestor, the Virulent Lausanne Strain. Journal of Virology 83, 2397-2403.
Moreno, S., Beltran, J.F., Cotilla, I., Kuffner, B., Laffite, R., Jordan, G., Ayala, J., Quintero, C.,
Jimenez, A., Castro, F., Cabezas, S., Villafuerte, R., 2007. Long-term decline of the
European wild rabbit (Oryctolagus cuniculus) in south-western Spain. Wildlife Research
34, 652-658.
Moreno, S., Villafuerte, R., Cabezas, S., Lombardi, L., 2004. Wild rabbit restocking for predator
conservation in Spain. Biological Conservation 118, 183-193.
Moss, S.R., Turner, S.L., Trout, R.C., White, P.J., Hudson, P.J., Desai, A., Armesto, M., Forrester,
N.L., Gould, E.A., 2002. Molecular epidemiology of Rabbit haemorrhagic disease virus.
Journal of General Virology 83, 2461-2467.
Mossman, K., Nation, P., Macen, J., Garbutt, M., Lucas, A., McFadden, G., 1996. Myxoma Virus M-
T7, a Secreted Homolog of the Interferon-[gamma] Receptor, Is a Critical Virulence Factor
for the Development of Myxomatosis in European Rabbits. Virology 215, 17-30.
Muller, A., 2004. Prevalência da mixomatose e doença hemorrágica viral no Algarve. In: III
Jornadas Cinegéticas do Algarve, Tavira, Portugal, 16th October.
Muller, A., Freitas, J., Silva, E., Le Gall-Recule, G., Zwingelstein, F., Abrantes, J., Esteves, P.J., Alves,
P.C., Loo, W.D., Kolodziejek, J., Nowotny, N., Thompson, G., 2009. Evolution of rabbit
haemorrhagic disease virus (RHDV) in the European rabbit (Oryctolagus cuniculus) from
the Iberian Peninsula. Veterinary Microbiology 135, 368-373.
Muller, A., Silva, E., Abrantes, J., Esteves, P.J., Ferreira, P.G., Carvalheira, J.C., Nowotny, N.,
Thompson, G., 2010. Partial sequencing of recent Portuguese myxoma virus field isolates
exhibits a high degree of genetic stability. Veterinary Microbiology 140, 161-166.
154
Muller, A., Silva, E., Paupério, S., Thompson, G., 2004. Mixomatose e doença hemorrágica viral em
populações de coelhos do Algarve. In: IV Encontro da Sociedade Portuguesa de
Epidemiologia e Medicina Veterinária Preventiva, Escola Superior Agrária de Coimbra,
October 23-24.
Muñoz, G., 1960. Anverso y reverso de la mixomatosis. Dirección General de Montes, Caza y
Pesca, Madrid.
Nagesha, H.S., Wang, L.F., Hyatt, A.D., Morrissy, C.J., Lenghaus, C., Westbury, H.A., 1995. Self-
Assembly, Antigenicity, and Immunogenicity of the Rabbit Hemorrhagic-Disease Virus
(Czechoslovakian Strain V-351) Capsid Protein Expressed in Baculovirus. Archives of
Virology 140, 1095-1108.
Neill, J.D., 1992. Nucleotide-Sequence of the Capsid Protein Gene of 2 Serotypes of San-Miguel
Sea Lion Virus - Identification of Conserved and Nonconserved Amino-Acid-Sequences
among Calicivirus Capsid Proteins. Virus Research 24, 211-222.
Nowotny, N., Bascunana, C.R., Ballagi-Pordany, A., Gavier-Widen, D., Uhlen, M., Belak, S., 1997.
Phylogenetic analysis of rabbit haemorrhagic disease and European brown hare syndrome
viruses by comparison of sequences from the capsid protein gene. Archives of Virology
142, 657-673.
Nowotny, N., Schilcher, F., Fuchs, A., Loupal, G., 1992. Zum Auftreten der Rabbit Haemorrhagic
Disease (RHD) in Oesterreich: II. Epizootiologische Untersuchungen. Wiener Tierärztliche
Monatsschrift, 134-140.
O'Brien, S.J., Evermann, J.F., 1988. Interactive influence of infectious disease and genetic diversity
in natural populations. Trends in Ecology & Evolution 3, 254-259.
Ohlinger, V.F., Haas, B., Meyers, G., Weiland, F., Thiel, H.J., 1990. Identification and
Characterization of the Virus Causing Rabbit Hemorrhagic-Disease. Journal of Virology 64,
3331-3336.
OIE 2009a. Chapter 2.6.1. Myxomatosis. In Manual of Diagnostic Tests and Vaccines for Terrestrial
Animals 2009.
OIE 2009b. Rabbit haemorrhagic disease. In OIE Technical Disease Cards.
Oliver, S.L., Asobayire, E., Dastjerdi, A.M., Bridger, J.C., 2006. Genomic characterization of the
unclassified bovine enteric virus Newbury agent-1 (Newbury1) endorses a new genus in
the family Caliciviridae. Virology 350, 240-250.
Paoletti, E., 1996. Applications of pox virus vectors to vaccination: an update. Proceedings of the
National Academy of Sciences of the United States of America 93, 11349-11353.
Parer, I., 1995. Relationship Between Survival Rate and Survival-Time of Rabbits, Oryctolagus-
Cuniculus (L), Challenged With Myxoma Virus. Australian Journal of Zoology 43, 303-311.
Parer, I., Sobey, W., Conolly, D., Morton, R., 1994. Virulence of Strains of Myxoma Virus and the
Resistance of Wild Rabbits, Oryctolagus-Cuniculus (L), From Different Locations in
Australasia. Australian Journal of Zoology 42, 347-362.
Parra, F., Prieto, M., 1990. Purification and Characterization of a Calicivirus as the Causative Agent
of a Lethal Hemorrhagic-Disease in Rabbits. Journal of Virology 64, 4013-4015.
Paupério, J., Ferreira, C., Alves, P.C., 2006. Aspectos gerais da biologia do coelho-bravo, In:
Ferreira, C., Alves, P.C. (Eds.) Gestão de populações de coelho-bravo (Oryctolagus
cuniculus algirus). Federação Alentejana de Caçadores, Loulé, pp. 33-48.
Pérez-Filgueira, D.M., Resino-Talaván, P., Cubillos, C., Angulo, I., Barderas, M.G., Barcena, J.,
Escribano, J.M., 2007. Development of a low-cost, insect larvae-derived recombinant
subunit vaccine against RHDV. Virology 364, 422-430.
Petit, F., Boucraut-Baralon, C., Py, R., Bertagnoli, S., 1996. Analysis of myxoma virus genome using
pulsed-field gel electrophoresis. Veterinary Microbiology 50, 27-32.
Pignolet, B., Boullier, S., Gelfi, J., Bozzetti, M., Russo, P., Foulon, E., Meyer, G., Delverdier, M.,
Foucras, G., Bertagnoli, S., 2008. Safety and immunogenicity of myxoma virus as a new
viral vector for small ruminants. Journal of General Virology 89, 1371-1379.
155
Piorno, V., 2006. Uso de cercados de reprodução para recuperação de populações de coelho-
bravo: Caso-estudo da Galiza., In: Ferreira, C., Alves, P.C. (Eds.) Gestão de populações de
coelho-bravo (Oryctolagus cuniculus algirus). Federação Alentejana de Caçadores., Loulé,
pp. 133-149.
Prasad, B.V., Matson, D.O., Smith, A.W., 1994. Three-dimensional structure of calicivirus. Journal
of Molecular Biology 240, 256-264.
Prieto, J.M., Fernandez, E., Alvarez, V., Espi, A., Marin, J.F.G., Alvarez, M., Martin, J.M., Parra, F.,
2000. Immunohistochemical localisation of rabbit haemorrhagic disease virus VP-60
antigen in early infection of young and adult rabbits. Research in Veterinary Science 68,
181-187.
Psikal, I., Smid, B., Rodak, L., Valicek, L., Bendova, J., 2003. Atypical Myxomatosis - Virus Isolation,
Experimental Infection of Rabbits and Restriction Endonuclease Analysis of the Isolate.
Journal of Veterinary Medicine B 50, 259-264.
Queney, G., Ferrand, N., Marchandeau, S., Azevedo, M., Mougel, F., Branco, M., Monnerot, M.,
2000. Absence of a genetic bottleneck in a wild rabbit (Oryctolagus cuniculus) population
exposed to a severe viral epizootic. Molecular Ecology 9, 1253-1264.
Rademacher, C., Krishna, N.R., Palcic, M., Parra, F., Peters, T., 2008. NMR experiments reveal the
molecular basis of receptor recognition by a calicivirus. Journal of the American Chemical
Society 130, 3669-3675.
Ratcliffe, F.N., Myers, K., Fennessy, B.V., Calaby, J.H., 1952. Myxomatosis in Australia: A Step
Towards the Biological Control of the Rabbit. Nature 170, 7-11.
RIPAC 2004. Projecto RIPAC: Relatório Final. (Tavira, Federação de Caçadores do Algarve e
Direcção Regional de Agricultura do Algarve).
Rodak, L., Smid, B., Valicek, L., Vesely, T., Stepanek, J., Hampl, J., Jurak, E., 1990. Enzyme-Linked-
Immunosorbent-Assay of Antibodies to Rabbit Hemorrhagic-Disease Virus and
Determination of Its Major Structural Proteins. Journal of General Virology 71, 1075-1080.
Ross, J., Sanders, M.F., 1977. Innate Resistance to Myxomatosis in Wild Rabbits in England.
Journal of Hygiene 79, 411-415.
Ross, J., Sanders, M.F., 1984. The Development of Genetic-Resistance to Myxomatosis in Wild
Rabbits in Britain. Journal of Hygiene 92, 255-261.
Ross, J., Sanders, M.F., 1987. Changes in the Virulence of Myxoma Virus-Strains in Britain.
Epidemiology and Infection 98, 113-117.
Ross, J., Tittensor, A.M., Fox, A.P., Sanders, M.F., 1989. Myxomatosis in Farmland Rabbit
Populations in England and Wales. Epidemiology and Infection 103, 333-357.
Rouco, C., Delibes-Mateos, M., Ferreras, M., Castro, F., Villafuerte, R., 2006a. Recuperação das
populações de coelho-bravo no Sul de Espanha: Caso-estudo de Melonares., In: Ferreira,
C., Alves, P.C. (Eds.) Gestão de populações de coelho-bravo (Oryctolagus cuniculus
algirus). Federação Alentejana de Caçadores., Loulé, pp. 153-168.
Rouco, C., Górtazar, C., Villafuerte, R., 2006b. Sanidade das populações de coelho-bravo., In:
Ferreira, C., Alves, P.C. (Eds.) Gestão de populações de coelho-bravo (Oryctolagus
cuniculus algirus). Federação Alentejana de Caçadores., Loulé, pp. 171-187.
Russell, R.J., Robbins, S.J., 1989. Cloning and molecular characterization of the myxoma virus
genome. Virology 170, 147-159.
Ruvoen-Clouet, N., Ganiere, J.P., Andre-Fontaine, G., Blanchard, D., Le Pendu, J., 2000. Binding of
rabbit hemorrhagic disease virus to antigens of the ABH histo-blood group family. Journal
of Virology 74, 11950-11954.
Saint, K.M., French, N., Kerr, P., 2001. Genetic variation in Australian isolates of myxoma virus: an
evolutionary and epidemiological study. Archives of Virology 146, 1105-1123.
Sanarelli, G., 1898. Das myxomatogene Virus. In: Beitrag zum Studium der Krankheitserreger
ausserhalb des Sichtbaren (vorläufige Mitteilung). Zentr. Bakt. Parasitenk. I 23, 865-873.
156
Santos, N., Pereira, S., Tavares, E., 2006. Myxomatosis and rabbit haemorrhagic disease in low-
density population of wild rabbits Oryctolagus cuniculus in northwestern Portugal. In:
EWDA Conference, Saint-Vincent, Italy, 27th-30th September.
Saurat, P., Gilbert, Y., Ganière, J.P., 1978. Etude d'une souche de virus myxomateux modifié.
Revue de Médecine Vétérinaire 129, 415–451.
Schirrmeier, H., Reimann, I., Kollner, B., Granzow, H., 1999. Pathogenic, antigenic and molecular
properties of rabbit haemorrhagic disease virus (RHDV) isolated from vaccinated rabbits:
detection and characterization of antigenic variants. Archives of Virology 144, 719-735.
Schnappinger, D., Ehrt, S., 2006. Introduction: genomic approaches in infectious diseases.
Microbes and Infection 8, 1611-1612.
Shien, J.H., Shieh, H.K., Lee, L.H., 2000. Experimental infections of rabbits with rabbit
haemorrhagic disease virus monitored by polymerase chain reaction. Research in
Veterinary Science 68, 255-259.
Sibilia, M., Boniotti, M.B., Angoscini, P., Capucci, L., Rossi, C., 1995. 2 Independent Pathways of
Expression Lead to Self-Assembly of the Rabbit Hemorrhagic-Disease Virus Capsid Protein.
Journal of Virology 69, 5812-5815.
Silvers, L., Inglis, B., Labudovic, A., Janssens, P.A., van Leeuwen, B.H., Kerr, P.J., 2006. Virulence
and pathogenesis of the MSW and MSD strains of Californian myxoma virus in European
rabbits with genetic resistance to myxomatosis compared to rabbits with no genetic
resistance. Virology 348, 72-83.
Smíd, B., Valícek, L., Rodák, L., Stepánek, J., Jurák, E., 1991. Rabbit haemorrhagic disease: an
investigation of some properties of the virus and evaluation of an inactivated vaccine.
Veterinary Microbiology 26, 77-85.
Smith, A.T., Boyer, A.F. 2008. Oryctolagus cuniculus. In IUCN Red List of Threatened Species.
Version 2010.1. , 2010, I., ed.
Smith, K.F., Acevedo-Whitehouse, K., Pedersen, A.B., 2009. The role of infectious diseases in
biological conservation. Animal Conservation 12, 1-12.
Sobey, W.R., 1969. Selection for Resistance to Myxomatosis in Domestic Rabbits (Oryctolagus
Cuniculus). Journal of Hygiene-Cambridge 67, 743-&.
Soledad Marín, M., Martín Alonso, J., Pérez Ordoyo García, L.I., Antonio Boga, J., Argüello-Villares,
J., Casais, R., Venugopal, K., Jiang, W., Gould, E.A., Parra, F., 1995. Immunogenic
properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a
recombinant baculovirus: an efficient vaccine. Virus Research 39, 119-128.
Stanford, M.M., Barrett, J.W., Nazarian, S.H., Werden, S., McFadden, G., 2007a. Oncolytic
virotherapy synergism with signaling inhibitors: Rapamycin increases myxoma virus
tropism for human tumor cells. Journal of Virology 81, 1251-1260.
Stanford, M.M., McFadden, G., Karupiah, G., Chaudhri, G., 2007b. Immunopathogenesis of
poxvirus infections: forecasting the impending storm. Immunology and Cell Biology 85,
93-102.
Stanford, M.M., Werden, S.J., McFadden, G., 2007c. Myxoma virus in the European rabbit:
interactions between the virus and its susceptible host. Veterinary Research 38, 299-318.
Strive, T., Wright, J., Kovaliski, J., Botti, G., Capucci, L., 2010. The non-pathogenic Australian
lagovirus RCV-A1 causes a prolonged infection and elicits partial cross-protection to rabbit
haemorrhagic disease virus. Virology 398, 125-134.
Strive, T., Wright, J.D., Robinson, A.J., 2009. Identification and partial characterisation of a new
lagovirus in Australian wild rabbits. Virology 384, 97-105.
Surridge, A.K., Bell, D.J., Ibrahim, K.M., Hewitt, G.M., 1999. Population structure and genetic
variation of European wild rabbits (Oryctolagus cuniculus) in East Anglia. Heredity 82, 479-
487.
Sypula, J., Wang, F., Ma, Y., Bell, J., McFadden, G., 2004. Myxoma virus tropism in human tumor
cells. Gene Therapy and Molecular Biology 8, 103-114.
157
Syrjala, P., Nylund, M., Heinikainen, S., 2005. European brown hare syndrome in free-living
mountain hares (Lepus timidus) and European brown hares (Lepus europaeus) in Finland
1990-2002. Journal of Wildlife Diseases 41, 42-47.
Takahashi, K., Nei, M., 2000. Efficiencies of fast algorithms of phylogenetic inference under the
criteria of maximum parsimony, minimum evolution, and maximum likelihood when a
large number of sequences are used. Molecular Biology and Evolution 17, 1251-1258.
Teifke, J.P., Reimann, I., Schirrmeier, H., 2002. Subacute liver necrosis after experimental infection
with rabbit haemorrhagic disease virus (RHDV). Journal of Comparative Pathology 126,
231-234.
Torres, J.M., Ramirez, M.A., Morales, M., Barcena, J., Vazquez, B., Espuna, E., Pages-Mante, A.,
Sanchez-Vizcaino, J.M., 2000a. Safety evaluation of a recombinant myxoma-RHDV virus
inducing horizontal transmissible protection against myxomatosis and rabbit
haemorrhagic disease. Vaccine 19, 174-182.
Torres, J.M., Ramírez, M.A., Morales, M., Bárcena, J., Vázquez, B., Espuña, E., Pagès-Manté, A.,
Sánchez-Vizcaíno, J.M., 2000b. Safety evaluation of a recombinant myxoma-RHDV virus
inducing horizontal transmissible protection against myxomatosis and rabbit
haemorrhagic disease. Vaccine 19, 174-182.
Torres, J.M., Sanchez, C., Ramirez, M.A., Morales, M., Barcena, J., Ferrer, J., Espuna, E., Pages-
Mante, A., Sanchez-Vizcaino, J.M., 2001. First field trial of a transmissible recombinant
vaccine against myxomatosis and rabbit hemorrhagic disease. Vaccine 19, 4536-4543.
Tuite, A., Gros, P., 2006. The impact of genomics on the analysis of host resistance to infectious
disease. Microbes and Infection 8, 1647-1653.
Upton, C., Macen, J.L., Schreiber, M., McFadden, G., 1991. Myxoma virus expresses a secreted
protein with homology to the tumor necrosis factor receptor gene family that contributes
to viral virulence. Virology 184, 370-382.
Upton, C., Mossman, K., McFadden, G., 1992. Encoding of a homolog of the IFN-gamma receptor
by myxoma virus. Science 258, 1369-1372.
van Leeuwen, B.H., Kerr, P.J., 2007. Prospects for fertility control in the European rabbit
(Oryctolagus cuniculus) using myxoma virus-vectored immunocontraception. Wildlife
Research 34, 511-522.
Vidal, S.M., Malo, D., Marquis, J.-F., Gros, P., 2008. Forward Genetic Dissection of Immunity to
Infection in the Mouse. Annual Review of Immunology 26, 81-132.
Villafuerte, R., Calvete, C., Blanco, J.C., Lucientes, J., 1995. Incidence of viral hemorrhagic disease
in wild rabbit populations in Spain. Mammalia 59, 651-659.
Wang, G., Barrett, J.W., Stanford, M., Werden, S.J., Johnston, J.B., Gao, X., Sun, M., Cheng, J.Q.,
McFadden, G., 2006. Infection of human cancer cells with myxoma virus requires Akt
activation via interaction with a viral ankyrin-repeat host range factor. Proceedings of the
National Academy of Sciences of the United States of America 103, 4640-4645.
Ward, D. 2005. Reversing rabbit decline. One of the biggest challenges for nature conservation in
Spain and Portugal. (IUCN Technical Report.).
White, P.J., Norman, R.A., Hudson, P.J., 2002. Epidemiological consequences of a pathogen having
both virulent and avirulent modes of transmission: the case of rabbit haemorrhagic
disease virus. Epidemiology and Infection 129, 665-677.
White, P.J., Norman, R.A., Trout, R.C., Gould, E.A., Hudson, P.J., 2001. The emergence of rabbit
haemorrhagic disease virus: will a non-pathogenic strain protect the UK? Philosophical
Transactions of the Royal Society of London Series B-Biological Sciences 356, 1087-1095.
White, P.J., Trout, R.C., Moss, S.R., Desai, A., Armesto, M., Forrester, N.L., Gould, E.A., Hudson,
P.J., 2004. Epidemiology of rabbit haemorrhagic disease virus in the United Kingdom:
evidence for seasonal transmission by both virulent and avirulent modes of infection.
Epidemiology and Infection 132, 555-567.
Willer, D.O., McFadden, G., Evans, D.H., 1999. The complete genome sequence of shope (rabbit)
fibroma virus. Virology 264, 319-343.
158
Williams, C., Moore, R., Robbins, S., 1990. Genetic-Resistance to Myxomatosis in Australian Wild
Rabbits, Oryctolagus-Cuniculus (L). Australian Journal of Zoology 38, 697-703.
Williams, R.T., Dunsmore, J.D., Sobey, W.R., 1973. Fluctuations in the titre of antibody to a soluble
antigen of myxoma virus in field populations of rabbits, Oryctolagus cuniculus (L.), in
Australia. Journal of Hygiene (London) 71, 487-500.
Wirblich, C., Meyers, G., Ohlinger, V.F., Capucci, L., Eskens, U., Haas, B., Thiel, H.J., 1994. European
Brown Hare Syndrome Virus - Relationship to Rabbit Hemorrhagic-Disease Virus and
Other Caliciviruses. Journal of Virology 68, 5164-5173.
Wirblich, C., Sibilia, M., Boniotti, M.B., Rossi, C., Thiel, H.J., Meyers, G., 1995. 3c-Like Protease of
Rabbit Hemorrhagic-Disease Virus - Identification of Cleavage Sites in the Orf1 Polyprotein
and Analysis of Cleavage Specificity. Journal of Virology 69, 7159-7168.
Wirblich, C., Thiel, H.J., Meyers, G., 1996. Genetic map of the calicivirus rabbit hemorrhagic
disease virus as deduced from in vitro translation studies. Journal of Virology 70, 7974-
7983.
Wu, Y., Lun, X., Zhou, H., Wang, L., Sun, B., Bell, J.C., Barrett, J.W., McFadden, G., Biegel, J.A.,
Senger, D.L., Forsyth, P.A., 2008. Oncolytic Efficacy of Recombinant Vesicular Stomatitis
Virus and Myxoma Virus in Experimental Models of Rhabdoid Tumors. Clinical Cancer
Research 14, 1218-1227.
Xing, K., Deng, R., Wang, J., Feng, J., Huang, M., Wang, X., 2006. Genome-Based Phylogeny of
Poxvirus. Intervirology 49, 207-214.
Yang, L., Wang, F., Hu, B., Xue, J., Hu, Y., Zhou, B., Wang, D., Xu, W., 2008. Development of an RT-
PCR for rabbit hemorrhagic disease virus (RHDV) and the epidemiology of RHDV in three
eastern provinces of China. Journal of Virological Methods 151, 24-29.
Zuniga, M.C., 2002. A pox on thee! Manipulation of the host immune system by myxoma virus and
implications for viral-host co-adaptation. Virus Res 88, 17-33.
Zuniga, M.C., 2003. Lessons in detente or know thy host: the immunomodulatory gene products
of myxoma virus. Journal of Biosciences 28, 273-285.
159
7. Appendices
Appendix 1 Identification of Iberian RHDV field strains obtained from European wild rabbits between 1994-2007. Information of non-identical sequences was included in our study (Muller et al., 2009) ........................................................................................................... 161
Appendix 2 Sequence alignment of variable nucleotide positions of RHDV field strains obtained from European wild rabbits between 1994-2007 in Portugal. The represented region numbered 1-546 represent positions 853-1398 of the major capsid VP60 gene and positions 6157-6702 of RHDV whole genome strain AST89 (Genbank accession number Z49271), respectively. ................................................................................................................ 163
Appendix 3 Nucleotide sequence alignment of the major capsid gene VP60 of RHDV strains. The localisation of two primer probe pairs for the use in real-time PCR are boxed and highlighted in bold letters. The newly designed primer-probe pair “RHD” spans the positions 309 to 427 of VP60, corresponding to positions 6513 to 5731 on strain AST89 (Genbank accession number Z49271). The primer-probe pair “VP60” described by Gall et al. 2007 spans the positions 1637 to 1740 of VP60, corresponding to positions 6941 to 7044 on strain AST89. The partial VP60 for mostly targeted for sequencing and phylogenetic studies spans positions 853 to 1399 of VP60, corresponding to positions 6157 to 6703 on strain AST89, here represented as shaded background on strain AST89. ........................................................................................................................................................ 165
Appendix 4 Publications ............................................................................................................ 181
160
161
Appendix 1 Identification of Iberian RHDV field strains obtained from European wild rabbits between 1994-2007. Information of non-identical sequences was included in our study (Muller et al., 2009)
Identification NEW identification Collection site Acession number
1994 1994
CB107 1994-01 Coruche /Infantado
CB109 1994-02 Coruche EU192136
CB110 1994-03 Santarém/Pernes
CB111 1994-04 Santarém/Pernes
CB113 1994-05 Santarém/Pernes
CB114 1994-06 Vila Viçosa
CB116 1994-07 Santarém/Pernes EU192131
CB117 1994-08 Golegã
CB118 1994-09 Santarém/Pernes
CB119 1994-10 Santarém/Casével
CB120 1994-11 Golegã
CB150 1994-12 Porto Santo
1995 1995
CB112 1995-01 Santarém/Pernes EU192132
CB121 1995-02 Penamacor/Malcata
CB123 1995-03 Idanha/Sra. Do Almortão
CB125 1995-04 Cast. Rodrigo/Devesas
CB128 1995-05 Sabugal/Lageosa
CB129 1995-06 Sabugal/Foios
CB130 1995-07 Guarda
CB131 1995-08 Belmonte
CB133 1995-09 Belmonte
CB135 1995-10 Coruche
CB136 1995-11 Coruche
CB137 1995-12 Alpiarça
1996 1996
CB141 1996-01 Sabugal /Malcata
CB145 1996-02 Santarém
CB149 1996-03 Santarém
CB151 1996-04 Bragança/Montesinho
CB160 1996-05 Guarda
CB161 1996-06 Vila do Conde
CB167 1996-07 Avis
CB168 1996-08 Coimbra/Pena EU192138
1997 1997
CB153 1997-01 Bragança
CB154 1997-02 Santarém/Casével EU192133
CB156 1997-03 Fornos EU192139
CB159 1997-04 Santarém
CB161 1997-05 Vila do Conde
2004 2004
C134 2004-01 Alcoutim
C137 2004-02 Alcoutim
C142 2004-03 Castro Marim/Alcoutim EU192134
C143 2004-04 Castro Marim
C144 2004-05 Alcoutim
C146 2004-06 Castro Marim
C147 2004-07 Castro Marim
C148 2004-08 Castro Marim
C153 2004-09 Tavira
C154 2004-10 Loulé/S.Brás
2005 2005
Coelho1 2005-01 Loulé/Tor EU192140
Coelho2 2005-02 Loulé/Tor
Coelho3 2005-03 Loulé/Alte
Coelho4 2005-04 Loulé/Alte
2006 2006
CB97 Opo 01/06 = 2006-01 Oporto City Park EF571322
CB98 Opo 02/06 Oporto City Park
CB99 Opo 03/06 Oporto City Park
CB100 Opo 04/06 = 2006-04 Oporto City Park EF571325
162
CB101 Opo 05/06 Oporto City Park
CB102 Opo 06/06 Oporto City Park
CB103 Opo 07/06 Oporto City Park
CB104 Opo 08/06 Oporto City Park
CB105 Opo 09/06 = 2006-09 Oporto City Park EF571330
CB106 Opo 10/06 Oporto City Park
2007 2007
CB193 2007-01 Chaves EU192135
CB194 2007-02 Chaves
CB195 2007-03 Chaves
CB196 2007-04 Valpaços
CB197 2007-05 Valpaços
OTHERS OTHERS
CB66 Toledo 1994 Spain 1994 EU192137
France 00-08 France 2000-08 France 2000 Pyrenée AJ319594
France 01-23 France 2001-23 France 2001 AM46980
France 02-20 France 2002-20 France 2002 AM746981
France 05-01 France 2005-01 France 2005 AM085133
Alicante 04-05 Alicante 2004 Spain 2004 AM884394
Albacete 04-08 Albacete 2004 Spain 2004 AM884395
163
Appendix 2 Sequence alignment of variable nucleotide positions of RHDV field strains obtained from European wild rabbits between 1994-2007 in Portugal. The represented region numbered 1-546 represent positions 853-1398 of the major capsid VP60 gene and positions 6157-6702 of RHDV whole genome strain AST89 (Genbank accession number Z49271), respectively. 1111 1111111111 1111111111 1112222222 2222222222 2222223333 3333333333 3333333333 3333333344 4444444444 4444444555 55555 112233344 4455566666 6667880111 1122223334 5567788889 9990001123 3333445566 7888990001 1123344444 5566777788 8888999900 2223344455 6678888012 34444 3594706913 4812401236 7895145147 8913690254 0621403690 2581473622 3467395814 3028174590 1883623489 4723234812 3479036907 0365714709 2570369198 70346 AST89 TCCTCCCTGA GCTGACCCTG AACACGTGTA ATGCTCACCA CTTCGTCCTG CTACGGCATA ACGTCCCTGT TTATCGGGCC TCAATGACCG GCATAACCAG CCAACCCATT TTCAGCCCCG CATACACCGC CGTGC 1994-01 ...C...... .......... ....T..... ....C..... .....C.... ...T...G.. .....T.C.. C..C..AA.. ...G...... .........A AT.G.A.... ....A..... ....T..... .A... 1994-02 ..c..c..A. ......T... .G........ ......G... ......T... ......T... TT........ .......... C...C..TT. ...C.....A ....T...C. .......... .......T.. ...A. 1994-03 ...t...... g......... ....T..... ....C..... .....C.... .......G.. .....T.C.. C..C..A... ...G...... .........A AT.G.A.... ....A..... ....T..... ..... 1994-04 .....c...G ...A...... ....T..... ....C..... .....C.... .......... .....T.C.. C..C.A.... .......... .........A AT.G.A.... ....A..... ....T..... ..... 1994-07 .........G ...A...... ....T..... ....C..... .....C.... .......... .....T.C.. C..C...... .......... .........A AT.G.A.... ....A..... ....T..... ..... 1994-10 ........A. ......T... .G........ .......... .......... ......T... TT........ ..G....... C...C..T.. .........A ....T...C. .C........ .......... .A... 1994-12 ........A. ......T... .a...AC... .........G ..C..Cc... ...T..T..G CT......A. ..g....... C......T.. g....GG..A ........C. .......... .G........ ...A. 1995-01 ........A. ......T... .G........ .......... .......... ......T... TT........ ..G....... C...C..T.. .........A ....T...C. .C........ .......... ..... 1995-02 ........A. ......T... .....A.... .C.......G ..C..C.... .C.T..T... CT........ ....A..... C......T.. ......G..A ........C. .......... .......... .A... 1995-04 ........A. ......T... .G...A.... .........G ..C..C..C. ...T..T.C. T......... .......... C.....GT.. ......G..A .......GC. .......... .......... ...A. 1995-05 C.......A. ......T... ....T..... G...C..T.. .C...C.... .CG...T... .T...A.... ..G...A... C.G.C..T.. .........A ....T...C. .......... ......T... ..... 1995-09 t.c..c.CA. ......T... .G........ .......... .......... ......T... TT........ .......... C...C..T.. .........A ....T...C. .......... .......... .A... 1995-10 C.......A. ....G.T... GGT....T.. .C.......G T.C..C.... .C.T..T..G CT........ C...A..... C......T.. ......G..A ......T.C. .......... ........A. .A.A. 1995-11 cc...c..A. ....G.T... GGT....T.. .C.......G T.C..C.... .C.T..T..G CT........ C...A..... C......T.. ......G..A ......T.C. .......... ...G....A. .A.A. 1995-12 ........A. ......T... .....A.... .C.......G ..C..C.... .C.T..T... CT........ ....A..... C......T.. ......G..A ........C. .....T.... .......... .A.A. 1996-01 ........A. .....TT... ........C. .......... ..C....T.. ......T... .T...T.C.. ..G....... C...C..TT. .........A ....T...C. .......... ......T... ..... 1996-04 ........A. ......T... .....A.... .........G ..C..C...A ...T..T..G T........C .......... C......T.. ......G..A ........C. .......... .......... ...A. 1996-05 .....c..A. A.....T... .....AC... .........G ..C..C.... ...T..T..G CT......A. ..G....... C......T.. A...G.G..A ........C. .......... .G........ ...A. 1996-06 .....c..A. ......T... .....AC... .........G ..C..C.... ...T..T..G CT......A. ..G....... C......T.. A...G.G..A ........C. .......... .G........ ...A. 1996-07 c.......A. ....G.T... GG....tT.. .CA.t....G T.C..C.... .C.T..T..G CTA....... t...A..... C......T.A g.T...G..A ......T..G ........cC T..G....g. .A.A. 1996-08 c....c..A. ....G.T... GG.....T.. .C.......G T.C..C.... .C.T..T..G CT........ C...A..... C....A.T.. ......G..A ......T.C. .......... ..CG...... .A.A. 1997-01 ..A.....A. ......T... .G...A.... .........G ..C..CT..A ...T..T..G T........C .......... C......T.. ......G..A ........C. .......... .......... ...A. 1997-02 .......... ........C. ....T..... ....C..... ..C..CT... TC....T... .....T.C.. CC.C..A... .......... .........A AT...A.... ....A....A .......... T.... 1997-03 .....c..A. .T....T... .........G G......... T.C....... ......T... TT..T..... .........A C......T.. .........A ........C. .......... .......... ..... 1997-05 .....c..A. ......T... .....AC... .........G ..C..C.... ...T..T..G CT......A. ..G....... C......T.. A...G.G..A ........C. .......... .G........ ...A. 2004-01 .T....T.A. A.....AA.. GGT....... ...TCTG... ..C....... T...ATT... TT........ ..G.....T. C...C..T.. ....GT.AGA ........C. C.T..TT.T. .....G.... ...A. 2004-02 .T....T.A. A.....AA.. GGT....... ...TCTG... ..C....... T...ATT... TT....T... ..G.....T. C......T.. ....GT.AGA ........C. C.T..TT.T. .....G.... ...A. 2004-03 .T....T.A. A.....AA.. GGT....... ...TCTG... ..C....... T...ATT... TT........ ..GC....T. C......T.. ....GT.AGA ........C. C.T..TT.T. .....G.... ...A. 2004-05 .T....T.A. A.....AA.. GGA....... ...TCTG... ..C....... T...ATT... TT........ ..G.....T. C......T.. ....GT.AGA ........C. C.T..TT.T. .....G.... ...A. 2004-07 .T....T.A. A.....AA.. GGT....... ...TCTG... ..C....... T...ATT... TT........ ..G.....T. C......T.. ....GT.AGA ........C. C.T..TT.T. .....G.... ...A. 2004-08 .....T..A. .T....AAC. GG........ ....CTG... ..C.a..... T...A.TG.. TT........ ..G....... C......T.. ....GT...A .....T..C. .C...TTT.. .......Aa. ..cA. 2004-09 .T....T.A. A.....AA.. GGT....... ...TCTG... ..C....... T...ATT... TT........ ..G.....T. C......T.. ....GT.AGA .....T..C. C.T..TT.T. .....G.... ...A. 2004-10 .T.C..T.A. A.....AA.. GGT....... ...TCTG... ..C....... T...ATT... TT........ ..G.....T. C......T.. ....GT.AGA ........C. C.T..TT.T. .....G.... ...A. 2005-01 .....T..A. .T....AAC. GG........ ....C.G... ..C....... T...A.TG.. TT....T... ..G....... C......T.. ....GT.T.A ........C. .C...TTT.. .......Aa. ..cAt 2005-03 .....T..A. .T....AACA GG........ ....C.G... ..C..C.... T...A.TG.. TT....T... ..G....... C......T.. ....GT.T.A ........C. .C...TTT.. .......Aa. ..cAt 2005-04 .....T..A. .T....AAC. GG........ G...C.G... ..CT...... T...A.TG.. TT....T... ..G....... C......T.. ....GT.T.A ........C. .C...TTT.. .......Aat ..cAt 2006-01 ..A.....A. A.....AA.. GG.T...... G...C.GT.. ..C....... T...A.TG.. TT.....C.. ........T. C......T.. .T..GT..GA ..G.....C. ...T.TTTT. .....G..A. ...A. 2006-04 ..A.....A. A.....AA.. GG.T...... G...C.GT.. ..C....... T...A.TG.. TT.....C.. ........T. C......T.. .T..GT..GA ..G.....C. ...T.TTTT. .....G..A. t..A. 2006-09 ..A.....A. A.....AA.. GG.T...... G...C.GT.. ..C....... T...A.TG.. TT.....C.. ......A.T. C......T.. .T..GT..GA ..G.....C. ...T.TTTT. .....G..A. t..A. 2007-01 ....T...A. A.C...T... GGT....... ....C.G.A. .......... ....A.T.C. TT.C.T.... ..GC....T. CT.....T.. ....GT..GA ........C. .......T.. ...G...... ...A. 2007-02 ....T...A. A.C...T... GGT....... ....C.G.A. ..C....... ....A.T.C. TT.C.T.C.. ..GC....T. CT.....T.. ....GT..GA ........C. .......T.. ...G...... ...A.
164
165
Appendix 3 Nucleotide sequence alignment of the major capsid gene VP60 of RHDV strains. The localisation of two primer probe pairs for the use in real-time PCR are boxed and highlighted in bold letters. The newly designed primer-probe pair “RHD” spans the positions 309 to 427 of VP60, corresponding to positions 6513 to 5731 on strain AST89 (Genbank accession number Z49271). The primer-probe pair “VP60” described by Gall et al. 2007 spans the positions 1637 to 1740 of VP60, corresponding to positions 6941 to 7044 on strain AST89. The partial VP60 for mostly targeted for sequencing and phylogenetic studies spans positions 853 to 1399 of VP60, corresponding to positions 6157 to 6703 on strain AST89, here represented as shaded background on strain AST89.
166
167
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 122 222 222 223 333 333 333 444 444 444 455 555 555 556 666 666 666 777 777 777 788 888 888 889 999 999 999 000 000 000 011 111 111 112 222 222 222 333 333 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 Z49271_RHDV-AST89 ATG GAG GGC AAA GCC CGC ACA GCG CCG CAA GGC GAA GCA GCA GGC ACT GCC ACC ACA GCA TCA GTC CCT GGA ACC ACA ACC GAT GGC ATG GAT CCC GGC GTT GTG GCC ACT ACC AGC GTG GTC ACT GCA GAG AAT AB300693_Hokkaido/2002/JPN ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..A ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... AF231353_NZ ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... .T. ... ... ... ... ..T ..C ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... AF258618_Iowa2000 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... AF295785_Mexico89 ... ... ... ... ... ..T G.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... AF402614_WX/China/1984 ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ... ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... AF453761_China/Harbin/TP ... ... ... ... A.. ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... AJ302016_99-05FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... AJ302016_99-05FR(2) ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... AJ303106_00-ReuFR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ... ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... AJ319594_00-08FR ... ... ... ... ... ..T ... ... ... ... ... ... ..T ..G ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ..T ... ... ... ... ..C ..T ..T ... ... ... ... ..A ... AJ495856_00-13FR ... ... ... ... ... ... ... ... ... ... A.. ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ..C ..T ... ..C ..T ... ..C ... ... ..A ..T ... ... ... ..C A.C ... ... AJ535092_95-05FR ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ... ... ... ..G ... ... ..T ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... AJ535094_95-10FR ... ... ... ... ... ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... AJ969628_03-24FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... AM085133_05-01FR ... ... ... ... ... ... ... ... ... ... A.. ..T ... ..G ... ... ..T ... ... ... ... ... ..C ... ... ... ... ..C ..T ... ..C ..T ... ..A ... ... ..A ..T ... ... ... ..C A.T ... ..C AY269825_NJ/China/1985 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ..T ..A ... ... G.A ..T ..T ... ... ... ... ..A ... AY523410_CD/China ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..A ... ..T G.A ..T ..T ... ... ... ... ... ... AY926883_Ireland12 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... T.. ... ..T ... ... ... ... ..C ..T ..T ... ... ... ... ... ... AY928268_Ireland18 ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... T.. ... ..T ... ... ... ... ..C ..T ..T ... ... ... ..G ... ... AY928269_Ireland19 ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... T.. ... ..T ... ... ... ... ..C ..T ..T ... ... ... ..G ... ... DQ069280_whn/China/01/2005 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..A ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... DQ069281_whn/China/02/2005 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..A ... ... G.A ..T ..T ... ... ... ... ..A ... DQ069282_whn/China/03/2005 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..A ... ... G.A ..T ..T ... ... ... ... ..A ... DQ189077_Bahrain ... ... ... ... ... ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ..C ... ... ... ... ... ..C ..T ..T ... ... ... ... ... ... DQ189078_SaudiArabia ... ... ... ... ... ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ... ... ... ..G ..T ... ... ... ... ..T ..T ... ..A ... ... ... ..T ... A.. ... ... ..A ... DQ205345_JX/CHA/97 ... ... ... ... A.. ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... DQ280493_ChinaWHNRH ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..A ... ... G.A ..T ..T ... ... ... ... ..A ... DQ530363_China-Yangling(YL) ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ..A ..A ... ... G.G ..T ..T ... ... ... ... ..A ... DQ841708_CUB5-04 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... .TC ... ... ..G ... ..C ... ... ... ..T ... ..A ... ... G.A ..T ..T ... ... ... ... ..A ... EF363035_clonepJG-RHDV-DD06 ... ... ... ... ... ... ... ... ... ... ... ... .T. ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... T.. ... ..T ... ... ... ... ..C ..T ..T ... ... ... ... ... ... EF558572_Frankfurt12 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... EF558573_Frankfurt5 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... EF558574_Wika_Germany ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... EF558576_Jena_Germany ... ... ... ... ... ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ..C ..T ... ... ... ... ... ... ... EF558577_Meiningen_Germany ... ... ... ... ... ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..T ... ... ... ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C EF558579_NZ54 ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ..C ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... EF558580_NZ61 ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ..C ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... EF558581_Erfurt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..A ... ... G.A ..T ..T ... ..T ... ... ..A ... EF558582_Dachswald ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... EF558583_Triptis ... ... ... .G. ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... EF558584_Rossi ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... EF558585_Hagenow ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... EF558587_Ashington --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --- --. ... ... ... ... ..C ... ... ... ..T ... ..T ... ..C ..T ..T ... ... ... ..A ... ..T ... ... ..C A.T ... ..C EU003578_IN-05 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ... ... ... ..T ... ..A ... ... G.A ..T ..T ... ... ... ... ..A ..C EU003579_Italy90 ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ..C ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... AC. ... ... ..A ... EU003580_Korea90 ... ..A ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ... ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... EU003581_NY-01 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..T ..C ... ... ..G ... ..C ..T ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... EU003582_UT-01 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ..G ... ..C ... ... ... ..T ... ..G ... ... G.A ..T ..T ... ... ... ... ..A ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ..C ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... NC_001543_FRG ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ..C ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... RHU49726_Haute-Saone/FR88 ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ..T ... ... ..T ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... U54983_V351 ... ... ... ... ... ..T G.. ... ... ... ... ... ... ..G C.G ... ... ... ... ... ... ..T ..C ... ... ..G ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... A.. ... ... ..A ... X87607_BS89 ... ... ... ... ... ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C X96868_RCV ... ... ... ... ... ..A .T. A.. ... ... ... ... ... ..G ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ..T ... ... ..T ... ..A ... ..T ... ... ..C A.T ... ..C Y15424_Frankfurt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... T.. ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... Y15427_Wriezen ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ... ... ..C ..T ..T ... ... ... ... ... ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C
168
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 122 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 333 344 444 444 445 555 555 555 666 666 666 677 777 777 778 888 888 888 999 999 999 900 000 000 001 111 111 111 222 222 222 233 333 333 334 444 444 444 555 555 555 566 666 666 667 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 Z49271_RHDV-AST89 TCA TCC GCA TCG ATT GCA ACG GCA GGG ATT GGC GGA CCA CCC CAA CAG GTG GAC CAA CAA GAG ACA TGG AGA ACG AAC TTT TAT TAT AAT GAC GTT TTC ACT TGG TCA GTC GCG GAT GCC CCT GGC AGC ATA CTT AB300693_Hokkaido/2002/JPN ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ..G ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ..C ..G ..C ... ... ..T ... AF231353_NZ ... ..T ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AF258618_Iowa2000 ... ..T ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ... ..C ... ..T ... ... ... ... ..C ... ... ..C ..G ..C ... ... ..T ..C AF295785_Mexico89 ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ..A ... ..G ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AF402614_WX/China/1984 ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AF453761_China/Harbin/TP ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..T ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C AJ302016_99-05FR ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C AJ302016_99-05FR(2) ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C AJ303106_00-ReuFR ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C AJ319594_00-08FR ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ..C ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AJ495856_00-13FR ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ..C ... ... ..T ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... AJ535092_95-05FR ... ..T ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ..C ... ... ... ... ..C ... ... ... ..T ... ... AJ535094_95-10FR ... ... ..G ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ..T ... ... ... ..C ... ... ... ... AJ969628_03-24FR ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ..G ..A ... ... ..G ..A ... ... ..C ..C ..C ... ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C AM085133_05-01FR ... ... ..G ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ... ... ... ... ... ... ..T ... ..C ... ..C ... ... ... ... AY269825_NJ/China/1985 ... ... ... ... G.. ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C AY523410_CD/China ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ..C ... ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C AY926883_Ireland12 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ..C AY928268_Ireland18 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... AY928269_Ireland19 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... DQ069280_whn/China/01/2005 ... ... ... ... G.. ... ... ..G ... ... ..A ..C ... ... ... ... ... ... ... ..G ..A ... ... ..G ..A ... ... ..C ..C ... ... ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C DQ069281_whn/China/02/2005 ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ..G ..A ... ... ..C ..C ..C ..T ... ... ... ... ..C ... ... ..C ..G ..C ... ... ..T ..C DQ069282_whn/China/03/2005 ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ..C ..G ..C ... ... ..T ..C DQ189077_Bahrain ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ..C ... ... ... ... ... ... ..C ... ..C ... ... ... ... DQ189078_SaudiArabia ... ..A ..T ... ... ... ..A ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... DQ205345_JX/CHA/97 ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..T ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C DQ280493_ChinaWHNRH ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ..C ..G ..C ... ... ..T ..C DQ530363_China-Yangling(YL) ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C DQ841708_CUB5-04 ... ... ... ... G.. ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C EF363035_clonepJG-RHDV-DD06 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... EF558572_Frankfurt12 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... EF558573_Frankfurt5 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... EF558574_Wika_Germany ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... EF558575_Ascot_UK ... ..T ..G ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ..T ... ... EF558576_Jena_Germany ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... EF558577_Meiningen_Germany ... ... ..G ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ..T ... ..C ... ..C ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ..T ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ... ..G ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... EF558580_NZ61 ... ..T ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ... ..G ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... EF558581_Erfurt ... ... ..G ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ..T ... ... ..G ..C ... ... ..T ..C EF558582_Dachswald ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C EF558583_Triptis ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C EF558584_Rossi ... ... ... ... G.. ... ..A ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ..C ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C EF558585_Hagenow ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... EF558587_Ashington G.G ... ... ... G.C ..G ... ..G ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ..G ..A ... ... ..C ..C ..C ..T ... ..T ... ... ... ..T ... ..C ... ... ... ..T ..C ..G EU003578_IN-05 ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ..G ..A ... ... ..C ..C ..C ... ... ... ... ... ..C ... ... ..C ..G ..C ... ... ..T ..C EU003579_Italy90 ..G ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... EU003580_Korea90 ... ... ... ... ... ... ..A ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... EU003581_NY-01 ... ... ... ... G.. ... ... ..G ... ... ..T ..C ... ... ... ... ... ... ... ..G ..A ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C EU003582_UT-01 ... ... ... ... G.. ... ... ..G ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ..C ..C ... ..T ... ... ... ... ..C ... ... ... ..G ..C ... ... ..T ..C L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... NC_001543_FRG ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... RHU49726_Haute-Saone/FR88 ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..A ... ..C ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... U54983_V351 ... ..T ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... X87607_BS89 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..G ... ... ... ... X96868_RCV G.G ... A.. ... G.C ... ... ..G ... ... ..T ..T ... ... ... ... ... ... ... ..G ... ... ... ..G ..T ... ... ..C ..C ..C ..T ... ... ..C ... ... ..T ..T ... ... ..G ... ... ..C ..G Y15424_Frankfurt ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ..T ... ... ... ... ... ..C ... ..C ... ... ... ... Y15427_Wriezen ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..T ... ... ..C ... ..T ... ... ... ... ... ..T ..C .TA .GA ..C ... ... ... ... Z24757_AST/89 ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
169
222 222 222 222 222 222 222 222 222 223 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 444 444 777 777 777 888 888 888 899 999 999 990 000 000 000 111 111 111 122 222 222 223 333 333 333 444 444 444 455 555 555 556 666 666 666 777 777 777 788 888 888 889 999 999 999 000 000 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 Z49271_RHDV-AST89 TAC ACC GTT CAA CAT TCT CCA CAG AAC AAC CCA TTC ACA GCC GTG CTG AGC CAG ATG TAT GCT GGC TGG GCT GGT GGC ATG CAG TTT CGC TTC ATA GTT GCC GGA TCG GGT GTG TTT GGT GGG CGG TTG GTT GCG AB300693_Hokkaido/2002/JPN ..T ..T ..C ... ..C ..C ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... AF231353_NZ ... ... ..C ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ... AF258618_Iowa2000 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... AF295785_Mexico89 ... ... ..C ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ... AF402614_WX/China/1984 ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ... AF453761_China/Harbin/TP ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... AJ302016_99-05FR ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... AJ302016_99-05FR(2) ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... AJ303106_00-ReuFR ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... AJ319594_00-08FR ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ..G ... ..C ... ... ... ... ... ... ... ... AJ495856_00-13FR ... ... ..C ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ..G ..A ... ... ..C ... ... ..A C.. ..C ..A AJ535092_95-05FR ... ... ... ... ... ..C ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A AJ535094_95-10FR ... ... ..C ... ... ..C ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..C ... ... ..C ..C ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A AJ969628_03-24FR ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... AM085133_05-01FR ... ... ... ... ... ..C ... ..A ... ... ... ..T ... ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ..T ..G ..A ... ... ..C ... ... ..A C.. ..C ..A AY269825_NJ/China/1985 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ..A ... ..A C.. ..C ... AY523410_CD/China ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ..A ..A C.. ..C ... AY926883_Ireland12 ... ... ..C ... ... ... ... ..A ..T ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A AY928268_Ireland18 ... ... ..C ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A ... ..C ..A AY928269_Ireland19 ... ... ..C ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A ... ..C ..A DQ069280_whn/China/01/2005 ..T ..T ..C ..G ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... DQ069281_whn/China/02/2005 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ..A ..A C.. ..C ... DQ069282_whn/China/03/2005 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ..A ..A C.. ..C ... DQ189077_Bahrain ... ... ..C ... ... ... ... ..A ..T ... ... ..T ..C ... ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ..C ... ... ... ... ... ..G ..A ..C ... ... ... ... ..A C.. ..C ..A DQ189078_SaudiArabia ... ... ... ... ... ... ... ..A ..T ... ... ..T ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ... DQ205345_JX/CHA/97 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... DQ280493_ChinaWHNRH ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ..A ..A C.. ..C ... DQ530363_China-Yangling(YL) ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... DQ841708_CUB5-04 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... EF363035_clonepJG-RHDV-DD06 ... ... ..C ... ... ... ... ..A ..T ... ... ..T ... ... ... ... ... ..A ... ..C ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EF558572_Frankfurt12 ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EF558573_Frankfurt5 ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EF558574_Wika_Germany ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EF558575_Ascot_UK ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EF558576_Jena_Germany ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EF558577_Meiningen_Germany ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..G ..A ... ... ... ... ... ..A ... ..C ..A EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ... EF558580_NZ61 ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ... EF558581_Erfurt ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ..A ..A C.. ..C ... EF558582_Dachswald ... ..T ..C ... ..C ..C ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ..A ... ... ... ... ... ..A C.. ..C ... EF558583_Triptis ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ..A ... ... ... ... ... ..A C.. ..C ... EF558584_Rossi ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ..C ... ... ..A ... ... ... ... ... ..A C.. ..C ... EF558585_Hagenow ... ... ..C ... ... ... ... ..A ... .G. ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EF558587_Ashington ... ... ... ..G ..C ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ..C ... ... ... ..C ... ... ... ..C ... ... ... ... ..T ..G ..A ... ... ..C ... ... ..A ... ..C ..T EU003578_IN-05 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..C ..T ... ..A ... ... ... ... ..A ..A C.. ..C ... EU003579_Italy90 ... ... ..C ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ... EU003580_Korea90 ... ... ..C ... ..C ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A EU003581_NY-01 ..T ..T ..C ... ..C ... ... ... ..T ... ... ..T ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ..G ..A ... ... ... ... ... ..A C.. ..C ... EU003582_UT-01 ... ..T ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ..A ... ... ... ... ... ..A C.. ..C ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ..C ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C CG. NC_001543_FRG ... ... ..C ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C CG. RHU49726_Haute-Saone/FR88 ... ..T ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A ... ..C ... U54983_V351 ... ... ..C ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C CG. X87607_BS89 ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A X96868_RCV ..T ..T ... ... ..C ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ..C ..C ... ... ... ... ... ... ... ..C ... ... ... ... ..T ..G ..A ... ... ... ..C ..A ..A C.. ... ..A Y15424_Frankfurt ... ... ..C ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A Y15427_Wriezen ... ... ..C ... ... ... ... ..A ..T ... ..G ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..A ... ... ... ... ... ..A C.. ..C ..A Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ATC ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Primer-Probe “RHD” A GCC GTG CTG AGC CAG AT FAM-T GGC ATG CAG TTY CGC TTC ATA GTT GC-TAMRA
170
444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 455 555 555 555 555 555 555 555 555 555 555 555 555 555 000 011 111 111 112 222 222 222 333 333 333 344 444 444 445 555 555 555 666 666 666 677 777 777 778 888 888 888 999 999 999 900 000 000 001 111 111 111 222 222 222 233 333 333 334 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 Z49271_RHDV-AST89 GCC GTG ATA CCA CCG GGC ATC GAG ATT GGA CCA GGG CTG GAG GTC AGG CAA TTC CCC CAT GTT GTC ATC GAC GCT CGT TCA CTT GAA CCT GTC ACC ATC ACC ATG CCA GAC TTG CGT CCC AAC ATG TAC CAT CCA AB300693_Hokkaido/2002/JPN ..T ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..G ... ... ..T ... ... ..C ... ... ..C ... ... ..T ..T ... ... ... ... ... C.. ... ... ... ... ... ..C ... AF231353_NZ ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ..G ..T ..T ... ... ... ... ..T ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF258618_Iowa2000 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... AF295785_Mexico89 ..T ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF402614_WX/China/1984 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF453761_China/Harbin/TP ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ..G ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ302016_99-05FR ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ302016_99-05FR(2) ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ303106_00-ReuFR ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ..G ..T ..T ... ... ... ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ319594_00-08FR ..T ..C ... ... ... ..T ..T ... ... ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..C ..G AJ495856_00-13FR ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ..T ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ535092_95-05FR ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ535094_95-10FR ... ... ..T ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ969628_03-24FR ..T ..A ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ..T ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AM085133_05-01FR ... ... ... ... ..A ... ... ... ... ... ... ... T.A ... ... ... ... ..T ..T ..C ... ... ..T ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... AY269825_NJ/China/1985 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T AY523410_CD/China ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... AY926883_Ireland12 ..T ... ... ... ..A ... ... ... ..C ... ... ... T.. ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AY928268_Ireland18 ..T ... ... ... ..A ... ... ... ..C ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ... ... C.. ... ... ... ... ... ..C ... AY928269_Ireland19 ..T ... ... ... ..A ... ... ... ..C ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ... ... C.. ... ... ... ... ... ..C ... DQ069280_whn/China/01/2005 ..T ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ... ..T ... ... ..C ... ... ..C ... ... ..T ..T ... ... ... ... ... ..A ... ... ... ... ... ..C ... DQ069281_whn/China/02/2005 ..T ..C ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... DQ069282_whn/China/03/2005 ..T ..C ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... DQ189077_Bahrain ..T ... ... ... ..A ... ... ..A ..A ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... DQ189078_SaudiArabia ..T ..A ... ... ..A ... ... ... ... ..G ... ... T.. ... ... ... ... ... ..T ... ..C ... ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... DQ205345_JX/CHA/97 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... DQ280493_ChinaWHNRH ..T ..C ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... DQ530363_China-Yangling(YL) ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ..C ... ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... DQ841708_CUB5-04 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... EF363035_clonepJG-RHDV-DD06 ..T ... ... ... ..A ... ... ... ..C ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... EF558572_Frankfurt12 ... ... ... ... ..A ... ... ... ... ... ... ... T.. ..A ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558573_Frankfurt5 ... ... ... ... ..A ... ... ... ... ... ... ... T.. ..A ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558574_Wika_Germany ... ... ... ... ..A ... ... ... ... ... ... ... T.. ..A ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558575_Ascot_UK ..T ... ... ... ... ... ... ... ... ... ... ... T.. ... ..T ... ... ..T ..T ... ... ... ..T ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558576_Jena_Germany ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558577_Meiningen_Germany ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ..T ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ..T ... ... ... ..A ... ... ... ... ... ... ..A T.. ... ... ... ..G ..T ..T ... ... ... ... ..T ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... EF558580_NZ61 ..T ... ... ... ..A ... ... ... ... ... ... ..A T.. ... ... ... ..G ..T ..T ... ... ... ... ..T ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... EF558581_Erfurt ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ..C ... ..T ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558582_Dachswald ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... EF558583_Triptis ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558584_Rossi ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ... ..T ... ... ..T ... ... ..C ... ... ..C ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... EF558585_Hagenow ..T ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... ... ... ... ... ... EF558587_Ashington ..A ... ... ... ..A ..T ..A ... ... ... ..T ... T.. ... ... ... ... ... ... ..C ... ... ... ... ..C ..C ... ..C ..G ..A ... ... ..T ..A ... ..G ..T C.A ... ... ..T ... ... ..C ... EU003578_IN-05 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ..T ... ... ..T ..T ... ... ..T ... ... ... ... ... ..C ... ... ..T ..T ... ... ... ... ..T ... ... ... ... ... ... ... ... EU003579_Italy90 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ..G ..T ..T ... ... ... ... ..T ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... EU003580_Korea90 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EU003581_NY-01 ..T ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ..T ... ... ..C ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... ... ... ... ..C ... EU003582_UT-01 ..T ... ... ... ..A ... ... C.. ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ..G ... ... ... ... ... ... ... ... ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ..T ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ..T ... ..G ..T ..T ... ... ... ... ..T ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... NC_001543_FRG ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ..T ... ..G ..T ..T ... ... ... ... ..T ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... RHU49726_Haute-Saone/FR88 ..T ... ... ... ..A ... ... ..A ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... U54983_V351 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ..T ... ..G ..T ..T ... ... ... ... ..T ..C ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... X87607_BS89 ..T ... ... ... ..A ... ... ... ... ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... X96868_RCV ..A ... ... ... ..A ... ..T ..A ..C ... ... ... T.A ... ..T ... ... ..T ... ... ... ..T ... ..T ... ... ... ..C ..G ..G ..T ..T ... ... ... ... ... ... ... ... ... ... ... ... ... Y15424_Frankfurt ... ... ... ... ..A ... ... ... ... ... ... ... T.. ..A ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ..T ... .A. ... ... ... ... ... ... ... ... ... ... ... ... Y15427_Wriezen ..T ... ... ... ..A ... ... ... ..C ... ... ... T.. ... ... ... ... ..T ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ..A ... ... ... ... ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Primer-Probe “RHD” TG ATA CCA CCY GGC ATC G
171
555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 556 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 444 444 444 555 555 555 566 666 666 667 777 777 777 888 888 888 899 999 999 990 000 000 000 111 111 111 122 222 222 223 333 333 333 444 444 444 455 555 555 556 666 666 666 777 777 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 Z49271_RHDV-AST89 ACT GGT GAC CCT GGC CTT GTT CCC ACA CTA GTC CTT AGT GTT TAT AAC AAC CTC ATC AAC CCG TTT GGT GGG TCC ACC AGC GCA ATC CAG GTG ACA GTG GAA ACA AGG CCA AGT GAA GAT TTT GAG TTC GTG ATG AB300693_Hokkaido/2002/JPN ... ... ... ... ..T ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ... ... ... ..T ..C ... ... ... ..A ... AF231353_NZ ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... AF258618_Iowa2000 ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ..T ... ... ... ... ..A ... ... ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ..T ..C ... ... ... ... ... AF295785_Mexico89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... AF402614_WX/China/1984 ... ... ... ... ... ... ... ... ... T.. ... ..C ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... AF453761_China/Harbin/TP ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ..A ... ... ..T ..C ... ... ..T ... ... AJ302016_99-05FR ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ... ... ... ..T ..C ... ... ... ... ... AJ302016_99-05FR(2) ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ... ... ... ..T ..C ... ... ... ... ... AJ303106_00-ReuFR ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ... ... ... ..T ..C ... ... ... ... ... AJ319594_00-08FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ495856_00-13FR ... ... ... ... ..T ... ... ... ... ..G ... ..A ... ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... AJ535092_95-05FR ... ... ... ... ..T ... ... ... ... ..G ... ..C ... ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... AJ535094_95-10FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..C ... ... ... ... ... AJ969628_03-24FR ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ... ... ... ..T ..C ... ... ... ... ... AM085133_05-01FR ... ... ... ... ..T ..C ..C ... ... ..G ... ... ... ... ..C ..T ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... G.. ..G ... ... ... ... ... ... ... ... AY269825_NJ/China/1985 ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ..A ... ... ..A ... ... .A. ... ... ... ..A ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... AY523410_CD/China ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... AY926883_Ireland12 ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ... ..A ... ... ... ..T ... ..T ... ... ... ... ... ... ..A ..G ... ... ..C ... ... ... ... ... AY928268_Ireland18 ... ... ... ... ... ... ... ... ... ... ... ... ..C ..C ..C ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... AY928269_Ireland19 ... ... ... ... ... ... ... ... ... ... ... ... ..C ..C ..C ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... DQ069280_whn/China/01/2005 ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ... ... ... ..T ..C ... ... ... ... ... DQ069281_whn/China/02/2005 ... ... ... ... ... ... ..C ... ... ... ... ..C ... ... ..C ... ... ... ..T ..T ... ... ... ... ... ... .A. ... ... ... ... ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... DQ069282_whn/China/03/2005 ... ... ... ... ... ... ..C ... ... ... ... ..C ... ... ..C ... ... ... ..T ..T ... ... ... ... ... ... .A. ... ... ... ... ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... DQ189077_Bahrain ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..A ..A ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... DQ189078_SaudiArabia ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ... ... ... ..T ..A ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... DQ205345_JX/CHA/97 ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ..A ... ... ..T ..C ... ... ..T ... ... DQ280493_ChinaWHNRH ... ... ... ... ... ... ..C ... ... .C. ... ..C ... ... ..C ... ... ... ..T ..T ... ... ... ... ... ... .A. ... ... ... ... ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... DQ530363_China-Yangling(YL) ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... DQ841708_CUB5-04 ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... EF363035_clonepJG-RHDV-DD06 ..C ... ... ... ... ... ..A ..T ... ... ... ... ..C ..C ..C ... ... ..T ... ... ... ... ..A ... ... ... ..T ... ... ..A ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... EF558572_Frankfurt12 ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EF558573_Frankfurt5 ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EF558574_Wika_Germany ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ..A ... EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EF558576_Jena_Germany ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... EF558577_Meiningen_Germany ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ..C ... ... ..T ..T ... ... ... ... ..T ... ..T ..T ... ..T ... ... ... ... ... ... ..A ..G ... ... ..C ... ... ... ... ... EF558580_NZ61 ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ..C ... ... ..T ..T ... ... ... ... ..T ... ..T ..T ... ..T ... ... ... ... ... ... ..A ..G ... ... ..C ... ... ... ... ... EF558581_Erfurt ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... EF558582_Dachswald ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ..A ... ... ... ... ... ... ... ..T ..C ... ... ... ... ... EF558583_Triptis ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..G ..C ... ... ... ... ... EF558584_Rossi ... ..C ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..G ..C ... ... ... ... ... EF558585_Hagenow ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..A ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EF558587_Ashington ... ... ... ... ... ... ..C ..T ... T.G ..T T.G ... ... ... ... ... ..T ..T ... ..A ... ... ..A ..T ..T ..T ... ... ..A ..T ... ... ... ... ... ... ... ... ..C ... ... ..T ... ... EU003578_IN-05 ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ... ... ... ... ..G ... ..G ... ..T ..C ... ... ... ... ... EU003579_Italy90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EU003580_Korea90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EU003581_NY-01 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ... .A. ... ..T ... ..A ... ... ... ... ... ... ... ... ..C ... ... ... ... ... EU003582_UT-01 ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ..A ... ... ... ... ... ... ... ..G ..C ... ... ... ... ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... NC_001543_FRG ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... RHU49726_Haute-Saone/FR88 ... ... ... ... ..T ... ..A ... ... T.. ... ..C ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... U54983_V351 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..T ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... X87607_BS89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... X96868_RCV ... ..C ... ... ..T ... ... ... ... T.G ... ..C ... ... ..C ... ... ..A ... ... ..T ... ..A ..A ..T ... ... ..G ... ... ... ... ... ... ... ... ... ... ..G ..C ... ... ..T ..A ... Y15424_Frankfurt ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... Y15427_Wriezen ... ... ... ... ... ... ... ... ..G ... ... ... ..C ... ..C ... ... ... ... ... ... ... ..A ... ... ... ..T ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
172
666 666 666 666 666 666 666 666 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 777 788 888 888 888 777 788 888 888 889 999 999 999 000 000 000 011 111 111 112 222 222 222 333 333 333 344 444 444 445 555 555 555 666 666 666 677 777 777 778 888 888 888 999 999 999 900 000 000 001 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 Z49271_RHDV-AST89 ATT CGA GCC CCC TCC AGC AAG ACT GTT GAC TCA ATT TCA CCC GCA GGC CTC CTC ACG ACC CCA GTC CTC ACT GGG GTT GGC AAT GAC AAC AGG TGG AAT GGC CAA ATA GTG GGA CTG CAA CCA GTA CCT GGA GGG AB300693_Hokkaido/2002/JPN ... A.. ... ... ... ... ... ... ... ... ... G.C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... AF231353_NZ ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..C ... ... AF258618_Iowa2000 ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..G ... AF295785_Mexico89 ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... AF402614_WX/China/1984 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... AF453761_China/Harbin/TP ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... AJ302016_99-05FR ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... AJ302016_99-05FR(2) ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... AJ303106_00-ReuFR ... A.G ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..G ... ..G ... AJ319594_00-08FR ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... G.. ... ... ... ... ... ... ... ... ..C ..T ... ... ... ..G ... ... ... ..T ... ... ... AJ495856_00-13FR G.. ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ... ... ..T ... ... ... ..C ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ..C ... ... AJ535092_95-05FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ..T ... ... ... ... ... ..A ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ... ... ..C ... ... AJ535094_95-10FR ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ..C ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... AJ969628_03-24FR ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..G ... ..G ... AM085133_05-01FR ... ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ... ... ..T ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ..C ..T ... AY269825_NJ/China/1985 ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ..T ..T ... ... ... ... ... ... ..T ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... AY523410_CD/China ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ..T ..C ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... AY926883_Ireland12 ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ..A ... ... ... ... ... ... ..C ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ..G ..C ... ... AY928268_Ireland18 ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ..A ... ... ..T ... ... ... ..C ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ..C ... ... AY928269_Ireland19 ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ..A ... ... ..T ... ... ... ..C ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ..C ... ... DQ069280_whn/China/01/2005 ... A.. ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... DQ069281_whn/China/02/2005 ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ..T ... ... ..T ..C ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ..G ... DQ069282_whn/China/03/2005 ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ..G ... DQ189077_Bahrain ... ... ... ..T ... ..T ..A ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ..T ... G.. ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... .C. ... ..C ..A DQ189078_SaudiArabia ... ... ... ... ... ... ... ... ... ..T ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..G ... ... ... ... DQ205345_JX/CHA/97 ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... DQ280493_ChinaWHNRH ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ..T ..C ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ..G ... DQ530363_China-Yangling(YL) ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... DQ841708_CUB5-04 ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... A.. ... ... ... ... ... ... ..G ... EF363035_clonepJG-RHDV-DD06 ... ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ..A ... ... ..T ... ..C ... ..C ... ... ... ... ..A ... ..C ... ... ... ... ..G ... ... ... ... ..C ..T ... EF558572_Frankfurt12 ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... ... ... ... ..A ... ... ..T ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... EF558573_Frankfurt5 ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... EF558574_Wika_Germany ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... EF558575_Ascot_UK ..C A.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ..T ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... EF558576_Jena_Germany ... ... ... ..T ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ..T ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... EF558577_Meiningen_Germany ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..C ... ... EF558580_NZ61 ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..C ... ... EF558581_Erfurt ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ..T ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... EF558582_Dachswald ... A.. ..T ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... T.. ... ... ... ... ..G ... EF558583_Triptis ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ..G ... EF558584_Rossi ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... EF558585_Hagenow ... A.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ..T ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... EF558587_Ashington ... ..T ... ... ... ... ..A ... ... ... ... G.. ..G ... ... ... ..G ... ... ... ... ... ... ... ... ... ... .C. ... ... ..A ... ..C ... ... ... ... ..G ... ... ..G ..C ... ..T ... EU003578_IN-05 ... A.. ... ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... EU003579_Italy90 ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..G ... ... ... EU003580_Korea90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... EU003581_NY-01 ... A.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..G ... EU003582_UT-01 ... A.G ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ... ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... NC_001543_FRG ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... RHU49726_Haute-Saone/FR88 ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... U54983_V351 ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... .A. ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..C ... ... X87607_BS89 ... ... ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... X96868_RCV ... ..C ... ... ... ... ..A ..C ... ... ... G.C A.C ..T ... ... ..T ... ..C ... ..G ..T ... ..C ... ... ... .C. ... ... ... ... ... T.. ... ... ... ..G ..A ... ... ... ... ... ... Y15424_Frankfurt ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... Y15427_Wriezen ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C .A. ... ..T ... ... ... ..C ... ... ..T ... ... ... ..C ... ... ... ... ..G ... ... ... ... ..C ... .T. Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
173
888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 888 889 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 111 111 111 222 222 222 233 333 333 334 444 444 444 555 555 555 566 666 666 667 777 777 777 888 888 888 899 999 999 990 000 000 000 111 111 111 122 222 222 223 333 333 333 444 444 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 Z49271_RHDV-AST89 TTC TCT ACG TGC AAC AGG CAT TGG AAC TTG AAT GGC AGC ACA TAT GGC TGG TCA AGC CCC CGG TTT GCC GAC ATT GAC CAT CGA AGA GGC AGT GCA AGT TAC CCT GGG AAC AAC GCA ACC AAC GTG CTT CAG TTT AB300693_Hokkaido/2002/JPN ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... .TT G.. ... ... ... T.C ... ... ... ..C ... ... AF231353_NZ ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... .A. ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... AF258618_Iowa2000 ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ..G ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ..C ... ... AF295785_Mexico89 ..T ... ... ... ..T ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... AF402614_WX/China/1984 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... AF453761_China/Harbin/TP ..T ..C ... ... ... ... ... ... ... ..A ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ..C ... ... AJ302016_99-05FR ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ..C ... ... AJ302016_99-05FR(2) ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ..C ... ... AJ303106_00-ReuFR ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... .G. ... T.C ... ... ... ..C ... ... AJ319594_00-08FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... .A. ... ... ... ... ... ... AA. ... GG. ... ..T ... ... ... ... ... ..C AJ495856_00-13FR ..T ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ..T ... ... ..T ... ... ... ... ..G ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ535092_95-05FR ..T ..C ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ... C.. ... ... ... ..C ... ... AJ535094_95-10FR ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ969628_03-24FR ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ..C ... ... AM085133_05-01FR ..T ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ..T ... ... ..T ... ..C ... ... ... ..G ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... AY269825_NJ/China/1985 ..T ..C ... ... ... ... ... ... ... C.. ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ..T ... ... ... ..T T.. ... ... ... ..C ... ... ... ... ... ... AY523410_CD/China ..T ..C ... ... ... ... ... ... ... C.. ..C ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ..T T.. ... ... ... T.C ... ... ... ... ... ... AY926883_Ireland12 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ..T ... ... ... ... ..T ... ... .G. ... ... ... ... ... ... ... ... AY928268_Ireland18 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ..T ... ... ... ... ... ... ... .G. ... ... ... ... ..A ... ... ... AY928269_Ireland19 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ..T ... ... ... ... ... ... ... .G. ... ... ... ... ..A ... ... ... DQ069280_whn/China/01/2005 ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... .TT G.. ... ..T ... T.C ... ... ... ..C ... ... DQ069281_whn/China/02/2005 ..T ..C ... ... ... ... ... ... ... C.. ..C ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ... ... ... DQ069282_whn/China/03/2005 ..T ..C ... ... ... ... ... ... ... C.. ..C ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ..T T.. ... ... ... T.C ... ... ... ... ... ... DQ189077_Bahrain ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..C ... .G. ... ... ... ..T ... ..C ... ... DQ189078_SaudiArabia ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... GG. ... ... ..T ... ... ... ... ..C DQ205345_JX/CHA/97 ..T ..C ... ... ... ... ... ... ... ..A ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... .G. T.C ... ... ... ..C ... ... DQ280493_ChinaWHNRH ..T ..C ... ... ... ... ... ... ... C.. ..C ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ... ... ... DQ530363_China-Yangling(YL) ..T ..C ... ... ... ... ... ... ... C.. ..C ..T ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ..T T.. ... ... ... T.C ... ... ... ... ... ... DQ841708_CUB5-04 ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ..C ... ... EF363035_clonepJG-RHDV-DD06 ..T ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ..T ... ... ... ... ... ... ..A ... ... ... ... ... ..A ... ... ... EF558572_Frankfurt12 ..T ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558573_Frankfurt5 ..T ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558574_Wika_Germany ..T ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558575_Ascot_UK ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... EF558576_Jena_Germany ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ..T ... ... ... ... ... ... ... .G. ... ... ... ... ... ..C ... ... EF558577_Meiningen_Germany ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ..C ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... EF558579_NZ54 ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ..C EF558580_NZ61 ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ..C EF558581_Erfurt ..T ..C ... ... ... ... ... ... ... C.. ..C ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.C ... ... ... ... ... ... EF558582_Dachswald ..T ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ..T T.. ... ... ... T.C ... ... ... ..C ... ... EF558583_Triptis ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..T T.. ... ... ... T.. ... ... ... ..C ... ..C EF558584_Rossi ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ... ... ..T T.. ... ... ... T.. ... ... ... ..C ... ..C EF558585_Hagenow ..T ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... EF558587_Ashington ..T ..C ..A ... ... ... ..C ... G.. ... ... ..T ... ..G ..C ..T ... ... ... ..T TC. ..C A.. ... ... ... ..C ..C ..G ..T GT. ... .CC CG. ... ..C --- --- A.C ..G G.. ... ... ... ..C EU003578_IN-05 ..T ..C ... ... ... ... ... ... ... C.. ..C ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ..C ..T T.. ... ... ... T.C ... ... ... ... ... ... EU003579_Italy90 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... .C. EU003580_Korea90 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... ... ... ... ... ... T.. ... .G. ... ... ... ... ... ... ... ... EU003581_NY-01 ..T ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... .TT G.. ... ... ... T.C ... ... ... ..C ... ... EU003582_UT-01 ..T ..C ... ... ... ... ..C ... ..T ... ..C ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... T.. ... ... ... ..C ... ..C L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... .G. ... ... ... ... ... ... ... ... ... ... ... T.. ... .G. ... ... ... ... ... ... ... ... NC_001543_FRG ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... .G. ... ... ... ... ... ... ... ... ... ... ... T.. ... .G. ... ... ... ... ... ... ... ... RHU49726_Haute-Saone/FR88 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ..T ... ... ... ... ... U54983_V351 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... .A. ... ... ... ... ... ... ... .G. ... ... ... ... ..A ... ... ... X87607_BS89 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... X96868_RCV ..G ..C ... ... ... ..A ..C ... ... ... ... ... ... ... ... ..T ... ..G ... ..T ... ... A.T ... ... ... ..C ..C ... ..T --- ... ... C.A ... ..A --- --- .GT .A. ... ... ..C ... ..C Y15424_Frankfurt ..T ..C ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Y15427_Wriezen ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ..T ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .G. ... ... .G. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
174
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 999 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 000 444 455 555 555 556 666 666 666 777 777 777 788 888 888 889 999 999 999 000 000 000 011 111 111 112 222 222 222 333 333 333 344 444 444 445 555 555 555 666 666 666 677 777 777 778 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 Z49271_RHDV-AST89 TGG TAT GCC AAT GCT GGG TCT GCA ATC GAC AAT CCC ATC TCC CAG GTT GCA CCA GAC GGC TTT CCT GAT ATG TCG TTC GTG CCC TTT AAC GGC CCT GGC ATT CCA GCC GCG GGG TGG GTC GGA TTT GGT GCA ATC AB300693_Hokkaido/2002/JPN ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ..T ... ... A.. ... AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T AF231353_NZ ... ... ... ... ..A ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ..T ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ... ... ... AF258618_Iowa2000 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ..T ..G ... ... .GT ..T AF295785_Mexico89 ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... AF402614_WX/China/1984 ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... AF453761_China/Harbin/TP ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T AJ302016_99-05FR ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T AJ302016_99-05FR(2) ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T AJ303106_00-ReuFR ... ..C ..T ... ... ... ... ..G ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C A.. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T AJ319594_00-08FR ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..G ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ..A ... ... ..T ..G ... ... ... ... AJ495856_00-13FR ... ... ... ... ... ... ... ..G G.T ... ..C ... ... ... ... ... ... ..G ..T ... ..C ... ..C ... ... ... ... ... ... ... ..T ... ..T ..C ... ... ... ..A ... ... ... ... ... ... ... AJ535092_95-05FR ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... AJ535094_95-10FR ... ... ... ... ... ... ... ... G.. ... ..C ... ... ... ... ... ... ... ..T ... ... ..C ..C ... ... ... ... ... ..C ... ..T ..A ..T ... ... ... ..A ... ... ... ... ... ... ... ... AJ969628_03-24FR ... ..C ..T ... ... ... ... ... ..T ... ..C ... ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ..T ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T AM085133_05-01FR ... ... ... ... ... ..C ... ..G G.T ... ..C ... ... ... ... ... ... ..G ... ... ..C ... ..C ... ... ... ... ... ... ... ..T ... ..T ..C ... ... ... ... ... ..T ... ... ... ... ... AY269825_NJ/China/1985 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... A.. ... ... ... ... ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G ... ... ... ... ... ..G ... ... .GT ..T AY523410_CD/China ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ..T ... ... ... ... ..G ..T ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ... A.. ... ... ... ... ..G ... ... .GT ..T AY926883_Ireland12 ... ... ... ... ... ... ... ... G.. ... ..C ..T ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ... ... AY928268_Ireland18 ... ... ... ... ... ... ... ... G.. ... ..C ..T ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ..C ... ... ... ... ... ... ... ... ... ... ... AY928269_Ireland19 ... ... ... ... ... ... ... ... G.. ... ..C ..T ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ..C ... ... ... ... ... ... ... ... ... ... ... DQ069280_whn/China/01/2005 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ..T ... ... A.. ..C AA. ... ..G A.. ... ... ... ..T ..G ... ... .GT ..T DQ069281_whn/China/02/2005 ... ..C ..T ... ... ... ... ... ..T ... ..C ... ... ... ... ... ... ..G ... ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ..T ..G ... ... .GT ..T DQ069282_whn/China/03/2005 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ..T ..G ... ... .GT ..T DQ189077_Bahrain ... ... ... ... ... ... ... ... G.. ... ..C ... ... ..T ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ... ... DQ189078_SaudiArabia ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..C ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ... ... ... DQ205345_JX/CHA/97 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T DQ280493_ChinaWHNRH ... ..C ..T ... ... ... ... ... ..T ... ..C ... ... ... ... ... ... ..G ... ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ..T ..G ... ... .GT ..T DQ530363_China-Yangling(YL) ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ..C ... ..G ..T ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T DQ841708_CUB5-04 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ..C ..G A.. ... ... ... ... ..G ... ... .GT ..T EF363035_clonepJG-RHDV-DD06 ... ... ... ... ... ... ... ... G.. ... ..C ..T ... ... ... ..C ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ... ... EF558572_Frankfurt12 ... ... ... ... ... ... ... ... G.. ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ..A ... ..C ... ..T ..C ..T ... ..G ... ..A ... ... ... ... ... ... ... ... EF558573_Frankfurt5 ... ... ... ... ... ... ... ... G.. ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ..A ... ..C ... ..T ..C ..T ... ..G ... ..A ... ... ... ... ... ... ... ... EF558574_Wika_Germany ... ... ... ... ... ... ... ... G.. ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ..A ... ..C ... ..T ..C ..T ... ..G ... ..A ... ... ... ... ... ... ... ... EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ... ..A ... ... ..G ... ... ... ... EF558576_Jena_Germany ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ... ... EF558577_Meiningen_Germany ... ... ... ... ... ... ... ... G.. ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ..A ... ... ... ... ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... ... ... G.. ... ..C ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ..A ... ... ... ..G ... ... ... ... EF558580_NZ61 ... ... ... ... ... ... ... ... G.. ... ..C ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ..A ... ... ... ..G ... ... ... ... EF558581_Erfurt ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T EF558582_Dachswald ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ... ... ..C ... ..A ... ... ... ..C ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T EF558583_Triptis ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ... ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .G. ... EF558584_Rossi ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ... ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ..A ... ... ... ..G ... ... .GG ... EF558585_Hagenow ... ... ... ... ... ... ... ... .C. ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ... ... EF558587_Ashington ... ..C ..T .G. ... ... ... ... .C. ..G ..C ..T ..T ... ... A.C ..G ... ..T ..T ..C ..G ..C ... ... ... A.T ..T ... ... ... ..C A.T G.C ..C ..T ..A ... ... ... ..G ... ... ... ... EU003578_IN-05 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ..G ... ... ..C ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ... A.. ... ... ... ... ..G ... ... .GT ..T EU003579_Italy90 ... ... ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ... ... ... EU003580_Korea90 ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ... ... EU003581_NY-01 ... ..C ..T ... ... ... ... ... ..T ... ..C ..T ... ... ... ... ... ... ..T ... ... ... ..C ... ..A ... ... ..T ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..G ... ... .GT ..T EU003582_UT-01 ... ..C ... ... ... ... ... ... ..T ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ..C ... ..A ... ... ... ... ... A.. ..C AA. ... ..G A.. ... ... ... ... ..T ... ... .G. ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ..T ... ... ... ... ... NC_001543_FRG ... ... ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ..T ... ... ... ... ... RHU49726_Haute-Saone/FR88 ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... U54983_V351 ... ... ... ... ... ... ... ... ... ... ..C ... ..T ... ... ... ..T ... ... ... C.. ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ..T ... ... ... ... ... ... ... ... ... X87607_BS89 ... ..C ... ... ... ... ... ... G.. ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ..C ... ..T ..C ..T ... ... ... ... ... ... ... ... ... ... ... ... X96868_RCV ... ... ... ... ..C ... ... ..G G.T ... ..C ... ..T .GT ... ... ... ... ... ..G ... ... ..C ... ... ... ... ..T ..G ... ... ..C AA. G.C ..C A.. ... ... ... ..T ..G ... ... ... ... Y15424_Frankfurt ... ... ... ... ... ... ... ... G.. ... ..C ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ..A ... ..C ... ..T ..C ..T ... ..G ... ..A ... ... ... ... ... ... ... ... Y15427_Wriezen ... ... ... ... ... ... ... ... ... ... ..C ..T ... ... ... ... ... ... ..T ... ... ... ..C ... ... ... ... ... ... ... .T. ... ..T ... ... ... ... ... ... ... ... ... ... ... ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ..T ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
175
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 000 000 000 000 000 000 011 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 112 222 222 222 222 222 888 888 888 999 999 999 900 000 000 001 111 111 111 222 222 222 233 333 333 334 444 444 444 555 555 555 566 666 666 667 777 777 777 888 888 888 899 999 999 990 000 000 000 111 111 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 Z49271_RHDV-AST89 TGG AAC AGT AAC AGC GGT GCC CCC AAC GTT ACG ACT GTG CAG GCT TAT GAG TTA GGT TTT GCC ACT GGG GCA CCA GGC AAC CTC CAG CCC ACC ACC AAC ACT TCA GGT TCA CAG ACT GTC GCC AAG TCC ATA TAT AB300693_Hokkaido/2002/JPN ... ... ... ... ..T ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ..T ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... AF231353_NZ ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... AF258618_Iowa2000 ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... AF295785_Mexico89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... AF402614_WX/China/1984 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... AF453761_China/Harbin/TP ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ..T ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... AJ302016_99-05FR ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... AJ302016_99-05FR(2) ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... AJ303106_00-ReuFR ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... AJ319594_00-08FR ... .T. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .C. ... ... ... ... ... ... ... ... ..G ... .T. ... ... ... ... ... ... AJ495856_00-13FR ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.G ..A ... ... ... ..A ... ..T ... AJ535092_95-05FR ... ... ... ... .A. ... ... ... ..T ... ... ... ... ... ..C ... ... ... ..C ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... AJ535094_95-10FR ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ..T ... ... ... ..T ... AJ969628_03-24FR ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... AM085133_05-01FR ... ... ..C ..T ... ... ..T ... ... ..C ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.G ..A ... ... ... ..A ... ..T ... AY269825_NJ/China/1985 ... ... ... ... .A. ... ... ... GCT .C. ..A ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AAT ... ... ... ... ... ... ... ... ..G ... G.. ... ... ... ..T ... ... ..T ... AY523410_CD/China ... ... ... ... .A. ... ... ..T GCT .CC ... ..C ... ... ..C ... ... ... ... ... ... ... ... ... ... AAT ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... AY926883_Ireland12 ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... G.. ..A ... ... ... ... ... ..T ... AY928268_Ireland18 ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... G.. ..A ... ... ... ... ... ..T ... AY928269_Ireland19 ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... G.. ..A ... ... ... ... ... ..T ... DQ069280_whn/China/01/2005 ... ... ..C ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... DQ069281_whn/China/02/2005 ... ... ..C ... .A. ... ..T ... GCT .C. ... ... ... ... ..C ... ... ... ..C ... ... ... ... ... ... AAT ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... DQ069282_whn/China/03/2005 ... ... ..C ... .A. ... ..T ... GCT .C. ... ... ... ... ..C ... ... ... ..C ... ... ... ... ... ... AAT ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... DQ189077_Bahrain ... ... ... ... ... ... ..T ... ... ..A ... ... ... ... ..C ... ... C.. ... ... ..T ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ..A .T. ... ... ... ... ..T ... DQ189078_SaudiArabia ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ..C ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... DQ205345_JX/CHA/97 ... ... ... ... .A. ... ... ... GCT .CC ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... DQ280493_ChinaWHNRH ... ... ..C ... .A. ... ..T ... GCT .C. ... ... ... ... ..C ... ... ... ..C ... ... ... ... ... ... AAT ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... DQ530363_China-Yangling(YL) ... ... ..C ... .A. ... ... ... GCT .CC ..A ... ... ... ..C ... ... ... ... ... ... ..C ... ... ... AAT ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... DQ841708_CUB5-04 ... ... ... ... .A. ... ... ... GCT .C. ..A ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AAT ... .C. ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EF363035_clonepJG-RHDV-DD06 ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... G.. ..A ... ... ... ... ... ..T ... EF558572_Frankfurt12 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ..T ... ... ... ..T ... EF558573_Frankfurt5 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ..T ... ... ... ..T ... EF558574_Wika_Germany ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ..T ... ... ... ..T ... EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..A ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EF558576_Jena_Germany ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ..A ... ... ... ... ... ..T ... EF558577_Meiningen_Germany ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..A ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..C ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EF558580_NZ61 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..C ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EF558581_Erfurt ... ... ... ... .A. ... ... ... GCT .C. ..A ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AAT ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... EF558582_Dachswald ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ..A ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... EF558583_Triptis ... ... ... ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... EF558584_Rossi ... ... ... ..T .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... EF558585_Hagenow ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... A.T ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EF558587_Ashington ... ... ..C ... ..T ..C ... ... ..T ..C ... ... ..T ... ..A ... C.A ..G ... ... ... ..C ..T ... ... A.. ..T ..T ... ... ..T ... ... ..C ... ... G.G ... GT. ... ... ... ... ..T ... EU003578_IN-05 ... ... ..C ... .A. ... ... ... GCT .CC ... ..C ... ... ..C ... ... ... ... ... ... ... ... ... ... AAT ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EU003579_Italy90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EU003580_Korea90 ... ... ... ... .A. ... ... ... ... ... ..A ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... EU003581_NY-01 ... ... ..C ... ... ... ... ... GCT .C. ... ... ... ... ..C ... ... ..G ..C ... ... ... ... ... ... AA. ... ... ... ... ..T ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... EU003582_UT-01 ... ... ..C ... .A. ... ... ... GCT .C. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... AA. ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ..T ... ... ..T ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... NC_001543_FRG ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... RHU49726_Haute-Saone/FR88 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... U54983_V351 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... X87607_BS89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ..T ... X96868_RCV ... ... ... ... ..T ... ... ... ... ..C ..A ..C ... ... ..C ... ... ..G ... ... ... ..C ..A ... ... AA. ... ... ... ..T G.. ... ... ... ... ..C ... ..A .T. ..T ... ..A ... ..T ... Y15424_Frankfurt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... G.. ... ... ..T ... ... ... ..T ... Y15427_Wriezen ... ... ... ... ... ... ..T ... ... CG. ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ..A ... ... ... ... ... ..T ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ...
176
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 222 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 111 122 222 222 223 333 333 333 444 444 444 455 555 555 556 666 666 666 777 777 777 788 888 888 889 999 999 999 000 000 000 011 111 111 112 222 222 222 333 333 333 344 444 444 445 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 Z49271_RHDV-AST89 GCC GTG GTA ACT GGC ACA GCC CAA AAC CCC GCC GGA TTG TTT GTG ATG GCC TCG GGT GTT ATC TCC ACC CCA AGT GCC AAC GCC ATC ACA TAC ACG CCC CAA CCA GAC AGA ATT GTA ACC ACA CCC GGC ACT CCT AB300693_Hokkaido/2002/JPN ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... ... ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... AF231353_NZ ... ..A ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... .G. ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... AF258618_Iowa2000 ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.A ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ..T ... ... ..G ..T ... ... ... ... ... AF295785_Mexico89 ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ..T ... ... AF402614_WX/China/1984 ... ..A ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... .A. ... .G. ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... AF453761_China/Harbin/TP ... ... ..G ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ..T ... ... ..G ..T ... ... ... ... ... AJ302016_99-05FR ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ..T ... ... ..G ..T ... ... ... ... ... AJ302016_99-05FR(2) ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ..T ... ... ..G ..T ... ... ... ... ... AJ303106_00-ReuFR ... ... ..G ..C ... ... AA. ... ... ..A A.. ... C.A ... ... ... ... ... ... ... ... ... ... ... .AC ... ... ... G.. ... ... ... ... ... ... ..T ... ... ..G ..T ... ... ... ... ... AJ319594_00-08FR ... ... ..G T.. ... ..G A.. ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ... ... ... ..T ..T ..T ..T ... ..T ..A ... ... ... ... ... ... ... ... ... ... ... ... ... AJ495856_00-13FR ... ... ... ... ... ... .G. ... ... ..A ... ..G ... ... ... ... ..T ... ..C A.C ... ..T ... ... .A. ... ... ... ... ... ... ..A ..T ... ..G ..T ... ..C ... ... ... ... ... ... ..A AJ535092_95-05FR ..T ... ... ... ... ... A.. ... ... ..A ... ..G ..A ... ..A ... ... ... ..C ... ... ... ... ... .A. ... .G. ... ... ... ... ..A ... ... ... ... ... ... ... ..T ... ... ... ... ..A AJ535094_95-10FR ... ... ... ... ... ... ... ... ... ..A ... ..G ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... ... ... ..T ... ... ..A ..T ... ... ... ... ... ... ..T ... ... ... ... ..A AJ969628_03-24FR ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ..T ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ..A ... AM085133_05-01FR ... ... ... ... ... ... .G. ... ... ..A ... ..G ... ... ... ... ... ... ... A.C ... ..T ..T ... .A. ..T ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A AY269825_NJ/China/1985 ... ... ... ..C ... ... AA. ... ..T ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... ... ... G.. ... ... ... ... ..G ... ... ... ... ..G ... ... ... ... ... ... AY523410_CD/China ... ... ... ..C ... ... AA. ... ..T ..A A.. ... C.. ... ... ... ... ... ... A.. ... ... ... ... ..C ... .G. ... G.. ... ... ..A ... ... ... ... ... ... ..G ..T ... ... ... ... ... AY926883_Ireland12 ... ... ... ... ... ... .G. ... .G. ..A ... ..G ... ..C ... ... ... ... ..C A.C ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A AY928268_Ireland18 ... ... ... ... ... ... .G. ... .G. ..A ... ..G ... ... ... ... ... ... ..C A.. ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A AY928269_Ireland19 ... ... ... ... ... ... .G. ... .G. ..A ... ..G ... ... ... ... ... ... ..C A.. ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A DQ069280_whn/China/01/2005 ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ..T ... .AC ... ... ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... DQ069281_whn/China/02/2005 ... ... ... ..C ... ... AA. ... ..T ..A A.. ..G C.. ... ... ... ... ... ... ..C ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... DQ069282_whn/China/03/2005 ... ... ... ..C ... ... AA. ... ..T ..A A.. ..G C.. ... ... ... ... ... ... ..C ... ... ... ... .AC ... ... ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... DQ189077_Bahrain ... ... ... ... ... ... .G. ... ... ..A ... ..G ... ... ... ... ... ... ..C A.A ... ... ... ... .A. ... ... ... ... ..C ... ..A ..T ... ... ... ... ... ... ..T ... ... ... ..C ..G DQ189078_SaudiArabia ... ... ... ... ... ... A.. ... ... ..G ... ... C.. ... ... ... ..T ... ... A.. ... ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... DQ205345_JX/CHA/97 ... ... ..G ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ..T ... ... ..G ..T ... ..T ... ... ... DQ280493_ChinaWHNRH ... ... ... ..C ... ... AA. ... ..T ..A A.. ..G C.. ... ... ... ... ... ... ..C ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... DQ530363_China-Yangling(YL) ... ... ... ..C ... ... AA. ... ..T ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... ... ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... DQ841708_CUB5-04 ... ... ... ..C ... ... AA. ... ..T ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ..T ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... EF363035_clonepJG-RHDV-DD06 ... ... ... ... ... ... .G. ... .G. ..A ... ..G ... ... ... ... ... ... ..C A.. ... ... ... ... ... ... ..T ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ..C ..A EF558572_Frankfurt12 ... ... ... ... ... ... A.. ... ... ..A ... ..G ... ... ... ... ... ... ... A.C ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A EF558573_Frankfurt5 ... ... ... ... ... ... ... ... ... ..A ... ..G ... ... ... ... ... ... ... A.C ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A EF558574_Wika_Germany ... ... ... ... ... ... ... ... ... ..A ... ..G ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ..A ... ..G ... ... ... ... ... ... ..C ... ... ... ... ... .A. ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..T ... ... ... ... ..A EF558576_Jena_Germany ... ... ... ... ... ... .G. ... ... ..A ... ..G ... ... ... ... ... ... ..C A.. ... ... ... ... .A. ... ... ... ... ... ... ..A ..T .C. ... ... ... ... ... ..T ... ... ... ..C ..A EF558577_Meiningen_Germany ... ... ... ... ... ... A.. ... ... ..A ... ..G ... ... ... ... ... ... ..C ... ... ..T ... ... .A. ... .G. ... ... ... ... ..A ... ... ... A.. ... ... ... ..T ... ... ... ... ..A EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ..A ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ..C EF558580_NZ61 ... ..A ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ..C EF558581_Erfurt ... ... ... ..C ... ... AA. ... ..T ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... EF558582_Dachswald ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .GT ... G.. ... ... ... ... ... ... ..T ... ... ... ..T ... ... ... ... ... EF558583_Triptis ... ... ... ..C ... ..T AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... .G. ... G.. ... ... ... ... ... ... ..T ... ... ..G ..T ... ... ... ... ... EF558584_Rossi ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... G.. ... ... ... ... ... ... ..T ... ... ..G ... ... ... ... ... ... EF558585_Hagenow ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ..C ... ... ... ... .A. ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..T ... ... ... ... ..A EF558587_Ashington ... ..T TC. ... ..T GTG ... ... ... ..G ... ..G ... ..C ... ... ... ... ... A.C ..A ... ... ... .A. ... .CT ... ... ..G ... ..A ... ... ... ... ... ... ..C .AT G.. ... ..T ... ..C EU003578_IN-05 ... ... ... ..C ... ... AA. ... ..T ..A A.. ... C.. ... ... ... ... ... ... A.. ... ... ... ... .AC ... .G. ... G.. ... ... ..A ... ... ... ... ... ... ..G ..T ... ... ... ... ..A EU003579_Italy90 ... ... ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... .G. ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... EU003580_Korea90 ... ... ... ... ... ... A.. ... ... ..A ... ... ... ... ... ... ..T ... ... ... ... ... ... ... .A. ... .G. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EU003581_NY-01 ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ... ... ... ... ... ... .AC ... ... ... G.. ... ... ... ... ... ... ... ... ... ..G ..T ... ... ... ... ... EU003582_UT-01 ... ... ... ..C ... ... AA. ... ... ..A A.. ... C.. ... ... ... ... ... ..C A.. ... ... ... ... .A. ... .G. ... G.. ... ... ..A ... ... ... ... ... ... ..G ..T ... ... ... ... ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G CG. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... .G. ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... NC_001543_FRG ... ... ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... .G. ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... RHU49726_Haute-Saone/FR88 ... ... ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ..C ... ... ... ... ... .A. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... U54983_V351 ... ..A ..G ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... A.. ... ... ... ... .A. ... .G. ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... X87607_BS89 ... ... ... ... ... ... ... ... ... ..A ... ..G ... ... ... ... ..T ... ..C ... ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ..T ... ..T ... ... ..A X96868_RCV ..T ..T TC. ... ..T G.. AA. ... ... ..A ... ..G ... ..C ... ... ..G ..T ..C ..C ... ... ... ... .C. ... .GA ... ... ..G ... ..A ..T ... ..G ... ..G ... ..C .A. G.C ..A ..A ..G ..G Y15424_Frankfurt ... ... ... ... ... ... ... ... ... ..A ... ..G ... ... ... ... ... ... ... ..C ... ... ... ... .A. ... ... ... ... ... ... ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A Y15427_Wriezen ... ... ..G ... ... ... .G. ... ... ..A ... ..G ... ... ... ... ... ... ..C A.. ... ... ... ... .A. ... ..T ... ... ... ..T ..A ..T ... ... ... ... ... ... ... ... ... ... ... ..A Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ...
177
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 333 344 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 444 555 555 555 666 666 666 677 777 777 778 888 888 888 999 999 999 900 000 000 001 111 111 111 222 222 222 233 333 333 334 444 444 444 555 555 555 566 666 666 667 777 777 777 888 888 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 Z49271_RHDV-AST89 GCC GCT GCA CCT GTG GGT AAG AAC ACA CCC ATC ATG TTC GCG TCT GTC GTC AGG CGC ACC GGT GAC GTC AAC GCC ACA GCT GGG TCA GCT AAC GGG ACC CAG TAC GGC ACA GGC TCT CAA CCA CTG CCA GTA ACA AB300693_Hokkaido/2002/JPN ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AF231353_NZ ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... .TC ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... AF258618_Iowa2000 ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ..A ... ... A.C ... ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... AF295785_Mexico89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .T. ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... AF402614_WX/China/1984 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ..C ... ... ... ... ..G ... AF453761_China/Harbin/TP ..T ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AJ302016_99-05FR ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AJ302016_99-05FR(2) ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... AJ303106_00-ReuFR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... AJ319594_00-08FR ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... A.. ..T ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ495856_00-13FR ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... A.. ... ..C ..T ... ... ... ... ... ..C ... ... ... ... ..G ... AJ535092_95-05FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..T ..T ... ... ..T ... ..G ... ..C ... ... ... ... ..G ... AJ535094_95-10FR ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ..C .G. ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... AJ969628_03-24FR ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... A.C ... ... ... ..A ... ... ... ... ..C ... ... ... ... ... ... AM085133_05-01FR ... ... ... ... ... ..G ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ..C ..T ... ... ... ... ... ..C ... ... ... ... ..G ... AY269825_NJ/China/1985 ... ..C ... ... ... ... ... ... T.. ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... AY523410_CD/China ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... .T. G.. ... ... ... A.C .G. ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... AY926883_Ireland12 ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... A.. ... ..T ... ... ... ... ... ... ..C ... ..G ... ... ..G ... AY928268_Ireland18 ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... A.. ... ..C ... ... ... ... ... ... ... ... ... ... ... ..G ... AY928269_Ireland19 ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... A.. ... ..C ... ... ... ... ... ... ... ... ... ... ... ..G ... DQ069280_whn/China/01/2005 ... ..C ... ... ... ... ... ... ..G ... ... ... ... ... ... ..T ... .A. ... ..T ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... DQ069281_whn/China/02/2005 ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... ..C ... ... ... ... ... ... ..G ... ..C ..G ... ... ... ... ... DQ069282_whn/China/03/2005 ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ..G ... ..C ..G ... ... ... ... ... DQ189077_Bahrain ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ... ..T ... ... ... ... ... ... A.. ..T ..C ... ... ... ... ... ... ..C ..G ... ... ... ..G ... DQ189078_SaudiArabia ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... T.. ... ... ... ..C .G. ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... DQ205345_JX/CHA/97 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... DQ280493_ChinaWHNRH ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... ..C ... ... ... ... ... ... ..G ... ..C ..G ... ... ... ... ... DQ530363_China-Yangling(YL) ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... DQ841708_CUB5-04 ... ..C ... ... ... ... ... ... ... ..T ... ... ... ... C.. ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ..T ..G ... ..C ... ... ... ... ..G ... EF363035_clonepJG-RHDV-DD06 ... ... ... ... ... ... ..A ... ... ... ... ... ..T ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558572_Frankfurt12 ... ... ... ... ..A ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... .G. ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558573_Frankfurt5 ... ... ... ... ..A ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... .G. ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558574_Wika_Germany ... ... ... ... ..A ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... .G. ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558576_Jena_Germany ... ... ... ... ... ..A ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... T.. ... ... ... A.. ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558577_Meiningen_Germany ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558578_Eisenhuttenstadt ... A.C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..A ... .TC ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558580_NZ61 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ..A ... .TC ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558581_Erfurt ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... EF558582_Dachswald ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..T ... ... G.. ... ... ... A.C ... ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... EF558583_Triptis ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... EF558584_Rossi ... ..C ... ... ... ... ... ... ... ..T ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ... ... ..C ... ... ..A ... ... ... EF558585_Hagenow ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... .T. ... ..C ... ... ... ... ... ... ..C ... ... ... ... ..G ... EF558587_Ashington ... ..C ..C ... ... ..C .G. ..T GTG ... ... ... ... ... ..C ... ... ... ... ... ... ... A.. ... ..T G.G ... ... ... T.C ..T ... ..T ..A ..T ... ... ... ... ..G ... T.. ... ..G ... EU003578_IN-05 ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.C ... ... ... ... ... ... ..G ... ..C ..G ... ... ... ... ... EU003579_Italy90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... EU003580_Korea90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... .T. ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... EU003581_NY-01 ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ... ... G.. ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... EU003582_UT-01 ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... G.. ... ... ... A.. ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... NC_001543_FRG ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... RHU49726_Haute-Saone/FR88 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..C ... ... ... ... ..G ... U54983_V351 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..G ..C ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... X87607_BS89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... X96868_RCV ..T ... ..C ..A ... ..C ... ..T GTG ... ... ... ..T ..A ... ... ... ... ... ... ... ..T ... ... ... GAG ... ..A ..T .AC ..T ... ... ... ..T ..A ... ... ..C ..G ... ... ... ..G ... Y15424_Frankfurt ... ... ... ... ..A ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... .G. ..T ... ... ... ... ... ... ..C ... ... ... ... ..G ... Y15427_Wriezen ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ..C ... ... A.. ... ... TA. ... ... ... ... ... ..C ... ... ... ... ..G ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..A ... ... ... ... ... ... ... ... ... ... ... .G. ... ... ... ... ... ... ... ...
178
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 444 444 444 444 445 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 555 666 666 666 666 666 666 666 888 899 999 999 990 000 000 000 111 111 111 122 222 222 223 333 333 333 444 444 444 455 555 555 556 666 666 666 777 777 777 788 888 888 889 999 999 999 000 000 000 011 111 111 112 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 Z49271_RHDV-AST89 ATT GGA CTT TCG CTC AAC AAC TAC TCG TCA GCA CTT ATG CCC GGA CAG TTT TTC GTT TGG CAG TTA ACC TTT GCA TCT GGT TTC ATG GAG ATT GGT TTA AGT GTG GAC GGG TAT TTT TAT GCA GGA ACA GGA GCC AB300693_Hokkaido/2002/JPN ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF231353_NZ ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..G ... AF258618_Iowa2000 ... ... ... ... ..T ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... AF295785_Mexico89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF402614_WX/China/1984 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... AF453761_China/Harbin/TP ... ... ... ... ... ... ... C.. ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... AJ302016_99-05FR ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... AJ302016_99-05FR(2) ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... AJ303106_00-ReuFR ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... T.. AJ319594_00-08FR ... ... ..C ... ..T ... ... ... ... ... ... ..C ... ..T ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..C ... ... ..T ..G ... ... ... AJ495856_00-13FR ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ..T ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... AJ535092_95-05FR ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ..A ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..G ... AJ535094_95-10FR ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... AJ969628_03-24FR ... ... ..A ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... AM085133_05-01FR ... ..G ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ..C ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ..C ... ... ... ..G ... AY269825_NJ/China/1985 ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..C ... ... ... ... ... ... ... AY523410_CD/China ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..C ... ... ... ... ... ... ... AY926883_Ireland12 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..G ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... AY928268_Ireland18 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..G ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..G ... AY928269_Ireland19 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..G ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ..G ... DQ069280_whn/China/01/2005 ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... DQ069281_whn/China/02/2005 ... ... ... ... ... ... ... ... ... ... ... ..C G.. ..T ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ..G ... ... ... ... ..C ... ... ... ..G ... ... ... DQ069282_whn/China/03/2005 ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T ..G ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ..C ..C ..G ... ... ... ... ..C ... ... ... ..G ... ... ... DQ189077_Bahrain ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... DQ189078_SaudiArabia ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... DQ205345_JX/CHA/97 ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... DQ280493_ChinaWHNRH ... ... ... ... ... ... ... ... ... ... ... ..C G.. ..T ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ..G ... ... ... ... ..C ... ... ... ..G ... ... ... DQ530363_China-Yangling(YL) ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T ..G ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..C ... ... ... ... ... ... ... DQ841708_CUB5-04 ... ... ... ... ... ... ... ... ... ... ... ..C ..A ..T ..G ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..C ... ... ... ... ... ... ... EF363035_clonepJG-RHDV-DD06 ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... EF558572_Frankfurt12 ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... EF558573_Frankfurt5 ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... EF558574_Wika_Germany ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ..G ... EF558576_Jena_Germany ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..T EF558577_Meiningen_Germany ... ... ... ... ..A ... ... ... ... ... ... ... ... ..T ... ... ... ... ..A ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..A ..C ... ... ... ... ... ... ..C ..C ... ... ... ..G ... EF558580_NZ61 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ..A ..C ... ... ... ... ... ... ..C ..C ... ... ... ..G ... EF558581_Erfurt ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ..C ... ... ... ... ... ... ... EF558582_Dachswald ... ... ..C ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... EF558583_Triptis ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ..C ... ... ... ... ... ... ... EF558584_Rossi ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ..C ... ... ... ... ... ... ... EF558585_Hagenow ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... EF558587_Ashington ... ... ... ..A ... ... ... ... ..A ... ... ..C .C. ..T ..G ..A ... ... ... ... ... ..G ... ... A.C ... ..C ... ... ... ... ... ..G ..C ..T ..T ... ... ..C ... ... ... ... ..T ... EU003578_IN-05 ... ... ... ... ... ... ... ... ... ... ... ..C ... ..T ..G ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ..G ... ... ... ... ..C ... ... ... ... ... ... ... EU003579_Italy90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ..A ..C C.. ... ... ... ... ... ... ... ... ... ... ..G ... EU003580_Korea90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..G ... EU003581_NY-01 ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EU003582_UT-01 ... ... ... ... ... ... ..T ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..G ... NC_001543_FRG ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..G ... RHU49726_Haute-Saone/FR88 ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ..C ..C ... ... ... ... ..G ... U54983_V351 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..G ... X87607_BS89 ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... X96868_RCV ... ..T ..G ... ... ... ... ... ..A ... ... ..C .CA ... ..G ... ... ... ... ... ... ... .AT ... ..C ... ..C ... ... ... ... ..G ..G .A. ..T ..T ... ... ... ... ... ..G ... ... ..T Y15424_Frankfurt ... ... ... ... ... ... ... ... ... ... T.. ... ... ... ... ... ... ... ..A ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... Y15427_Wriezen ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ...
179
111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 111 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 666 677 777 777 777 777 777 777 777 777 777 777 777 777 777 222 222 222 333 333 333 344 444 444 445 555 555 555 666 666 666 677 777 777 778 888 888 888 999 999 999 900 000 000 001 111 111 111 222 222 222 233 333 333 334 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 123 456 789 012 345 678 901 234 567 890 Z49271_RHDV-AST89 TCA ACC ACA CTC ATT GAC TTG ACT GAA CTC ATT GAC GTA CGC CCT GTG GGA CCC AGG CCA TCC AAG AGC ACA CTC GTG TTC AAC CTG GGG GGC ACA GCC AAT GGC TTT TCT TAT GTC TGA AB300693_Hokkaido/2002/JPN ... ... ..G ... ... ... C.. ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. A.T ... ... ... ... ... ... ... AF231353_NZ ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF258618_Iowa2000 ... ... ..G ..T ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... AF295785_Mexico89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ..T ..A ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF402614_WX/China/1984 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AF453761_China/Harbin/TP ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... AJ302016_99-05FR ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... AJ302016_99-05FR(2) ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... AJ303106_00-ReuFR ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ319594_00-08FR ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ... ... AJ495856_00-13FR ... ... ... ..T ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... G.. ... ... ..T ... ... ... ... ... AJ535092_95-05FR ... ... ..G ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ... AJ535094_95-10FR .T. ..T ... ... ... ... ... ... ... ... ... ..T ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AJ969628_03-24FR ... ... ..G ... ... ... ... ..C ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ..T ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... AM085133_05-01FR ... ... ... ..T ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ..T ..A ... ... ... .C. ... ... ... ... ... G.. ... ... ... ... ... ... ... ... AY269825_NJ/China/1985 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... AY523410_CD/China ... ..T ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... G.. A.. ... ... ... ... ... ... ... AY926883_Ireland12 ... ... ... ... ... ... ... ... ... ..G ... ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ... ... ..T ... ... ... ... G.. ... ... ... ..C ... ... ... ... AY928268_Ireland18 ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... G.. ... ... ... ..C ... ... ... ... AY928269_Ireland19 ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... G.. ... ... ... ... ... ... ... ... DQ069280_whn/China/01/2005 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ..G ... ... ... ... ... ... ... ... ... ..T ... ... ... ... G.. A.. ... ... ... ... ... ... ... DQ069281_whn/China/02/2005 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... DQ069282_whn/China/03/2005 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... DQ189077_Bahrain ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... DQ189078_SaudiArabia ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..A ... ... ..T ..A ... ... ... ... ... G.. ... ... ... ... ... ... ... ... DQ205345_JX/CHA/97 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... DQ280493_ChinaWHNRH ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... C.. ... ... ... ... DQ530363_China-Yangling(YL) ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... DQ841708_CUB5-04 ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... EF363035_clonepJG-RHDV-DD06 ... ... ... ... ... ... ... ... ... ... ..C ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... G.. ... ... ... ..C ... ... ... ... EF558572_Frankfurt12 .T. ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558573_Frankfurt5 .T. ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558574_Wika_Germany .T. ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558575_Ascot_UK ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558576_Jena_Germany ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558577_Meiningen_Germany ... ... ... ... ... ... ... ... ... ..T ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... .G. ... ... ... ... A.. ... ... ... ... ... ... ... EF558578_Eisenhuttenstadt ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558579_NZ54 ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558580_NZ61 ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558581_Erfurt ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... EF558582_Dachswald ... ... ..G ... ..C ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558583_Triptis ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558584_Rossi ... ... ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EF558585_Hagenow ... ... ... ... ... ... ... .TC ... ... ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... EF558587_Ashington ... ... ..C ..T ... ... ... ..C ... ... ... ... A.. ... ... ... ... ... ... ... ... .CA ... ... ... ... ..T ..- --- --- --- --- --- --- --- --- --- --- --- --- EU003578_IN-05 ... ..T ..G ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... EU003579_Italy90 ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ..C ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EU003580_Korea90 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... EU003581_NY-01 ... ... ..G ... ... ... C.. ... ... ... ... ... ..G ... ..C ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... EU003582_UT-01 ... ... ..G ... ... ... ... ..A ... ... ... ... ... ... ..C ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... L48547_MC-89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..C ... ... ... ... ... ... ... ... ... ... ... M67473_FRG ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... NC_001543_FRG ... ... ... ... ... ... C.. ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... RHU49726_Haute-Saone/FR88 ..T ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... U54983_V351 ... ... ... ... ... ... C.. ... ... ..T ... ... ... ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... X87607_BS89 ... ... ... ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... X96868_RCV ..G ... ..C ..T ..C ... ... ... ... ... ... ... A.. ... ... ... ... ... ... ... ... .C. ... ..T ..T ... ... ... ... ... ... G.. A.. .G. ... ... ... ... ... ... Y15424_Frankfurt .T. ... ..T ... ... ... ... ... ... ... ... ... ..T ... ... ... ... ... ... ..G ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Y15427_Wriezen ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ... ... ... A.. G.. ... ... ... ... ... ... ... ... Z24757_AST/89 ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... Z29514_SD ... ... ... ... ... ... ... .T. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... PRIMER-PROBE “VP60” AC YTG ACT GAA CTY ATT GAC G FAM-CC AAR AGC ACR CTC GTG TTC AAC C T-TAMRA CC AAT GGC TTT TCT TAT GTC TGA
180
181
Appendix 4 Publications
182
183
184
185
186
187
188
189
190
191
192
193
194